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Summary 
Appropriate cell-cell signaling is critical for proper tissue homeostasis. Protein 
sorting of cell surface receptors at the early endosome is important for both the 
delivery of the signal and the inactivation of the receptor, and its alteration can cause 
malignancies including cancer. In a genetic screen for suppressors of the pro-
apoptotic gene hid in Drosophila, we identified two alleles of vps25, a component of 
the ESCRT machinery required for protein sorting at the early endosome. 
Paradoxically, although vps25 mosaics were identified as suppressors of hid-induced 
apoptosis, vps25 mutant cells die. However, we provide evidence that non-
autonomous increase of Diap1 protein levels, an inhibitor of apoptosis, accounts for 
suppression of hid. Furthermore, before they die, vps25 mutant clones trigger non-
autonomous proliferation through a failure to down-regulate Notch signaling which 
activates the mitogenic JAK/STAT pathway. The apoptotic phenotype of vps25 
mutant tissue is the result of autonomous activation of at least two cell death 
pathways. Both Hid and JNK contribute to apoptosis of vps25 mutant cells. Inhibition 
of cell death in vps25 clones causes dramatic overgrowth phenotypes. In addition, 
Hippo signaling is increased in vps25 clones, and hippo mutants completely block 
apoptosis in vps25 clones. 
 
Furthermore, we genetically analyze the remaining ESCRT-II components 
vps22 and vps36. Like vps25, mutants in vps22 and vps36 display endosomal defects 
causing increased Notch and JAK/STAT signaling and autonomous cell death. 
However, while vps22 mutants cause strong non-autonomous overgrowth, they do not 
affect non-autonomous apoptotic resistance. vps36 mutants display the reciprocal 
phenotype and increase the apoptotic resistance, but have little effect on non-
autonomous proliferation. Therefore, despite their intimate physical relationship, the 
ESCRT-II components vps22, vps25 and vps36 display distinct genetic properties. In 
summary, the phenotypic analysis of vps22, vps25 and vps36 mutants highlights the 
importance of receptor down-regulation by endosomal protein sorting for appropriate 
tissue homeostasis, and may serve as a model for a better understanding of the 
mechanisms causing tumorigenesis in humans. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Zusammenfassung 
Die Aufrechterhaltung der Integrität für die Signalübertragung zwischen 
Zellen ist eine notwendige Voraussetzung für die Homöostase im Organismus. Die 
Sortierung von Proteinen als Rezeptoren am frühen Endosom spielt dabei eine 
wichtige Rolle sowohl für die Übertragung des Signals als auch die Inaktivierung des 
Rezeptors. Regulatorische Veränderungen in diesem Prozess können unter anderem 
zur Entstehung von Krankheiten wie unter anderem auch der Krebsentwicklung 
beitragen. 
 
In einem genetischen Screen für Suppressoren des proapoptotischen Gens hid 
in Drosophila haben wir zwei Allele von vps25 identifiziert. Vps25 ist eine 
Komponente der ESCRT Maschinerie, die für die Sortierung von Proteinen am frühen 
Endosom benötigt wird. Paradoxerweise wurden vps25 Mosaike als Suppressoren von 
hid-induzierter Apoptose identifiziert obwohl Zellen, die mutant für vps25 sind, 
sterben. Wir zeigen jedoch, daß die nichtautonome Erhöhung von Diap1 Protein, 
einem Apoptoseinhibitor, für die Suppression von hid verantwortlich ist. 
Darüberhinaus lösen Klone die mutant fuer vps25 sind nichtautonome Proliferation 
durch eine Störung im Abbau des Notch Rezeptors aus, dessen ektopische 
Aktivierung zur Stimulation des mitogenen JAK/STAT Signalweges führt. Der 
apoptotische Phänotyp von mutantem vps25 Gewebe ist das Resultat autonomer 
Aktivierung von mindestens zwei Zelltod Signalwegen. Sowohl Hid als auch JNK 
tragen zur Apoptose von vps25 mutanten Zellen bei. Eine Inhibition von Zelltod in 
vps25 Klonen verursacht starke Überwachstumsphänotypen. Desweiteren ist die 
Signalübertragung durch den Hippo Signalweg in vps25 Klonen erhöht und hippo 
Mutanten blockieren Apoptose vollständig in vps25 Klonen. 
 Wir führen auch eine Analyse der anderen ESCRT-II Komponenten vps22 und 
vps36 durch. Wie im Fall von vps25 zeichnen sich vps22 und vps36 Mutanten durch 
endosomale Defekte aus, die in erhöhter Notch und JAK/STAT Signalübertragung 
und automomem Zelltod resultieren. Überraschenderweise haben vps22 Mutanten 
keine Auswirkung auf nichtautonome apoptotische Resistenz, verursachen aber 
starkes nichtautonomes Überwachstum. vps36 Mutanten weisen hingegen einen 
reziproken Phänotyp auf, der sich durch eine Erhöhung der apoptotischen Resistenz 
auszeichnet, aber kaum nichtautonome Proliferation beeinflusst. Obwohl also vps22, 
vps25 und vps36 eine innige physikalische Verwandtschaft als ESCRT-II 
Komponenten teilen, haben sie verschiedenartige genetische Eigenschaften. 
 
 Zusammenfassend lässt sich sagen, dass die phänotypische Analyse von 
vps22, vps25 und vps36 Mutanten die Notwendigkeit der Regulation von Rezeptoren 
durch Sortierung von Proteinen am frühen Endosom hervorhebt, um eine adaequate 
Gewebshomöostase zu gewährleisten und ein Modell zu einem besseren Verständnis 
der Mechanismen bereitstellt, die zur Krebsentstehung im Menschen beitragen. 
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2 Summary 
Appropriate cell-cell signaling is critical for proper tissue homeostasis. Protein 
sorting of cell surface receptors at the early endosome is important for both the 
delivery of the signal and the inactivation of the receptor, and its alteration can cause 
malignancies including cancer. In a genetic screen for suppressors of the pro-
apoptotic gene hid in Drosophila, we identified two alleles of vps25, a component of 
the ESCRT machinery required for protein sorting at the early endosome. 
Paradoxically, although vps25 mosaics were identified as suppressors of hid-induced 
apoptosis, vps25 mutant cells die. However, we provide evidence that non-
autonomous increase of Diap1 protein levels, an inhibitor of apoptosis, accounts for 
suppression of hid. Furthermore, before they die, vps25 mutant clones trigger non-
autonomous proliferation through a failure to down-regulate Notch signaling which 
activates the mitogenic JAK/STAT pathway. The apoptotic phenotype of vps25 
mutant tissue is the result of autonomous activation of at least two cell death 
pathways. Both Hid and JNK contribute to apoptosis of vps25 mutant cells. Inhibition 
of cell death in vps25 clones causes dramatic overgrowth phenotypes. In addition, 
Hippo signaling is increased in vps25 clones, and hippo mutants completely block 
apoptosis in vps25 clones. 
 
Furthermore, we genetically analyze the remaining ESCRT-II components vps22 
and vps36. Like vps25, mutants in vps22 and vps36 display endosomal defects causing 
increased Notch and JAK/STAT signaling and autonomous cell death. However, 
while vps22 mutants cause strong non-autonomous overgrowth, they do not affect 
non-autonomous apoptotic resistance. vps36 mutants display the reciprocal phenotype 
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and increase the apoptotic resistance, but have little effect on non-autonomous 
proliferation. Therefore, despite their intimate physical relationship, the ESCRT-II 
components vps22, vps25 and vps36 display distinct genetic properties. In summary, 
the phenotypic analysis of vps22, vps25 and vps36 mutants highlights the importance 
of receptor down-regulation by endosomal protein sorting for appropriate tissue 
homeostasis, and may serve as a model for a better understanding of the mechanisms 
causing tumorigenesis in humans. 
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3 Introduction 
Regulation of tissue homeostasis involves the concerted action of several 
signaling pathways. An imbalance in this fine-tuned signaling network leads to 
overgrowth or apoptosis, and patterning defects in developing organisms. Hence, it is 
of exorbitant importance for the cell to hold excessive signaling in check for proper 
regulation of tissue homeostasis. 
 
3.1 The significance of endosomal trafficking 
Appropriate cell/cell signaling requires both coordinated activation and 
inactivation of cell surface signaling receptors. Usually, the receptors are bound by 
their respective ligands on the cell surface upon which they induce an intra-cellular 
response. An intrinsic part of this response is the recruitment of specific ubiquitin 
ligases that trigger ubiquitinylation of the receptor’s cytoplasmic domain, usually 
mono-ubiquitinylation, which provides the signal for receptor internalization by 
endocytosis (reviewed in Hicke and Dunn, 2003; Haglund and Dikic, 2005; Hicke et 
al., 2005; Duncan et al., 2006; Huang et al., 2006). Endocytosis is regulated by 
Dynamin (shibire in Drosophila) which facilitates the formation of endocytic vesicles 
(reviewed in Hinshaw, 2000). Subsequently, the ubiquitinylated cargo is transported 
via these vesicles to an endosomal compartment and there undergoes Rab5-mediated 
fusion with the early endosome (Gorvel et al., 1991; Bucci et al., 1992). Recently, 
evidence has been accumulating that ascribes the early endosome a major function in 
regulating receptor sorting and signaling. The early endosome seems to form a hub for 
controlling the steady-state levels of cell surface receptors as well as their activation 
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by several mechanisms. First, the receptors may be recycled back to the cell surface 
which applies mostly to unliganded receptors. Second, the environment at the early 
endosome appears to be required for several signaling molecules as it brings the 
receptor/ligand complex in close proximity to intracellular signaling components and 
is thus required for regulation of receptor activation (Seto and Bellen, 2006) 
(reviewed in Gonzalez-Gaitan, 2003; Seto and Bellen, 2004; Le Roy and Wrana, 
2005b). Third, it is also needed to turn off signaling (Urbanowski and Piper, 2001). 
This is achieved by the assembly of ubiquitinylated protein cargo into vesicles that 
pinch off from the limiting membrane of the early endosome into the lumen of 
emerging multi-vesicular bodies (MVB) (Felder et al., 1990; Odorizzi et al., 1998) 
(reviewed in Katzmann et al., 2002; Raiborg et al., 2003; Gruenberg and Stenmark, 
2004; Babst, 2005; Hurley and Emr, 2006; Slagsvold et al., 2006; Saksena et al., 
2007; Williams and Urbe, 2007; Hurley, 2008; Tanaka et al., 2008). In the process, 
MVBs mature to become late endosomes by fusing with vesicles that are derived from 
the trans-Golgi network (TGN) and contain the precursors of lysosomal enzymes. 
These hydrolases themselves are enzymatically tagged with mannose-6-phosphate in 
the cis-Golgi network and subsequently bind to mannose-6-phosphate receptors in the 
trans-Golgi network. The binding of the tagged hydrolases is released upon fusion of 
the trans-Golgi derived vesicles with the MVB due to a decreased luminal pH in the 
late endosome which is the result of acquisition of proton pumps (Nishi and Forgac, 
2002). This allows for a recycling of the mannose-6-phosphate receptors back to the 
Golgi to be reused for additional transport cycles to the MVB. The dissociated 
hydrolases of the late endosome continue onward to the lysosome where they perform 
the degradation of internalized proteins (Luzio et al., 2007). 
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3.2 The ESCRT machinery is involved in receptor turnover at 
the early endosome 
The sorting process of ubiquitinylated proteins at the early endosome into 
MVBs is highly regulated and requires class E Vps (Vacuolar Protein Sorting) 
proteins, first identified in Saccharomyces cerevisiae (Raymond et al., 1992). So far, 
fifteen class E Vps proteins have been described to participate in the formation of four 
ESCRT (Endosomal Sorting Complex Required for Transport) complexes: ESCRT-0, 
-I, -II and -III (reviewed in Katzmann et al., 2002; Gruenberg and Stenmark, 2004; 
Babst, 2005; Hurley and Emr, 2006; Slagsvold et al., 2006; Saksena et al., 2007; 
Williams and Urbe, 2007; Hurley, 2008; Tanaka et al., 2008). Besides many 
accessory proteins they are the major constituents in sorting the ubiquitinylated 
receptors into MVBs. 
 
3.3 Function of ESCRT complexes on the early endosome 
ESCRT-0, ESCRT-I and ESCRT-II bind ubiquitinylated receptors on early 
endosomes. According to the current model ESCRT-0 initiates the recruitment of the 
receptors and subsequently passes them on to the other ESCRT complexes in their 
numerical order. ESCRT-III catalyzes the internalization of the ubiquitinylated cargo 
into MVBs (reviewed in Babst, 2005; Hurley and Emr, 2006; Slagsvold et al., 2006; 
Saksena et al., 2007; Williams and Urbe, 2007; Hurley, 2008). This process separates 
the intracellular domain of activated signaling receptors from the cytosolic 
environment and thus, inactivates them. 
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3.3.1 Subunits of ESCRT complexes 
ESCRT-0 is constituted by Vps27 (Hrs in metazoans) and Hse1 (STAM in 
metazoans) (Lohi and Lehto, 2001; Bilodeau et al., 2002). Vps23 (Tsg101 in 
metazoans), Vps28, Vps37 and Mvb12 form the 104 kD heterotetramer ESCRT-I 
(Katzmann et al., 2001; Kostelansky et al., 2007). ESCRT-II (Babst et al., 2002b) 
consists of the three subunits Vps22, Vps25 and Vps36. Vps2, Vps20, Vps24, Vps32 
(synonymous: Snf7), Vps60 and Did2 associate to form the largest complex, ESCRT-
III (Amerik et al., 2000; Howard et al., 2001; Kranz et al., 2001; Babst et al., 2002a; 
Nickerson et al., 2006). 
 
3.3.1.1 ESCRT-0 
Due to the current model the process of receptor internalization at the early 
endosome is initialized by the recruitment of GGA (Golgi-associated, γ-adaptin 
homologs, Arf-binding) proteins (Bonifacino and Traub, 2003; Bonifacino, 2004) and 
ESCRT-0 to the early endosomal membrane. The structures of the N-terminal VHS 
(Vps27, Hrs and STAM) and FYVE (Fab1, YOTB, Vac1 and EEA1) domains of 
Vps27 have been resolved to atomic scale (Mao et al., 2000). VHS domains are 
commonly found with proteins that are involved in intracellular trafficking. Vps27 
binds to the endosome through the interaction of its FYVE domain with 
phospatidylinositol-3-phosphate (PtdIns3P) (Burd and Emr, 1998; Misra and Hurley, 
1999; Raiborg et al., 2001b) which is highly enriched on early endosomal membranes. 
Vps27 and Hse1 form a heterodimer through their intertwined GAT domains (Prag et 
al., 2007) and both interact with ubiquitinylated receptors through their UIM 
(ubiquitin interaction motif) domains, respectively (Bilodeau et al., 2002; Raiborg et 
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al., 2002; Shih et al., 2002; Raiborg et al., 2003). Both, Vps27 with its C-terminus and 
Hse1 interact with Clathrin resulting in a flat Clathrin coat on the early endosome (ter 
Haar et al., 2000; Raiborg et al., 2001a; Raiborg et al., 2002; Sachse et al., 2002). This 
Clathrin coat is thought to act as an organizer or condensation point for 
ubiquitinylated cargo to allow for the proper initialization of subsequent ESCRT 
complex recruitment. 
 
3.3.1.2 ESCRT-I 
Vps27 then binds to the ESCRT-I complex through its interaction with the 
ESCRT-I subunit Vps23 (Bache et al., 2003a; Bilodeau et al., 2003; Katzmann et al., 
2003; Lu et al., 2003). Involved in this interaction is a short amino acid motif of 
Vps27 (P(S/T)XP) and the UEV (ubiquitin E2 variant) domain of Vps23 (Pornillos et 
al., 2002a; Pornillos et al., 2002b; Pornillos et al., 2003) that also recognizes 
ubiquitinylated cargo . The ESCRT-I core has been crystallized and forms a fan-like 
structure with Vps23 in the middle and Vps37 and Vps28 on its sides (Kostelansky et 
al., 2006; Teo et al., 2006). A newly discovered ESCRT-I member Mvb12 seems to 
help stabilizing the complex and allows ESCRT-I oligomer formation, thus 
contributing to a higher efficiency of cargo sorting (Chu et al., 2006; Curtiss et al., 
2007; Gill et al., 2007; Kostelansky et al., 2007; Oestreich et al., 2007). 
 
3.3.1.3 ESCRT-II 
In yeast ESCRT-I is directly connected to ESCRT-II by the association of the 
C-terminus of Vps28 (ESCRT-I) with a zinc finger-like domain (NZF1) of Vp36 
(ESCRT-II) (Teo et al., 2006; Gill et al., 2007), which is not conserved in mammals. 
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Therefore, no direct link between ESCRT-I and ESCRT-II has been established in 
mammalian systems, yet. It should also be noted that ESCRT-I and –II in the yeast 
cytosol seem to co-exist as separate complexes suggesting the prerequisite of 
endosomal recruitment for their physical association (Katzmann et al., 2001; Babst et 
al., 2002b). Human Vps36 is also required for the binding of ESCRT-II to 
ubiquitinylated receptors and PtdIns3P by means of its N-terminal GLUE (Gram-like 
ubiquitin-binding in EAP45) domain in mammals. The binding of the GLUE domain 
to PtdIns3P is conserved in yeast as well. However, in yeast the association with 
ubiquitin is mediated by the NZF1 domain (Alam et al., 2004; Slagsvold et al., 2005; 
Alam et al., 2006; Hirano et al., 2006; Teo et al., 2006). Nonetheless, a general 
conservation of ESCRT-II in its ability to bind ubiquitinylated cargo and PtdIns3P can 
be observed. The core of the ESCRT-II complex has the shape of a Y and is a 
heterotetramer with one copy each of Vps36 and Vps22 and two copies of Vps25. The 
arms of the Y are formed by one of the Vps25 subunits and the stalk by Vps36 and 
Vps22. Each of the ESCRT-II subunits contains two tandem repeats of a winged helix 
domain that are involved in the protein interactions of the respective subunits (Hierro 
et al., 2004; Teo et al., 2004; Wernimont and Weissenhorn, 2004). 
 
3.3.1.4 ESCRT-III 
ESCRT-II is associated with ESCRT-III through the cooperative interaction of 
the C-terminus of Vps25 with Vps20, a myristoylated subunit of ESCRT-III (Hierro 
et al., 2004; Teo et al., 2004; Yorikawa et al., 2005). Vps20 with Vps32 and Vps2 and 
Vps24 are thought to form two subcomplexes (Babst et al., 2002a). Much of what is 
known about the structure of ESCRT-III is derived from crystallization studies on 
Vps24 (Muziol et al., 2006). Generally, all ESCRT-III-like proteins can be subdivided 
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in a basic N-terminal core with four α-helices (α1-α4) and an acidic C-terminal auto-
inhibitory region that contains α-helix 5 and a MIR (MIT-interacting region) domain 
which prevents hetero- and homo-dimerization of individual ESCRT-III subunits by 
interacting with their respective core. It is inferred from the resolved structure of 
Vps24 that upon activation the release from the auto-inhibitory interaction of the MIR 
domain on the core of ESCRT-III components results in the formation of a flat lattice-
like array of dimericing subunits along the endosomal membrane (von Schwedler et 
al., 2003; Tsang et al., 2006; Zamborlini et al., 2006). Upon release from its binding 
to the basic core the MIR domain is now free to recruit MIT-domain containing 
proteins such as deubiquitinylases (DUBs: Doa4 in yeast, AMSH and UBPY in 
mammals) (McCullough et al., 2004; Agromayor and Martin-Serrano, 2006; 
McCullough et al., 2006; Kyuuma et al., 2007; Ma et al., 2007; Row et al., 2007) or 
the AAA+ ATPase Vps4 (Babst et al., 1997; Babst et al., 1998; Scott et al., 2005b). 
These DUBs catalyze the removal of ubiquitin moieties from cargo proteins at the 
formation of the MVB (Luhtala and Odorizzi, 2004). This allows ubiquitin to be 
reused in other cellular contexts without undergoing proteolysis in the lysosome. 
Another vps protein Bro1 (ALIX in mammals) (Odorizzi et al., 2003) also seems to be 
involved in the activation of these DUBs (Richter et al., 2007) by forming a linker 
that binds to ESCRT-III (Luhtala and Odorizzi, 2004), but also interacts with ESCRT-
I and Vps4 (Martin-Serrano et al., 2003a; von Schwedler et al., 2003; Bowers et al., 
2004; Nikko and Andre, 2007). 
 
3.3.2 Disassembly of ESCRT complexes 
Vps4 with another protein Vta1 forms a complex that is involved in the 
disassembly of the ESCRT-III lattice from the endosomal membrane (Azmi et al., 
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2006; Lottridge et al., 2006; Haas et al., 2007; Vajjhala et al., 2007; Azmi et al., 
2008). Vta1 stimulates the ATPase activity of Vps4 by promoting the assembly of a 
double hexameric Vps4 ring. Furthermore, the binding of the ESCRT-III subunits 
Did2 and Vps2 to Vps4 suggest a cooperative regulation of Vps4 activity (Obita et al., 
2007; Stuchell-Brereton et al., 2007). Based on structural and mechanistic studies of 
Vps4 the current model favors the idea that the Vps4 is involved in the disassembly of 
the ESCRT-III complex by pumping ESCRT-III monomers through the pore of its 
hexameric ring (Scott et al., 2005a). 
 
3.3.3 Models of ESCRT function 
Until recently the mode of action of individual ESCRT complexes at the early 
endosome was considered to be sequential. From the first step of recognition of 
ubiquitinylated cargo by ESCRT-0 a “conveyor belt” model was suggested in which 
the ubiquitinylated cargo would be passed on from complex to complex to be finally 
fed into the forming vesicles of the MVB (reviewed in Hurley and Emr, 2006). 
However, an explosion of data over the last few years now seems to paint a picture in 
which some of the obtained information is apparently hard to reconcile with a 
classical conveyor belt mechanism. It seems to become more and more apparent that a 
network of interactions between subunits of different ESCRT complexes and ESCRT-
related proteins exists. Among others, this could be shown by different yeast two-
hybrid analyses (Martin-Serrano et al., 2003a; von Schwedler et al., 2003; Bowers et 
al., 2004; Tsang et al., 2006) and it was already mentioned before that Bro1 forms a 
connection between ESCRT-I and –III (Luhtala and Odorizzi, 2004). Therefore, 
another model has recently gained attraction in which ESCRT-0, -I and –II would co-
assemble to cluster multiple ubiquitinylated receptors together. The assembly of 
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ESCRT-III at the perimeter of this ESCRT-0/I/II supercomplex would recruit the 
disassembly machinery (Bro1, Doa4 and Vps4) and after dissociation of the 
supercomplex catalyze the removal of ubiquitin from receptors and disassemble 
ESCRT-III from the endosomal membrane resulting in scission of the intraluminal 
vesicles of the MVB (Kostelansky et al., 2007; Nickerson et al., 2007). 
 
3.4 vps mutant phenotypes 
As crucial regulators of receptor turnover at the early endosome it is easy to 
imagine that interfering with the process of intraluminal vesicle formation by 
abolishing the function of individual members of the ESCRT machinery one might 
expect profound effects on the cell’s ability to keep excessive signaling in check. 
Mutants of ESCRT genes have been first described by their characteristic mutant 
phenotype in yeast. Interference with their function in MVB formation on the early 
endosome results in aberrantly shaped class E compartments (Raymond et al., 1992). 
Class E compartments represent malformed endosomal structures which are located 
adjacent to the yeast vacuole and accumulate ubiquitinylated cargo on their limiting 
membrane (reviewed in Katzmann et al., 2002). Mutations in genes with this 
phenotype consequently were termed vacuolar protein sorting (vps) implying their 
important function in regulating MVB formation. Compared to their spherical wild-
type counterparts MVBs in vps mutants consist of cisternae-like structures that form 
unconnected sheets of membrane which lie on top of each other (Nickerson et al., 
2006). Biochemical studies in mammalian cell lines have revealed a similar function 
for endosomal protein sorting (Scheuring et al., 1999; Babst et al., 2000; Bishop and 
Woodman, 2000; Yoshimori et al., 2000; Howard et al., 2001; Scheuring et al., 2001; 
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Bache et al., 2003a; Bache et al., 2003b; Fujita et al., 2003; Bache et al., 2004; Peck et 
al., 2004). In Drosophila, among class E vps genes only mutations in hrs have been 
reported (Lloyd et al., 2002; Jekely and Rorth, 2003). Loss of hrs leads to 
accumulation of the epidermal growth factor receptor (EGFR), PVR (PDGF/VEGF 
receptor), Notch, Patched, Smoothened, and Thickveins on enlarged early endosomes 
consistent with a conserved role of hrs for endosomal protein sorting. 
 
3.5 Endosomal regulation of Notch signaling activity 
The regulation of Notch (N) activation through endocytosis has lately become 
the focus of several studies (reviewed in Le Borgne and Schweisguth, 2003a; Le 
Borgne et al., 2005; Le Borgne, 2006). The principle of signal transduction in the N 
pathway appears to be relatively simple on the first sight. N, as a transmembrane 
receptor is regulated by its ligands Delta (Dl) and Serrate (Ser) in Drosophila (Fehon 
et al., 1990). Upon ligand binding the N receptor undergoes two proteolytic cleavages. 
The first cleavage (S2 cleavage) occurs in the extracellular space and is catalyzed by 
the ADAM/TACE/Kuzbanian-family of metalloproteases (Qi et al., 1999; Brou et al., 
2000; Mumm et al., 2000). The second cleavage (S3 cleavage) is mediated by γ-
secretase, a protein complex that contains the subunits Presenilin, Nicastrin, PEN2 
and APH1 (Kopan et al., 1996; Schroeter et al., 1998; De Strooper et al., 1999; Struhl 
and Greenwald, 1999; Wolfe et al., 1999; Ye et al., 1999) (reviewed in Mumm and 
Kopan, 2000; Fortini, 2002; Selkoe and Kopan, 2003) which releases the intracellular 
domain of N for translocation into the nucleus. Once there, the intracellular domain of 
N forms a complex with the DNA-binding protein Suppressor of Hairless (Su(H)) 
(Fortini and Artavanis-Tsakonas, 1994; Tamura et al., 1995), the co-factor 
Mastermind (Mam) (Petcherski and Kimble, 2000; Wu et al., 2000; Zhou et al., 2000) 
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and additional other co-factors and replaces certain co-repressors to activate 
transcription of various N target genes (reviewed in Schweisguth, 2004; Bray, 2006; 
Fiuza and Arias, 2007) among which are Enhancer of Split (E(spl)) (Jennings et al., 
1994; Bailey and Posakony, 1995) and cut (de Celis et al., 1996; Micchelli et al., 
1997). 
 
Despite the simplicity of this pathway the roles that the N pathway plays in 
development are very diverse and in many cases just poorly understood. This is 
largely due to the fact that the N pathway is controlled at many levels which allows 
for its great diversity in regulation. Therefore, it is not surprising that N signaling has 
been described to be involved in a multitude of developmental decisions. The N 
pathway mainly operates by regulating cell fate decisions, cell proliferation and cell 
death. However, the misregulation of these processes is the cause for the development 
of various cancers. The oncogenic potential of N was first described in studies on T-
cell acute lymphoblastic leukemias (Reynolds et al., 1987; Ellisen et al., 1991; Weng 
et al., 2004), but later also for epithelial tumors (Gallahan and Callahan, 1987; 
Uyttendaele et al., 1996) such as human breast cancers (Weijzen et al., 2002) and 
other cancers (reviewed in Allenspach et al., 2002; Radtke and Raj, 2003; Grabher et 
al., 2006; Miele et al., 2006). 
 
More recently as mentioned above there has been accumulating evidence that 
endocytosis plays a prominent role in the regulation of Notch signaling (reviewed in 
Le Borgne and Schweisguth, 2003a; Le Borgne et al., 2005; Le Borgne, 2006). The 
first report opening a link to the control of N signaling through endocytosis was 
described by the analysis of temperature-sensitive shibire mutants which encode the 
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Drosophila homolog of Dynamin, a GTPase that is required to catalyze the pinching 
off of vesicles from the plasma membrane (Poodry, 1990; Chen et al., 1991; van der 
Bliek and Meyerowitz, 1991). Shibire has been shown to be required in both signal 
sending and receiving cells in Dl-dependent N signaling (Seugnet et al., 1997). The 
presence of Dl and Ser in intracellular vesicles which are absent in shibire mutants 
(Kramer and Phistry, 1996) and their uptake into living cells (Le Borgne and 
Schweisguth, 2003b) further supported the involvement of the endocytic machinery. 
Mutations in liquid facets (lqf, homolog of epsin), an ubiquitin binding protein, 
neuralized and mindbomb have been demonstrated to interfere with Dl (for mindbomb 
also Ser) internalization and signaling. epsin mutants result in the accumulation of Dl 
at the cell surface because of reduced levels of endocytosis (Overstreet et al., 2004; 
Tian et al., 2004; Wang and Struhl, 2004). Neuralized (Deblandre et al., 2001; Lai et 
al., 2001; Pavlopoulos et al., 2001; Yeh et al., 2001) and Mindbomb (Itoh et al., 2003; 
Lai et al., 2005) are E3 ubiquitin ligases that bind and ubiqutinylate Dl (Ser) and thus 
promote its endocytosis. Consistent with their role in regulating Dl all three have been 
shown to control N signaling non-autonomously (Pavlopoulos et al., 2001; Itoh et al., 
2003; Le Borgne and Schweisguth, 2003b). Besides the requirement of endocytosis 
for N ligands recent data also suggests that endocytosis precedes S3 cleavage of S2 
cleaved N and that endocytois as well as S3 cleavage of N are regulated by its mono-
ubiquitinylation on the intracellular domain (Gupta-Rossi et al., 2004). However, 
controversial data exist on this issue (Struhl and Adachi, 2000). Therefore, as of now, 
no conclusive inferences can be drawn as to whether the S3 cleavage of N occurs at 
the plasma membrane or after endocytosis in an endocytic compartment. One reason 
to explain the difference in these apparently contradicting findings might be the fact 
that ligand-dependent S3 cleavage of N occurs at another cellular location 
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(plasmamembrane) (Tarassishin et al., 2004) than a postulated ligand-independent S3 
cleavage (endocytic compartment) (Vetrivel et al., 2004). However, there is no doubt 
that the endocytic pathway plays an important role in the degradation of the N 
receptor. One of the mediators of targeting N to lysosomal compartments is Cbl, an 
E3 ubiquitin ligase (Jehn et al., 2002) and also two other E3 ubiquitin ligases, Nedd4 
(Sakata et al., 2004; Wilkin et al., 2004) and Suppressor of Deltex (Fostier et al., 
1998; Cornell et al., 1999). Both, Nedd4 and Supressor of Deltex antagonize Deltex a 
third E3 ubiquitin ligase which positively regulates N signaling (Diederich et al., 
1994; Matsuno et al., 1995; Cornell et al., 1999; Sakata et al., 2004). This seems to 
imply that ubiquitinylation represents a significant regulatory mechanism to target N 
for endocytic degradation. Furthermore as already mentioned above, in hrs mutant 
clones N also co-localizes with a marker that recognizes ubiquintinylated prtoteins 
(Jekely and Rorth, 2003). 
 
3.6 Non-endosomal functions of ESCRT components 
In addition to their function in endosomal trafficking ESCRT subunits also have 
been reported to be involved in various other cellular processes. These include 
topologically related processes such as the regulation of virus budding (reviewed in 
Pornillos et al., 2002c; Demirov and Freed, 2004; Morita and Sundquist, 2004; Fujii 
et al., 2007; Martin-Serrano, 2007; Welsch et al., 2007) and the regulation of 
cytokinesis (Spitzer et al., 2006; Carlton and Martin-Serrano, 2007; Morita et al., 
2007; Dukes et al., 2008). However, there is no direct requirement for the ESCRT 
machinery in exosome secretion -another analogous event- as has been previously 
suggested (Trajkovic et al., 2008) (reviewed in Thery et al., 2002; de Gassart et al., 
2004). This seems to imply that the cell utilizes other factors besides ESCRT which 
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convey the recruitment of protein cargo for recycling to the plasma membrane or the 
shedding into the extracellular lumen through MVBs. 
 
Surprisingly, more and more evidence has been accumulating that ascribes 
unique functions to the ESCRT machinery that apparently appear to be independent of 
its ‘classical’ role of catalyzing scission events on membranes. Some of these are the 
regulation of transcription (Shilatifard, 1998; Sun et al., 1999; Feng et al., 2000; 
Kamura et al., 2001; Burgdorf et al., 2004), regulation of chromatin modification 
(Stauffer et al., 2001), regulation of mRNA localization (Irion and St Johnston, 2007) 
and regulation of the cytoskeleton (Xie et al., 1998; Feng et al., 2000; Schmidt et al., 
2003; Sevrioukov et al., 2005). 
 
3.6.1 Endosome-related functions of ESCRT components 
3.6.1.1 Virus budding 
In order to be able to bud from their host cells some retroviruses need to hijack 
the cellular ESCRT machinery (Garrus et al., 2001; Martin-Serrano et al., 2003b; 
Stuchell et al., 2004). The release of virions from the cell is mediated by Late (L) 
domain-containing proteins. L domains contain a short amino acid motif with the 
consensus P(T/S)XP (X can be any amino acid) (Demirov and Freed, 2004) that is 
identical to the tetrapeptide in Vps27 (ESCRT-0) which mediates the interaction with 
Vps23 (ESCRT-I) (Pornillos et al., 2003; Bouamr et al., 2007). The PTAP sequence 
of the HIV-1 Gag protein can mimic this recruitment step by interacting with Vps23 
allowing HIV-1 to bud out of the host cytosol through the ESCRT machinery 
(Pornillos et al., 2003). This budding process is analogous in its function to the events 
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that lead to receptor internalization on the early endosome and is also used in the 
same way by other viruses such as Hepatitis B virus (Lambert et al., 2007), Ebola 
virus (Martin-Serrano et al., 2001; Licata et al., 2003), Rous sarcoma virus (Johnson 
et al., 2005; Medina et al., 2005), Bluetonge virus or African horse sickness virus 
(Wirblich et al., 2006). However, the virus egress of at least HIV-1 does not seem to 
require ESCRT-II suggesting context- or even subunit-specific requirements for 
ESCRT components (Langelier et al., 2006). 
 
3.6.1.2 Cytokinesis 
A subunit-specific requirement of ESCRTs has also been suggested for 
cytokinesis. In dividing cells Tsg101 (Vps23) and ALIX (Bro1) are initially 
concentrated at the centrosome but are subsequently recruited to the midbody by 
interaction with Centrosome protein 55 (Cep55). Cep55 is essential for the abscission 
event of the two daughter cells at the midbody a structure that contains proteins that 
are required for cell cleavage. Over-expression of either ESCRT-I or –III components 
or Vps4 results in multinucleated cells. Yet, this phenotype cannot be observed when 
ESCRT-II subunits are over-expressed (Carlton and Martin-Serrano, 2007; Morita et 
al., 2007). Cytokinesis is a topologically related event to virus budding and shows 
obvious parallels regarding the mechanisms that have been established to successfully 
achieve membrane scission events. 
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3.6.2 Endosome-independent functions of the ESCRT machinery 
3.6.2.1 Regulation of transcription and chromatin modification 
Strikingly, mammalian ESCRT-II components were first described to be 
involved in modifying RNA polymerase II activity (Shilatifard, 1998; Kamura et al., 
2001). The transcription elongation factor ELL was purified as a multiprotein 
complex containing three additional proteins which turned out to be ELL-associated 
protein 45 (EAP45), EAP30 and EAP20 which are the mammalian homologues of 
Vps36, Vps22 and Vps25. Together with ELL they form an ’holo-ELL’ complex 
which increases the efficiency of transcription elongation in vitro (Shilatifard, 1998). 
In addition, Tsg101 (Vps23) a mammalian ESCRT-I member has been described to 
control androgen receptor-mediated transcription (Sun et al., 1999; Burgdorf et al., 
2004). Depending on the context it either activates (Burgdorf et al., 2004) or represses 
(Sun et al., 1999) androgen receptor-controlled target genes. Furthermore, the 
ESCRT-III component CHMP1 (Did2) was originally identified as a nuclear matrix 
interactor and has been shown to be involved in chromatin regulation by recruiting the 
Polycomb group (PcG) protein BMI1 to heterochromatic regions of the genome 
(Stauffer et al., 2001). This suggests that ESCRT subunits also play a crucial role 
beyond the regulation of MVB formation and topologically related processes such as 
virus budding and cytokinesis. 
 
3.6.2.2 Regulation of mRNA localization 
One further example of an endosomal-independent function of ESCRT 
members is their role in the localization of bicoid mRNA in the Drosophila egg. 
bicoid mRNA is localized to the anterior part of the embryo and results in a smooth 
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Bicoid morphogen gradient that sets up the patterning of the head and thorax of the 
Drosophila embryo. All three ESCRT-II components have been shown to be 
necessary for this localization step (Irion and St Johnston, 2007). Interestingly, the 
interaction with the 3’ untranslated region of bicoid mRNA is mediated by the GLUE 
domain of Vps36. This implies a dual function of Vps36 in binding to ubiquitinylated 
cargo at the endosome on the one hand and on the other hand its ability to mediate an 
association with bicoid mRNA. It is striking that the interaction with bicoid mRNA 
solely relies on ESCRT-II subunits and is independent of at least Hrs (Vps27, 
ESCRT-0), Vps23 (Erupted in Drosophila) and Vps28 (both ESCRT-I) and Vps32 
(ESCRT-III). 
 
3.6.2.3 Regulation of the cytoskeleton 
From very early on, studies have been suggesting an involvement of Vps23 
(Tsg101) in organizing the microtubule cytoskeleton (Xie et al., 1998; Feng et al., 
2000). Additionally, a recent study on Drosophila embryos lacking Vps28 reveals 
cellularization defects as a result of a malfunctioning actin cytoskeleton (Sevrioukov 
et al., 2005) corroborating the idea of ESCRT involvement in cytoskeletal regulation. 
However, so far the molecular mechanism that drives those events has not been 
identified, yet. It is however possible that ALIX (Bro1) might perform a mediating 
function in this process as it has been proposed as an interactor with both actin and 
microtubules (Schmidt et al., 2003; Cabezas et al., 2005). 
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3.7 ESCRT in pathogenesis and disease 
The endosomal system is crucial to maintain proper tissue homeostasis by 
controlling various signaling pathways and mediating the decision of receptor 
internalization at the forming MVB resulting in receptor recycling or lysosomal 
degradation (see also: ‘The significance of endosomal trafficking’). Therefore, an 
impairment of the signaling events of various crucial pathways caused by 
dysfunctional endosomal machinery such as ESCRT might have fatal consequences 
for an organism. Furthermore, defects in non-endosomal ESCRT-mediated processes 
can result in apoptosis (Krempler et al., 2002; Wagner et al., 2003; Carstens et al., 
2004), autophagy (Filimonenko et al., 2007; Lee et al., 2007; Rusten et al., 2007a; 
Rusten et al., 2007b; Lee and Gao, 2008), neurodegeneration (Yamada et al., 2001; 
Sweeney et al., 2006; Filimonenko et al., 2007; Lee et al., 2007; Rusten et al., 2007a; 
Lee and Gao, 2008) and disruption of cell cycle control (Li et al., 2001; Ruland et al., 
2001; Krempler et al., 2002; Oh et al., 2002; Carstens et al., 2004) some of which are 
the cause of cancer. 
 
Additionally, the central role of the endosomal system has also been used by 
pathogens to exit or enter the cell. Under ‘virus budding’ we have already discussed 
how this is attained by retroviruses through hijacking the ESCRT machinery of the 
host cell. In order to survive, replicate and evade the immune system many other 
pathogens besides viruses including bacteria and parasites make use of the cellular 
machinery that controls the endosomal pathway. However, they have developed 
remarkable strategies in order to avoid degradation in the lysosome (Gruenberg and 
van der Goot, 2006). The mechanisms how this is achieved are complex and vary 
considerably between different species but ultimately serve the purpose of evading the 
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endosomal pathway before the pathogen enters the lysosome. Now, new evidence also 
implies the ESCRT machinery as a modulator of the mycobacterial phagosome 
(Vieira et al., 2004; Philips et al., 2008). 
 
3.7.1 Modulation of the mycobacterial phagosome by the ESCRT 
machinery 
Upon infection with pathogens the host defense of an organism reacts by 
recruiting macrophages to the infected site. Macrophages are specialized cells that 
internalize pathogenic invaders and exterminate them by forming pathogen-containing 
phagosomes which through the endosomal pathway are delivered to the lysosome for 
degradation. In order to resist the hydrolytic breakdown in the phagolysosome 
mycobacteria have developed a survival mechanism within macrophages to prevent 
further maturation of phagosomes. They are able to arrest phagosomal maturation at 
an early stage as has been determined by the absence of late endosomal markers by 
co-opting the cellular machinery of their host (Russell, 2001). The family of 
mycobacteria contains prominent members such as Mycobacterium tuberculosis 
which is the cause of approximately two million deaths every year. Now, ESCRT 
components are also surfacing as modulators of mycobacterial phagosomes. Earlier 
studies already suggested a role for Hrs (Vps27) in the arrest of mycobacterial 
phagosome maturation (Vieira et al., 2004). Furthermore, knockdown experiments 
with RNAi directed against Vps28, Tsg101 (Vps23) and Vps32 show an increase in 
mycobacterial proliferation (Philips et al., 2008) ascribing at least some ESCRT 
members an essential role in restricting bacterial growth. 
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3.7.2 The ESCRT machinery and cancer 
Several regulatory pathways need to be altered for cancer to be initiated, 
expand and ultimately metastasize. As mentioned above the ESCRT machinery plays 
a crucial role in controlling essential processes like the cell cycle, autophagy and 
apoptosis which all have been implicated in various kinds of cancers and other 
diseases (Abrams, 2002; Hipfner and Cohen, 2004; Kastan and Bartek, 2004; Lowe et 
al., 2004; Massague, 2004; Mathew et al., 2007; Levine and Kroemer, 2008). 
 
3.7.2.1 Cell cycle control 
The versatile potential of Tsg101 (Vps23) to act in various cellular processes 
could also be extended to its ability to control the cell cycle (Li et al., 2001; Krempler 
et al., 2002; Oh et al., 2002; Carstens et al., 2004). This is true for two factors –p53 
and p21- that take center stage in negatively regulating the progression of the cell 
cycle (Li et al., 2001; Ruland et al., 2001). Tsg101 affects p53 protein stability by 
stimulating its proteasomal degradation through the ubiquitin ligase MDM2. This is 
achieved by binding of Tsg101 to mono-ubiquitinylated MDM2 via its UEV 
(ubiquitin E2 variant) domain. The formation of a Tsg101/MDM2 complex is 
believed to prevent further poly-ubiquitinylation and thus to stabilize MDM2 (Li et 
al., 2001). 
 
3.7.2.2 Autophagy and neurodegeneration 
Autophagy is a cellular pathway that is utilized to remove damaged 
intracellular constituents, turn over organelles or remove protein aggregates but is also 
required during starvation periods to maintain the basic functions of the cell through 
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degradation of dispensable proteins or organelles. The mechanisms regulating 
autophagy are complex but ultimately serve the goal of homeostatic maintenance and 
viability of the organism (reviewed in Maiuri et al., 2007; Mathew et al., 2007; 
Mizushima, 2007; Xie and Klionsky, 2007; Levine and Kroemer, 2008). A host of 
factors is involved in the induction of autophagosome formation. Ultimately, the 
autophagocytosed material has to be degraded through the lysosomal system. Now, 
new evidence suggests that this interaction of the autophagosome pathway occurs at 
the level of the MVB. Recently, several reports have been implicating the ESCRT 
machinery in the removal of protein aggregates through autophagosome formation, 
making a functional MVB the key player therein (Filimonenko et al., 2007; Lee et al., 
2007; Rusten et al., 2007b; Lee and Gao, 2008). Protein aggregation is one of the 
hallmarks of neurodegenerative diseases such as frontotemporal dementia linked to 
chromosome 3 (FTD3) (Skibinski et al., 2005), amyotrophic lateral sclerosis (ALS) 
(Parkinson et al., 2006), hereditary spastic paraplegia (Reid et al., 2005) or 
Huntington’s disease (Rusten et al., 2007b), all of which could be linked indirectly or 
directly to impaired ESCRT function in these studies. 
 
3.7.2.3 Apoptosis 
There are several reports that suggest an involvement of ESCRT members and 
related proteins in the regulation of cell death (Krempler et al., 2002; Wagner et al., 
2003; Carstens et al., 2004; Mahul-Mellier et al., 2006; Khoury et al., 2007). 
Programmed cell death or apoptosis is involved in the removal of supernumerary or 
damaged cells during development of all organisms (Jacobson et al., 1997; Baehrecke, 
2002). The cell contains an extrinsic and an intrinsic program to execute apoptosis. 
The extrinsic program is activated through death receptors that pass the death signal 
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on by adaptor proteins. Ultimately the executioners of cell death –the caspases- are 
being activated. Caspases are cysteine proteases which upon activation cleave a set of 
target proteins at distinct loci after an aspartate residue. The cleavage of caspase 
targets results either in activation or inactivation of caspase substrates and ensures a 
regulated disintegration of the cell. Hallmarks of apoptotic cells are a loss of cell 
shape, membrane blebbing, nuclear condensation and DNA laddering. Ultimately, the 
dead cells are engulfed by neighboring tissue thus allowing a recycling of residual 
material. The intrinsic cell death pathway is regulated by pro- and anti-apoptotic 
proteins which control the integrity of the mitochondrial outer membrane. If for a 
reason a cell is depleted of survival factors or receives pro-apoptotic insults a cell 
death response is initiated which results in the release of mitochondrial proteins -
among which are cytochrome c, Smac/DIABLO, Omi/Htra2, Endo G and AIF- into 
the cytoplasm. Smac/DIABLO and Omi/Htra2 bind to Inhibitor of apoptosis proteins 
(IAPs). This binding releases the inhibitory interaction of IAPs with initiator caspases 
such as Caspase-9 and results in the formation of the apoptosome. The apoptosome as 
the major death initiating complex has to be assembled by the association of 
cytochrome c with the scaffolding protein Apaf-1 and the recruitment of Caspase-9. 
Activation of the apoptosome in turn induces downstream effector caspases that 
initiate the afore mentioned regulated destruction of the cell (reviewed in Hengartner, 
2000; Meier et al., 2000a; Danial and Korsmeyer, 2004; Hay et al., 2004; Taylor et 
al., 2008). It has been confirmed that the basic core machinery which is involved in 
the execution of the apoptotic program is conserved from Caenorhabditis elegans, 
over Drosophila melanogaster to mammals (reviewed in Jacobson et al., 1997; Meier 
et al., 2000a; Baehrecke, 2002; Hay et al., 2004). 
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Cell death in Drosophila is under control of the pro-apoptotic genes reaper (White et 
al., 1994), head involution defective (hid) (Grether et al., 1995), and grim (Chen et al., 
1996; reviewed in Bergmann et al., 2003). Expression of these genes results in 
caspase activation, most notably Dronc (Dorstyn et al., 1999), the Caspase-9 
homolog. In living cells, Dronc is kept inactive by binding to Diap1 (Drosophila 
inhibitor of apoptosis protein 1) to prevent cell death (Meier et al., 2000b; reviewed in 
Bergmann et al., 2003). Reaper, Hid, and Grim induce cell death through binding to 
and stimulation of proteolytic degradation of Diap1 (Holley et al., 2002; Ryoo et al., 
2002; Yoo et al., 2002). Dronc is released from Diap1 inhibition, and forms with the 
scaffolding protein Ark (Rodriguez et al., 1999; Zhou et al., 1999; Igaki et al., 2002) 
the active apoptosome, which activates DrICE (Fraser and Evan, 1997; Fraser et al., 
1997) and DCP-1 (Song et al., 1997), Caspase-3-like proteins, inducing cell death. 
 
3.7.2.4 ESCRT members as tumor suppressors 
In addition, human hrs (vps27) and Tsg101 (vps23) have been linked to a 
number of tumors including cervical, breast, prostate and gastrointestinal cancers (Li 
and Cohen, 1996; Gayther et al., 1997; Lee and Feinberg, 1997; Li et al., 1997; 
Steiner et al., 1997; Sun et al., 1997; Lin et al., 1998; Oh et al., 2007; Toyoshima et 
al., 2007). Most of these studies found genomic deletions or aberrant splicing of 
Tsg101 in certain breast cancers. However, the picture becomes increasingly more 
complex. It turned out that the reported aberrant splicing of Tsg101 in some tumor 
cell lines are in fact alternative splice products of Tsg101 (Steiner et al., 1997). 
Moreover, Tsg101 knockout mice die early in embryogenesis, but neither Tsg101 
haploinsufficient nor conditional knockout mice show any signs of tumorous 
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phenotypes (Wagner et al., 2003). In contrast, a variety of cancers show increased 
levels of Hrs and Tsg101 and their over-expression result in malignant transformation 
in mammary glands of ageing female mice (Oh et al., 2007; Toyoshima et al., 2007). 
In summary, this points toward a mild oncogenic property of Hrs and Tsg101 in 
mammary glands. Even though the present data seems to imply an involvement of 
ESCRT in tumor formation and or control a mechanistic model for the tumorous 
phenotypes associated with hrs and Tsg101 mutations or over-expression has not been 
brought forward yet. 
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4 Results 
4.1 Control of non-autonomous cell survival and overgrowth 
and autonomous apoptosis by vps25 
4.1.1 Identification of K2 and N55 as mutants of the Drosophila 
vps25 homolog 
Over-expression of the pro-apoptotic gene hid under control of the eye-
specific Glass Multimer Reporter (GMR-hid) causes a strong eye-ablation phenotype 
as a result of induction of apoptosis (Fig. 3A) (Grether et al., 1995). Using the 
recently described GheF (GMR-hid ey-FLP) method (Xu et al., 2005) we conducted 
an EMS-mutagenesis screen on chromosome arm 2R aimed at identifying recessive 
suppressors of the GMR-hid eye-ablation phenotype (not performed by me, Fig. 1). 
The GheF method takes advantage of the ey-FLP/FRT system which induces 
homozygous mutant clones specifically in the eye by mitotic recombination (Xu and 
Rubin, 1993; Newsome et al., 2000). Mutants which suppress the GMR-hid eye-
ablation phenotype were selected for further analysis. 
 
In the GheF screen, two mutants, su(GMR-hid)K2 and su(GMR-hid)N55 
(referred to as K2 and N55) were independently recovered as moderately strong 
recessive suppressors of the GMR-hid eye ablation phenotype (Fig. 3B, C). These 
mutants are homozygous lethal in trans to each other, thus affecting the same genetic 
function. By P-element (Zhai et al., 2003) (Fig. 2) and deficiency mapping, K2/N55 
was located to the cytological region 44D4-44D5 on the polytene map. Both alleles 
failed to complement the lethality of a P-element-induced mutation (l(2)44Dbk08904) 
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which is inserted in the gene CG14750. DNA sequencing of CG14750 of K2 revealed 
a transversion from T to A in the second base of the only intron presumably causing a 
splicing defect and subsequently premature termination of translation by an in-frame 
stop codon in the intron (Fig. 3M). CG14750 of N55 carries a premature termination 
codon at amino acid 93 (Fig. 3M). Genomic constructs of CG14750 rescue the 
phenotypes associated with K2 and N55 mutants (data not shown) suggesting that K2 
and N55 affect CG14750 (further details under ‘Materials and methods’). 
 
A BLAST search identified CG14750 as the Drosophila homologue of vps25 
in S. cerevisiae. It is a member of the class E Vps proteins (Raymond et al., 1992), 
and a component of ESCRT-II, which functions to catalyze the feeding of 
ubiquitinylated transmembrane receptors into intraluminal vesicles of MVBs, 
targeting them for degradation in lysosomes. From now on, we refer to K2 and N55 as 
vps25K2 and vps25N55, respectively. Drosophila vps25 encodes a protein of 174 amino 
acids and contains two winged helix (WH) domains, WHA and WHB (Fig. 3M). 
Because both WHA and WHB are essential for ESCRT-II function (Hierro et al., 
2004; Teo et al., 2004) and because of the molecular lesions of vps25K2 and vps25N55 
(Fig. 3M), these alleles are likely to be very strong hypomorphic alleles, if not null 
alleles. Recently, two papers reported the isolation of vps25 mutants in entirely 
different genetic screens (Thompson et al., 2005; Vaccari and Bilder, 2005). Our 
phenotypic characterization of vps25 is largely consistent with these studies. 
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4.1.2 Characterization of vps25 alleles 
To characterize these alleles, we induced vps25K2 and vps25N55 mosaics via the 
ey-FLP/FRT system in the eye (without simultaneous expression of GMR-hid). 
Surprisingly, homozygous mutant clones (marked by absence of red eye pigment, 
compare to Fig. 3D) were not recovered, although the twin-spots were (Fig. 3E, F) 
suggesting that the mosaic eyes are composed of wild-type and heterozygous tissue 
(marked by red eye pigment). Even more surprisingly, vps25K2 (Fig. 3E) and vps25N55 
(Fig. 3F) mosaic eyes were larger than a wild-type control (Fig. 3D). Thus, the mutant 
clones do not contribute to the adult eye tissue, but appear to be able to induce 
overgrowth in wild-type tissue. Analysis of third instar eye-antennal vps25K2 (Fig.3H) 
and vps25N55 (Fig. 3I) mosaic discs confirms these conclusions. These discs are 
overgrown and disorganized compared to wild-type (Fig. 3G). At this stage, mutant 
clones are detectable (marked by absence of GFP labeling in Fig. 3H, I). However, as 
shown below, they are eliminated by apoptosis. 
 
These results pose an apparent paradox. Although we identified vps25K2 and 
vps25N55 as recessive suppressors of GMR-hid, the mutant clones do not survive. We 
determined whether vps25K2 and vps25N55 mutant clones contribute to the suppression 
of GMR-hid by clonal analysis. However, the GMR-hid transgene used for GheF 
screening is marked with w+, and does not allow a clonal analysis based on red/white 
pigment selection in eyes. Thus, we generated a GMR-hid transgene which has lost 
w+, termed GMR-hidw-, allowing the determination of the genetic identity of the 
rescued tissue of GMR-hidw- in vps25K2 and vps25N55 mosaics. As a positive control, 
the strong suppression of GMR-hidw- by a mutant of ark, an essential component of 
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the cell death pathway, is largely mediated by ark mutant tissue (marked by absence 
of eye pigment in Fig. 3J). In contrast, in vps25K2 and vps25N55 mosaics, the rescued 
tissue of GMR-hidw- is genetically wild-type or heterozygous (marked by red pigment 
in Fig. 3K, L), suggesting that vps25K2 and vps25N55 mutant tissue does not contribute 
to the suppression of GMR-hidw-. Therefore, because the surviving wild-type tissue is 
exposed to GMR-driven hid expression, this tissue may have an increased apoptotic 
resistance induced by vps25K2 and vps25N55 mutant clones. Thus, these are 
unprecedented phenotypes, which merit further analysis. 
 
4.1.3 vps25K2 and vps25N55 mutant clones die, but induce non-
autonomous proliferation 
To examine the vps25K2 and vps25N55 mutant phenotypes in more detail, we 
performed TUNEL and BrdU labeling as assays for apoptosis and cell proliferation, 
respectively, in imaginal discs of third instar larvae. TUNEL labeling is increased in 
vps25N55 mutant clones (Fig. 4A), consistent with the observed lack of mutant clones 
in the adult eye (Fig. 3E, F). vps25N55 clones can grow to a fairly large size, 
suggesting that they are not growth-impaired (Fig. 4A). However, these clones are 
completely removed by apoptosis during pupal stages (data not shown). Similar data 
in this and all other figures were obtained for vps25K2 (data not shown). 
 
Interestingly, the number of cells in S phase in vps25N55 mosaics as 
demonstrated by BrdU incorporation is significantly increased in tissue adjacent to the 
mutant clones. This non-autonomous cell proliferation is best visible in wing imaginal 
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discs, where vps25N55 clones appear to be the origin for increased proliferation of 
adjacent tissue (Fig. 4B) whereas wing discs with wild-type clones show a 
homogenous distribution of proliferating cells both within and outside the clones (Fig. 
4C). Similar data were obtained in eye-antennal imaginal discs (Fig. 12C). 
 
In addition to the apoptotic and proliferation phenotypes, vps25N55 mutant 
clones fail to differentiate. Elav labeling as neuronal differentiation marker 
demonstrates that vps25N55 cells are unable to differentiate (Fig. 4D). In summary, 
these analyses reveal that the wild-type function of vps25K2 and vps25N55 is required 
for appropriate control of apoptosis, cell proliferation and cell differentiation. The 
overgrowth phenotype in vps25K2 and vps25N55 mosaics (Fig. 3E, F, H, I) might most 
likely be explained by emission of signaling molecules from the mutant cells initiating 
non-autonomous proliferation in the adjacent wild-type tissue. 
 
4.1.4 Increased Notch and JAK/STAT signaling in vps25 mosaics 
Cell surface receptors are able to signal after endocytosis as long as they are 
not incorporated into MVBs (Gonzalez-Gaitan, 2003; Seto and Bellen, 2004) because 
their intracellular domains are still exposed to the cytosol. As vps25 mutants likely 
impair MVB function, these receptors may still continue to signal. Thus, the 
proliferation phenotype of vps25 mosaics may be explained by continued signaling 
activity. Consistently, N protein and its ligand Dl accumulate in vps25 clones (Fig. 
5A, B) resulting in increased N activity as shown by the N reporter E(spl)m8 2.61-
lacz (Fig. 5C) (Kramatschek and Campos-Ortega, 1994; Thompson et al., 2005; 
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Vaccari and Bilder, 2005). However, not all known target genes of N are up-regulated 
in vps25 clones. The expression of cut, another N target (de Celis et al., 1996; 
Micchelli et al., 1997), is unaltered in vps25 mutant clones in wing discs or even in 
some cases seems to be slightly inhibited (data not shown) (Childress et al., 2006). N 
is able to promote global growth in the developing Drosophila eye by inducing 
unpaired (upd) expression (Chao et al., 2004; Tsai and Sun, 2004; Reynolds-
Kenneally and Mlodzik, 2005). Upd (Harrison et al., 1998) is a ligand of Domeless 
(Brown et al., 2001) and Master of marelle (Chen et al., 2002), which are receptors of 
the JAK/STAT signaling pathway and has been demonstrated to promote global 
growth of up to 20 cell diameters in eye imaginal discs (Tsai and Sun, 2004). 
Consistently, STAT activity is stimulated in vps25 mutant clones in eye imaginal 
discs (Fig. 5D) and can sometimes even be observed non-autonomously in the vicinity 
of vps25 mutant tissue. In summary, these data seem to support the previously 
reported link between N activation and stimulation of the mitogenic JAK/STAT 
pathway which may be the cause for the non-autonomous proliferation in vps25 
mosaics. 
 
4.1.5 N is required for non-autonomous proliferation in vps25 
mosaics 
To determine a genetic requirement of N signaling for non-autonomous 
proliferation in vps25 mosaics, we expressed a dominant negative N (NDN) transgene 
(Sen et al., 2003) in vps25 clones (referred to as vps25/NDN) using the MARCM 
technique (Lee and Luo, 2001). STAT activity in vps25/NDN eye mosaics was 
strongly reduced or absent compared to vps25 clones (Fig. 6A). Furthermore, BrdU-
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incorporation indicates that cell proliferation is not significantly increased in 
vps25/NDN mosaics (Fig. 6B). Consistently, eye imaginal discs obtained from 
vps25/NDN mosaics are normal in shape and size (data not shown). Furthermore, the 
overgrowth phenotype of vps25 eye mosaics can be significantly reduced by 
removing one copy of N (Fig. 13 C, G, K, O). These observations suggest that 
increased N activity in vps25 clones accounts for the non-autonomous proliferation 
phenotype of vps25 mosaics through activation of the JAK/STAT pathway. A similar 
conclusion was obtained by analyzing vps25 mosaics in a heterozygous stat92E 
mutant background (Vaccari and Bilder, 2005). Interestingly, Dl protein does not 
accumulate in vps25/NDN clones (Fig. 6C). This observation suggests that N controls 
Dl protein levels in vps25 clones. 
 
We wanted to determine whether non-autonomous proliferation mediated by 
Upd and JAK/STAT signaling is sufficient for suppression of GMR-hid as observed 
for vps25 mosaics (Fig. 3B, C). However, although over-expression of upd in the fly 
eye gives rise to enlarged eyes (Bach et al., 2003; Muller et al., 2005), it is not 
sufficient for suppression of GMR-hid (Fig.6E, F). Interestingly enough, over-
expression of the intracellular domain of N (Nintra) can completely suppress the GMR-
hid eye ablation phenotype, even though the surviving tissue displays strong 
pigmentation defects which are probably due to a failure in differentiation (Fig. 6G). 
Activating the N pathway by over-expressing a N construct that lacks its extracellular 
domain (NNEXT) and thus mimics S2 cleavage of N can also suppress GMR-hid (data 
not shown). Suppression can not be obtained by solely over-expressing full length N 
(data not shown). Thus, the suppression of GMR-hid in vps25 mosaics is not caused 
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by non-autonomous proliferation through Upd signaling. In agreement with our data, 
the N pathway may provide another postulated non-autonomous signal which results 
in suppression of GMR-hid. Alternatively, N signaling could control apoptosis 
autonomously and might not be involved in the non-autonomous suppression of cell 
death as observed in vps25 mosaics. Therefore it is possible that another mechanism 
may account for the observed suppression (see below). 
 
In contrast to our findings that the N pathway can inhibit apoptosis, it has also 
been implicated in inducing cell death in eye imaginal discs (Miller and Cagan, 1998; 
Yu et al., 2002). Thus, we tested whether increased N signaling accounts for the cell 
death phenotype of vps25 clones. However, labeling of vps25/NDN clones with 
activated Caspase-3 antibody is indistinguishable from vps25 clones (Fig.6D). Similar 
results were obtained by TUNEL labeling (data not shown). Thus, although N induces 
non-autonomous proliferation in vps25 mosaics, it is not responsible for the apoptotic 
phenotype of vps25 clones. 
 
We also tested the possibility that activation of cell death might activate N 
signaling, and thus induces compensatory proliferation (Huh et al., 2004; Perez-Garijo 
et al., 2004; Ryoo et al., 2004; Wells et al., 2006; Fan and Bergmann, 2008). To 
address this question we blocked cell death by expression of diap1 in vps25 mutant 
clones (see below). However, pSTAT92E activity (data not shown) and cell 
proliferation (Fig. 7C) was still evident under these conditions establishing that 
activation of the N pathway and induction of cell death in vps25 clones are 
independent of each other. 
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 4.1.6 Non-autonomous survival through up-regulation of Diap1 
protein 
Because N signaling does not induce cell death in vps25 clones, we analyzed 
the underlying cause of the apoptotic phenotype. vps25 clones contain increased 
protein levels of the cell death-inducer Hid (Fig. 7A). Hid, as well as Reaper and 
Grim, induce apoptosis by stimulating ubiquitin-mediated degradation of Diap1, an 
inhibitor of the initiator caspase Dronc (Meier et al., 2000b; Holley et al., 2002; Ryoo 
et al., 2002; Yoo et al., 2002). Indeed, Diap1 protein levels were markedly reduced in 
vps25 mutant clones (Fig. 7B) suggesting that Diap1 no longer inhibits Dronc. 
 
Strikingly, however, Diap1 immunoreactivity is increased in wild-type cells 
immediately abutting vps25 clones (Fig. 7B) suggesting that vps25 clones also 
promote non-autonomous cell survival. GMR-hid is sensitive to altered levels of 
Diap1 (Hay et al., 1995). Thus, the non-autonomous increase of Diap1 protein likely 
promotes the suppression of GMR-hid in vps25 mosaics (Fig. 3B, C). This activity is 
independent of Upd signaling because over-expression of upd does not alter Diap1 
protein levels (data not shown) and does not suppress GMR-hid (Fig. 6F) but may be 
dependent on N signaling (Fig. 6G). It is currently unknown, how the N pathway or 
another signaling mechanism cause non-autonomous survival by regulating Diap1 
protein levels or other apoptotic factors. 
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4.1.7 Blocking cell death induces massive overgrowth of vps25 
mosaics 
It has recently been demonstrated that dying cells are able to induce 
compensatory proliferation in neighboring cells (Huh et al., 2004; Perez-Garijo et al., 
2004; Ryoo et al., 2004; Wells et al., 2006; Fan and Bergmann, 2008). Thus, we 
tested whether compensatory proliferation contributes to non-autonomous 
proliferation in vps25 mosaics. If it does, then inhibition of apoptosis either through 
expression of Diap1 in vps25 clones (vps25/Diap1) or in vps25 ark double mutants 
(using an ark null allele (Srivastava et al., 2007), see also ‘Materials and Methods’) is 
expected to reduce proliferation and subsequently to suppress the overgrowth 
phenotype of vps25 mosaics. However, non-autonomous proliferation is still observed 
in vps25/Diap1 mosaics (Fig. 7C) and in vps25 ark mosaics (data not shown) 
suggesting that compensatory proliferation does not contribute significantly to non-
autonomous proliferation of vps25 mosaics. In contrast, eye-antennal discs of 
vps25/Diap1 mosaics are extremely overgrown and can be up to five times as large as 
wild-type discs (Fig. 7D). In addition, vps25/Diap1 and vps25 ark clones occupy a 
large fraction of the eye disc (Fig. 7D, E) suggesting that vps25 clones have no 
intrinsic growth disadvantage over wild-type tissue if cell death is blocked. The adult 
eye of vps25 ark mosaics is severely overgrown and folded (Fig. 7F). However, most 
of these flies do not eclose, probably due to massive overgrowth of the eye and head 
capsule. Thus, inhibiting cell death in vps25 clones gives rise to an even stronger 
overgrowth phenotype as has also been observed by expression of the caspase 
inhibitor P35 (Thompson et al., 2005). 
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4.1.8 Hid and JNK contribute to the elimination of vps25 mutant 
clones 
Caspase-3 labeling reveals that cell death is completely blocked in 
vps25/Diap1 clones (Fig. 7D). Surprisingly, Caspase-3 activity is still detectable in 
vps25 ark double mutant clones (Fig. 7E), suggesting that although ark, an essential 
component of the cell death pathway, is mutated, vps25 ark double mutant cells still 
die. This is also confirmed by the observation that vps25 ark clones (marked by 
absence of eye pigment) cannot be recovered in adult eyes of vps25 ark mosaics (Fig. 
7F). Diap1 inhibits both initiator (Dronc) (Meier et al., 2000b) and Caspase-3-like 
caspases (DrICE, DCP-1) (Kaiser et al., 1998; Hawkins et al., 1999), whereas Ark 
directly only activates Dronc (Igaki et al., 2002) (reviewed in Cashio et al., 2005). 
Thus, an alternative cell death pathway is operating in vps25 clones that can induce 
Caspase-3-like activity independently of Ark. 
 
We considered Jun N-terminal kinase (JNK, encoded by basket in Drosophila) 
signaling as candidate for the alternative cell death pathway (reviewed in Weston and 
Davis, 2007). JNK activation occurs under stress conditions, and can induce apoptosis 
(Adachi-Yamada et al., 1999; Adachi-Yamada and O'Connor, 2002). We found 
increased levels of activated JNK in vps25 clones (Fig. 8A). It was previously shown 
that inactivation of Diap1 can induce JNK activation (Kuranaga et al., 2002; Ryoo et 
al., 2004). Thus, we tested whether this applies to vps25 clones as well. However, 
JNK activity is not appreciably altered in vps25/Diap1 clones (Fig. 8B) excluding the 
possibility that JNK activation occurs as a result of Diap1 inactivation. To determine a 
requirement of JNK for the apoptotic phenotype, we inhibited JNK in vps25 clones by 
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over-expression of puckered (vps25/Puc), a phosphatase that dephosphorylates JNK 
(Martin-Blanco et al., 1998). However, Caspase-3 activity is still detectable in 
vps25/Puc clones (Fig. 8C). This caspase activity may be derived from Hid activity 
which is expressed in vps25/Puc clones (data not shown). Thus, we expressed puc in 
vps25 ark double mutant clones. In vps25 ark/Puc clones, Caspase-3 activity is mostly 
blocked (Fig. 8D), and vps25 ark/Puc mosaic discs are severely overgrown (Fig. 8D) 
similar to vps25/Diap1 eye discs (Fig. 7D). Taken together, these observations 
implicate Hid/Diap1/Dronc/Ark and JNK signaling as contributing factors to the 
apoptotic phenotype of vps25 mutant clones. Interestingly, we still detect Caspase-3 
activity at the clonal margin of vps25 ark/Puc clones suggesting that a third cell death 
pathway may operate in vps25 clones or that surrounding wild-type tissue is 
outcompeted. Alternatively, JNK inhibition by Puc may be incomplete. 
 
4.1.9 Hippo signaling, but not cell competition, controls apoptosis 
in vps25 clones 
Which process controls the apoptotic phenotype of vps25 mutants? One 
possibility is cell competition. Cell competition was originally described in studies 
using Minute (M) mutations in which faster growing cells (M+/M+) outcompete 
neighboring slow-growing cells (M -/M+) by inducing apoptosis (Morata and Ripoll, 
1975; Simpson and Morata, 1981; Moreno et al., 2002) (reviewed in Abrams, 
2002).Thus, we analyzed vps25 clones in a M background. However, although vps25 
clones are larger in a M background compared to a wild-type background (Thompson 
et al., 2005), they are still Caspase-3 positive and undergo apoptosis (Fig. 9A). In 
addition, it was recently shown that dMyc protein levels are critical for cell 
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competition (de la Cova et al., 2004; Moreno and Basler, 2004). An imbalance of 
dMyc protein levels between neighboring cells induces cell competition, 
outcompeting cells with lower dMyc levels by apoptosis. However, expression of 
dMyc in vps25 clones (vps25/dMyc) does not significantly change Caspase-3 activity 
(Fig. 9B). These data illustrate that cell competition is not an important contributor for 
cell death in vps25 clones. 
 
In recent years, the Hippo signaling pathway has emerged as an important 
regulator of tissue growth by controlling cell proliferation and apoptosis (Harvey et 
al., 2003; Pantalacci et al., 2003; Udan et al., 2003; Wu et al., 2003) (reviewed in 
Edgar, 2006; Harvey and Tapon, 2007; Pan, 2007; Saucedo and Edgar, 2007). Thus, 
we tested whether Hippo activity is altered in vps25 clones. Expanded (Ex) is a useful 
marker for the Hippo pathway and is inversely correlated with Hippo activity, such 
that low Ex levels at the apical plasma membrane are indicative of high Hippo activity 
(Hamaratoglu et al., 2006). Ex protein levels are low in vps25 clones (Fig. 9C, arrow) 
indicating that they contain high Hippo activity. Interestingly, in vps25 hippo double 
mutants, Caspase-3 is almost completely blocked (Fig. 9D) suggesting that Hippo 
signaling directly or indirectly controls apoptosis in vps25 mutant cells. The cause for 
increased Hippo signaling in vps25 clones is unknown. It is possible that a putative 
receptor which controls Hippo activity is deregulated at the vps25 endosome (see also 
‘Discussion’). 
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4.2 Shared and distinct genetic properties of ESCRT-II 
components 
4.2.1 Description of vps alleles used 
In order to obtain a better understanding of the genetic properties of ESCRT 
components in Drosophila we performed a comparative analysis between the 
members of the ESCRT-II complex. In this analysis the following mutant alleles of 
ESCRT-II members were used. vps225F8-3 (also known as lsn5F8-3) was previously 
described by Irion and St Johnston (2007) (Irion and St Johnston, 2007). It carries a 
premature termination codon at residue 2, likely encoding a null allele. vps25N55 has a 
premature termination codon at residue 93. Earlier, we have characterized this allele 
as a null allele (see also ‘Identification of K2 and N55 as mutants of the Drosophila 
vps25 homolog’) (Herz et al., 2006). vps36L5212 was also characterized by Irion and St 
Johnston (2007) (Irion and St Johnston, 2007). A P-element insertion in the first exon 
at nucleotide 59 disrupts the vps36 transcript. RT-PCR demonstrates that some vps36 
transcript still forms in vps36L5212 mutants (Fig. 10, compare lanes 2 and 3) suggesting 
that it is a hypomorph. Interestingly, transcript levels as detected by primers further 
downstream of the transcription start site of vps36 seem to be comparable between a y 
w control and vps36L5212 mutants, suggesting that the P-element insertion at the vps36 
locus just disrupts full length transcripts of vps36. Transcription from alternative start 
sites further downstream might not be affected by the P-element insertion and thus 
result in similar vps36 mRNA levels (Fig. 10, compare lanes 4 and 5, 6 and 7). 
Alternative transcripts of ESCRT components have already been reported before for 
Tsg101 (vps23) and vps24 (Steiner et al., 1997; Khoury et al., 2007). 
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4.2.2 vps22, vps25 and vps36 mutants contain enlarged 
endosomes accumulating ubiquitinylated proteins 
Because hrs mutants in Drosophila are characterized by enlarged early 
endosomes (Lloyd et al., 2002; Jekely and Rorth, 2003), we tested whether mutants in 
the three ESCRT-II components also contain abnormal endosomes. As endosomal 
marker we used an antibody raised against Hrs (Lloyd et al., 2002). Mutant clones of 
vps22, vps25 and vps36 in eye imaginal discs contain enlarged Hrs-positive particles, 
representing abnormal early endosomes (Fig. 11 A-C). In this study we used FK1 and 
FK2 antibodies which recognize mono-and poly-conjugated and poly-conjugated 
ubiquitin respectively, but not unconjugated ubiquitin (Fujimuro et al., 1994; 
Fujimuro et al., 1997; Lee et al., 2008). Using these FK antibodies, we found that 
these enlarged Hrs-positive particles accumulate ubiquitin-conjugated proteins 
(shown for FK1 in Fig. 11A-C; similar data were obtained for FK2 (Fig. 15D-F)). 
Thus, vps22, vps25, and vps36 mutant cells contain abnormally large early endosomes 
which accumulate ubiquitin-conjugated proteins. The accumulation of ubiquitin-
conjugated proteins is consistent with the notion that ubiquitinylation provides the 
signal for endocytosis into the early endosome (reviewed in Hicke and Dunn, 2003; 
Haglund and Dikic, 2005; Hicke et al., 2005; Williams and Urbe, 2007). As shown 
below (Fig. 14A-C), the enlarged Hrs-positive particles contain increased levels of 
signaling receptors such as Notch. 
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4.2.3 vps22 and vps25, but not vps36 mosaics, display strong non-
autonomous overgrowth 
We have already shown above that vps25 mutant mosaics cause non-
autonomous overgrowth (Fig. 4B) (see also Thompson et al., 2005; Vaccari and 
Bilder, 2005; Herz et al., 2006). Therefore, we determined whether this applies to 
vps22 and vps36 mosaic flies as well. We performed BrdU labelings to determine the 
number of cells in S-phase. vps22 mutant clones do not proliferate very well (Fig. 
12B). However, the wild-type tissue immediately adjacent to vps22 mutant clones 
shows increased density of BrdU-positive cells (compare Fig. 13B to wild-type in Fig. 
13A). Thus, similar to vps25 mosaics (Fig. 13C), vps22 controls cell proliferation 
non-autonomously. However, vps36 mosaics behave differently. BrdU-positive cells 
can be observed both within and outside of vps36 clones with homogeneous density 
(Fig. 13D). 
 
We also detect strong overgrowth in vps22 eye mosaics in adult flies (Fig. 
13B, J). This is very well visible for vps22 mosaic heads (Fig. 13J) which are 
significantly larger than wild-type controls (Fig. 13I). The overgrowth is also 
detectable in eye-antennal imaginal discs, the larval precursors of the adult eyes, of 
vps22 and vps25 mosaic animals. vps22 and vps25 mosaic eye discs are significantly 
larger compared to wild-type controls (Fig. 13Q-S). This overgrowth is non-
autonomous because vps22 mutant clones which are marked by the absence of red eye 
pigment are not recovered in mosaic vps22 eyes (compare Fig. 10B with the wild-type 
control in Fig. 10A). However, a similar strong overgrowth phenotype was not found 
for vps36 mosaic eyes and heads (Fig. 13D, L), although a roughening of the eye can 
be observed and vps36 mutant tissue does not survive (Fig. 13D). We also find this 
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confirmed at the level of eye imaginal discs. vps36 mosaic eye discs (Fig. 13T) are 
noticeably smaller than vps22 and vps25 mosaic discs (Fig. 13R, S), and are 
comparable to wild-type (Fig. 13Q). Thus, vps36 mutant clones appear to be unable to 
induce strong non-autonomous proliferation or secondly because of their 
hypomorphic nature still retain some residual activity which is sufficient to maintain 
the proper control of different signaling pathways, such as N. Our data below reveals 
that the second scenario is unlikely as it shares all the major endosomal phenotypes 
with vps22 and vps25 mutant clones, which are the reason for increased N signaling 
(Fig. 14 and 15). 
 
To analyze the absence of vps22 and vps36 mutant clones in adult eyes (Fig. 
13B, D), we performed Caspase-3 labelings as a marker for apoptosis. In third instar 
eye imaginal discs, vps22 and vps36 clones contain increased Caspase-3 activity 
explaining the loss of these clones in the adult eye (Fig. 12E, G). A similar apoptotic 
phenotype has also been observed for vps25 clones (Fig. 4A and 13F) (see also 
Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006). Thus, as for 
vps25, loss of vps22 and vps36 causes the apoptotic death of the affected cells. 
 
In summary, these analyses indicate that, although Vps22, Vps25 and Vps36 
are components of the ESCRT-II complex, they do not behave genetically identical. 
While mutants of all three ESCRT-II components display endosomal defects and are 
apoptotic, only vps22 and vps25 mutant clones trigger strong non-autonomous 
proliferation. vps36, on the other hand, does not display a strong non-autonomous 
effect on proliferation. We will reveal below that at least one other difference exists. 
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 4.2.4 Up-regulation of Notch protein and JAK/STAT activity in vps 
mosaics 
The non-autonomous overgrowth of vps25 mosaics has been attributed to a 
failure in down-regulation of N protein and activity in vps25 mutant endosomes (see 
also Thompson et al., 2005; Vaccari and Bilder, 2005; Herz et al., 2006). 
Consistently, removal of one copy of N, which does not affect head and eye size of 
wild-type flies (Fig. 13E, M) can suppress the strong overgrowth phenotypes of vps22 
and vps25 mosaic eyes and heads (Fig. 13F, G, N, O) and slightly reduces the 
roughening of vps36 eye mosaics (Fig. 13H). 
 
Additionally, in vps22, vps25 and vps36 mutant clones, Hrs-positive enlarged 
early endosomes accumulate N protein (Fig. 14A-C). Shown in Fig. 14A’’’-C’’’ are 
immunolabelings with an antibody that recognizes the intracellular domain of N. We 
also observe accumulation of N in vps22, vps25 and vps36 mutant tissue using an 
antibody against the extracellular domain of N (Fig. 15A-C). In addition, increased 
abundance of the N-ligand Dl is also detected in vps22, vps25 and vps36 clones (Fig. 
15G-I). 
 
To determine whether the increased abundance of N correlates with increased 
activity, we tested the JAK/STAT pathway, a known downstream target of N in eye 
development (Chao et al., 2004; Tsai and Sun, 2004; Reynolds-Kenneally and 
Mlodzik, 2005). The accumulation of N protein correlates with increased JAK/STAT 
activity in vps22, vps25 and vps36 mosaics, as judged by an antibody recognizing 
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activated phosphorylated STAT (pSTAT) (Fig. 14D-F). Increased pSTAT activity is 
predominantly observed in vps mutant clones, however, it can also be detected non-
autonomously (Fig. 5D and 14D-F) (Herz et al., 2006). 
 
Thus, the observed differences in non-autonomous overgrowth between vps22, 
vps25 and vps36 do not correlate with the de-regulation of N signaling. It is unclear 
why the de-regulation of N and JAK/STAT activity causes overgrowth in vps22 and 
vps25 mosaics, but not in vps36 mosaics. This observation further supports the notion 
that there are intrinsic differences between the components of the ESCRT-II complex. 
 
4.2.5 vps36 mosaics, but not vps22, promote strong apoptotic 
resistance 
Paradoxically, despite the fact that vps25 clones are highly apoptotic, we 
originally isolated vps25 mutants based on their ability to suppress apoptosis (Fig. 3B, 
C) (Herz et al., 2006). Specifically, the eye-ablation phenotype caused by expression 
of the pro-apoptotic gene hid under control of the eye-specific GMR promoter (GMR-
hid) is suppressed in vps25 mosaics compared to a control (Fig. 16A, C). However, 
this suppression occurs in a non-autonomous manner through up-regulation of the 
apoptosis inhibitor Diap1 in neighboring cells (Fig. 7B) (Herz et al., 2006) or another 
unknown apoptotic factor. Therefore, we tested whether vps22 and vps36 have a 
similar activity. However, to our surprise although vps22 mosaics cause a strong non-
autonomous proliferation phenotype (Fig. 12B and 13B, J) they do not suppress 
GMR-hid (Fig. 16B). In contrast, although vps36 mosaics display only a mild non-
autonomous proliferation phenotype (Fig. 12D and 13D, L), they are very strong 
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suppressors of GMR-hid (Fig. 16D), comparable to vps25 mosaics (Figure 16C). This 
observation provides another example of genetic differences between the individual 
components of ESCRT-II. 
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5 Figures 
 
P ♂ w ; FRT42D x ♀ w GMR-hid ey-FLP ; FRT42D w+
 
F1 ♂♀ w GMR-hid ey-FLP/w or Y ; FRT42D */FRT42D w+
 
 
F1 ♂♀ w GMR-hid ey-FLP/w or Y ; FRT42D */FRT42D w+
x 
♂♀ w GMR-hid ey-FLP ; FRT42D w+
 
F2 ♂ w GMR-hid ey-FLP ; FRT42D */FRT42D w+ 
 
Balance 
 
5.1 Fig.1. GMR-hid ey-FLP (GheF) screen scheme. 
P males were mutagenized with EMS and crossed to females of an ‘analyzer’ line 
containing GMR-hid. Flies in F1 were analyzed for recessive suppression of the 
GMR-hid-induced eye ablation phenotype (Fig. 3A) The star * indicates the 
introduced mutation on chromomsome arm 2R. Suppressors of GMR-hid were 
retested for germline transformation by backcrossing to the ‘analyzer’ line and 
balanced with a y w ; Sco/CyO line after confirmation of the GMR-hid suppression 
phenotype. 
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P ♂ w ; FRT42D K2/CyO  x  ♀ w ; P[w+]/CyO 
 
F1 ♀ w ; FRT42D K2/P[w+] 
 
P ♂ w ; FRT42D N55/CyO  x ♀ w ; Sco/CyO, GMR-hid 
 
F1 ♂ w ; FRT42D N55/CyO, GMR-hid 
 
F1 ♂ w ; FRT42D N55/CyO, GMR-hid x ♀ w ; FRT42D K2/P[w+] 
 
F2 no recombination 
1. w ; FRT42D K2/FRT42D N55   lethal 
2. w ; P[w+]/FRT42D N55    w+
3. w ; FRT42D K2/CyO, GMR-hid   CyO, small eye 
4. w ; P[w+]/CyO, GMR-hid    CyO, small eye 
 
F2 recombination 
5. K2 P[w+]/FRT42D N55    lethal 
6. FRT42D or +/FRT42D N55   w 
7. FRT42D P[w+] or K2 P[w+]CyO, GMR-hid CyO, small eye 
8. FRT42D or +/CyO, GMR-hid   CyO, small eye 
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 P-elements used Nr. of F2 flies with 
genotype 
P[w+]/FRT42D N55 
Nr. of F2 flies with 
genotype 
FRT42D or +/FRT42D N55 
KG01834 (43E11) 361 5 
KG01035 (49D6) 347 33 
KG04965 (56D1) 346 169 
KG02448 (57A5) 347 187 
 
 
 
 
5.2 Fig. 2. Mapping of K2/N55. 
Crossing scheme used to locate K2/N55 by P-element mapping. F2 progeny can have 
eight different genotypes, dependent on whether recombination occurred in F1 
females or not. Flies in F2 were counted for recombination between the respective P-
element and K2 by comparing the numbers of red-eyed with white-eyed flies. 
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5.3 Fig.3. Isolation and characterization of vps25K2 and vps25N55 alleles. 
(A) The unmodified GMR-hid ey-FLP (GheF) eye-ablation phenotype. 
(B, C) vps25K2 and vps25K2 alleles are moderate suppressors of the GheF-eye 
phenotype. 
(D-F) Adult eyes of ey-FLP-induced mosaics of (D) wild-type, (E) vps25K2 and (F) 
vps25N55. (E, F) vps25K2 and vps25N55 mosaic eyes lack mutant clones (marked by 
absence of red pigment) and are overgrown.  
(G-I) Eye-antennal discs from 3rd instar larvae of (H) vps25K2 and (I) vps25N55 
mosaics are overgrown and disorganized compared to (G) wild-type. Scale bar: 
100μm. 
(J-L) Non-autonomous suppression of GMR-hidw- in vps25K2 and vps25N55 mosaics. 
(J) Control: in arkG8 mosaics, largely arkG8 mutant clones (marked by absence of eye 
pigment) suppress GMR-hidw-. (K, L) In (K) vps25K2 and (L) vps25N55 mosaics, the 
suppression of GMR-hidw- is mediated by wild-type tissue (red pigment). vps25K2 and 
vps25N55 clones do not contribute. 
(M) Schematic outline of the Vps25 protein and the molecular lesions in Vps25K2 and 
Vps25N55. WHA and WHB are winged-helix domains A and B. 
Genotypes: (A) GMR-hid ey-FLP ; FRT42D y+/FRT42D w+, (B) GMR-hid ey-FLP ; 
FRT42D vps25K2/FRT42D w+, (C) GMR-hid ey-FLP ; FRT42D vps25N55/FRT42D w+, 
(D) w ey-FLP ; FRT42D y+/FRT42 w+, (E) w ey-FLP ; FRT42D vps25K2/FRT42D w+, 
(F) w ey-FLP ; FRT42D vps25N55/FRT42D w+, (G) ey-FLP ; FRT42D y+/FRT42D 
ubi-GFP, (H) ey-FLP ; FRT42D vps25K2/FRT42D ubi-GFP, (I) ey-FLP ; FRT42D 
vps25N55/FRT42D ubi-GFP, (J) w ey-FLP ; FRT42D arkG8/FRT42D w+ ; GMR-hidw-, 
(K) w ey-FLP ; FRT42D vps25K2/FRT42D w+ ; GMR-hidw-, (L) w ey-FLP ; FRT42D 
vps25N55/FRT42D w+ ; GMR-hidw-. 
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5.4 Fig. 4. TUNEL and BrdU analysis of vps25N55 mosaics. 
(A-A’’) Increased TUNEL-positive cell death in vps25N55 mutant clones of eye-
antennal imaginal discs from 3rd instar larvae. vps25N55 clones are marked by absence 
of GFP. 
(B-B’’) BrdU labeling of vps25N55 mosaic wing imaginal discs. Note increased 
proliferation in tissue adjacent to vps25N55 clones. 
(C-C’’) BrdU labeling of wild-type (control) clones in wing imaginal discs serve as 
control to (B-B’’). BrdU incorporation is homogeneous inside and outside the clones. 
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(D-D’’) Elav labeling of vps25N55 mutant clones in eye-antennal imaginal discs of 
third instar larvae. Clones are positively marked with GFP. 
Genotypes: (A-A’’, B-B’’) ey-FLP ; FRT42D vps25N55/FRT42D ubi-GFP. (C-C’’) ey-
FLP ; FRT42D/FRT42D ubi-GFP. (D-D’’) hs-FLP UAS-GFP ; FRT42D 
vps25N55/FRT42D tub-Gal80 ; tub-Gal4. 
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5.5 Fig. 5. Accumulation of N and Dl in vps25 clones, and increased 
pSTAT immunoreactivity adjacent to vps25 clones. 
(A-A’’) Accumulation of N in GFP-marked vps25N55 clones. 
(B-B’’) Accumulation of Dl in GFP-marked vps25N55 clones. 
(C-C’’) Increased N activity in GFP-marked vps25 clones. 
(D-D’’) Increased STAT activity inside and outside of vps25 clones by anti-
pSTAT92E labeling. Clones are marked by absence of GFP. 
Genotypes: (A-A’’, B-B’’, C-C’’) Note vps25N55 clones are positively marked with 
GFP using the MARCM technique (Lee and Luo, 2001). (A-A’’, B-B’’) hs-FLP UAS-
GFP ; FRT42D vps25N55/FRT42D tub-Gal80 ; tub-Gal4. (C-C’’) hs-FLP UAS-GFP ; 
E[spl]m8 2.61-lacZ FRT42D vps25N55/FRT42D tub-Gal80 ; tub-Gal4. (D-D’’) ey-
FLP ; FRT42D vps25N55/FRT42D ubi-GFP. 
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5.6 Fig. 6. N is required for non-autonomous proliferation of vps25 
mosaics, but not for apoptosis. 
All vps25N55 clones expressing NDN (vps25N55/NDN) are labeled with GFP using 
MARCM. (A-A’’) vps25N55/NDN clones have reduced levels of pSTAT92E. 
(B-B’’) vps25N55/NDN clones elicit non-autonomous cell proliferation (BrdU labeling 
in B and B’’). The strong BrdU signal in (B, B’’) is due to the second mitotic wave. 
(C-C’’) vps25N55/NDN clones show reduced levels of Dl. 
(D-D’’) Caspase-3-positive apoptosis is unchanged in vps25N55/NDN clones. 
(E) The unmodified GMR-hid GMR-Gal4 eye-ablation phenotype. 
(F) Over-expression of upd is not sufficient to suppress GMR-hid GMR-Gal4. 
(G) Over-expression of the intracellular domain of N strongly suppresses GMR-hid 
GMR-Gal4. 
Genotypes: (A-A’’, B-B’’, C-C’’, D-D’’) hs-FLP UAS-GFP ; FRT42D vps25N55 UAS-
NDN/FRT42D tub-Gal80; tub-Gal4. (E) GMR-hid GMR-Gal4. (F) GMR-hid GMR-
Gal4/UAS-upd. (G) GMR-hid GMR-Gal4/UAS-Nintra. 
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5.7 Fig. 7. Non-autonomous increase of Diap1 protein levels, and 
evidence of two cell death pathways. 
(A-A’’) Increased levels of Hid protein in vps25K2 clones of 3rd instar eye discs. 
Clones are marked by absence of GFP. 
(B-B’’) Diap1 protein levels are reduced in, and increased adjacent to, vps25K2 clones. 
(C-C’’) BrdU labeling of GFP-marked vps25N55/Diap1 mosaics. Over-expression of 
Diap1 does not block non-autonomous proliferation. 
(D-D’’) Caspase-3-labeling of GFP-marked vps25N55/Diap1 mosaics. Caspase-3 is 
completely blocked. Scale bar: 100μm. 
(E-E’’) Caspase-3-labeling of GFP-marked vps25N55 arkH16 double mutant mosaics. 
Caspase-3-dependent cell death is detectable in vps25N55 arkH16 clones. Scale bar: 
100μm. 
(F) Adult eyes of ey-FLP-induced mosaics of vps25K2 arkG8 double mutants are 
severely overgrown and folded. Note: vps25K2 arkG8 clones are absent (marked by 
lack of red pigment). 
Genotypes: (A-A’’, B-B’’) ey-FLP ; FRT42D vps25N55/FRT42D ubi-GFP. (C-C’’, D-
D’’) hs-FLP UAS-GFP/UAS-Diap1 ; FRT42D vps25N55/FRT42D tub-Gal80 ; tub-
Gal4. (E-E’’) hs-FLP UAS-GFP ; FRT42D vps25N55 arkH16/FRT42D tub-Gal80 ; tub-
Gal4. (F) ey-FLP ; FRT42D vps25N55 arkH16/FRT42D w+. 
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5.8 Fig. 8. JNK contributes to the apoptotic phenotype of vps25 clones. 
(A-A’’) Increased JNK activity in vps25N55 clones by anti-pJNK labeling. Clones are 
marked by absence of GFP. 
(B-B’’) pJNK labeling of GFP-marked vps25N55/Diap1 mosaics. 
(C-C’’) Caspase-3-labeling of GFP-marked vps25N55/Puc mosaics. Scale bar: 100μm. 
(D-D’’) Caspase-3-labeling of GFP-marked vps25N55 arkG8/Puc mosaics. Note, the 
clones marked with GFP are severely enlarged. Scale bar: 100μm. 
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Genotypes: (A-A’’) ey-FLP ; FRT42D vps25N55/FRT42D ubi-GFP. (B-B’’) hs-FLP 
UAS-GFP/UAS-Diap1 ; FRT42D vps25N55/FRT42D tub-Gal80; tub-Gal4. (C-C’’) hs-
FLP UAS-GFP ; FRT42D vps25N55/FRT42D tub-Gal80; tub-Gal4/UAS-puc. (D-D’’) 
hs-FLP UAS-GFP ; FRT42D vps25N55 arkG8/FRT42D tub-Gal80; tub-Gal4/UAS-puc. 
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5.9 Fig. 9. Increased Hippo signaling, but not cell competition, controls 
apoptosis in vps25 clones. 
(A-A’’) Caspase-3-labeling of vps25N55 mosaics in Minute (M) background. Caspase-
3 activity is unaffected. Clones are marked by the absence of β-Gal staining. 
(B-B’’) Caspase-3-labeling of GFP-marked vps25N55/dMyc mosaics. Caspase-3-
activity is unaffected. 
(C-C’’) Expanded (Ex) labeling of GFP-marked vps25N55 mosaics. Ex protein levels 
are reduced in vps25N55 clones (arrow), indicating increased Hippo activity. 
(D-D’’) Caspase-3-labeling of GFP-marked vps25N55 hippoD3 double mutant mosaics. 
Caspase-3 activity is blocked. 
Genotypes: (A-A’’) ey-FLP ; FRT42D vps25N55/FRT42D arm-lacZ M(2). (B-B’’) hs-
FLP UAS-GFP ; FRT42 vps25N55/FRT42D tub-Gal80 ; tub-Gal4/UAS-dMyc. (C-C’’) 
hs-FLP UAS-GFP ; FRT42D vps25N55/FRT42D tub-Gal80 ; tub-Gal4. (D-D’’) hs-
FLP UAS-GFP ; FRT42D vps25N55 hippo3D/FRT42D tub-Gal80; tub-Gal4. 
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5.10 Fig. 10. RT PCR analysis of vps36 mutants. 
Lanes 1 and 12 depict the 1kb DNA ladder (Promega, G571A). RT PCR with primer 
pairs directed against a vps36 transcript (lanes 2-7). RT PCR confirms reduced levels 
of vps36 transcript in vps36L5212 first instar larvae (lane 3) compared to y w controls 
(lane 2). However, transcript levels as detected with primer pairs targeting vps36 
transcription further downstream appear to be comparable between vps36L5212 and y w 
controls (compare lanes 4 and 5, 6 and 7). Comparable levels of vps25 (compare lanes 
8 and 9) and actin5c (compare lanes 10 and 11) transcripts are obtained in vps36L5212 
mutants and y w controls. 
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5.11 Fig. 11. Mutant clones of ESCRT-II components display endosomal 
defects and accumulate ubiquitinylated proteins at the early 
endosome. 
Shown are eye-anntenal imaginal discs of third instar larvae mocaic for ESCRT-II 
mutants. Mutant clones are marked by the absence of GFP. Mutant clones of ESCRT-
II components show changes in the subcellular localization of the early endosomal 
marker Hrs and accumulation of ubiquitin-conjugated proteins as visualized by the 
FK1 antibody. Hrs and ubiquitin-conjugated proteins accumulate in foci which co-
localize frequently. 
(A, B, C) GFP/Hrs/FK1 co-labelings of (A) vps225F8-3, (B) vps25N55 and (C) 
vps36L5212 eye mosaics. 
(A’, B’, C’) Hrs/FK1 co-labelings of (A’) vps225F8-3, (B’) vps25N55 and (C’) 
vps36L5212 eye mosaics. 
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(A’’, B’’, C’’) Hrs labeling of (A’’) vps225F8-3, (B’’) vps25N55 and (C’’) vps36L5212 eye 
mosaics. 
(A”’, B’’’, C’’’) FK1 labeling of (A’’’) vps225F8-3, (B’’’) vps25N55 and (C’’’) 
vps36L5212 eye mosaics. 
Areas of increased Ubiquitin concentration co-localize with increased levels of the 
Notch receptor (antibody against the extracellular domain of Notch) in ESCRT-II 
mutant tissue. 
(D, E, F) GFP/Ubiquitin/Nextra co-labeling of (A) vps225F8-3, (B) vps25N55 and (C) 
vps36L5212 eye mosaics. 
(D’, E’, F’) Ubiquitin/Nextra co-labeling of (D’) vps225F8-3, (E’) vps25N55 and (F’) 
vps36L5212 eye mosaics. 
(D’’, E’’, F’’) Ubiquitin labeling of (D’’) vps225F8-3, (E’’) vps25N55 and (F’’) 
vps36L5212 eye mosaics. 
(D’’’, E’’’, F’’’) Nextra labeling of (D’’’) vps225F8-3, (E’’’) vps25N55 and (F’’’) 
vps36L5212 eye mosaics. 
Genotypes: (A-A’’’, D-D’’’) ey-FLP ; FRT82B vps225F8-3/FRT82B ubi-GFP, (B-B’’’, 
E-E’’’) ey-FLP ; FRT42D vps25N55/FRT42D ubi-GFP and (C-C’’’, F-F’’’) ey-FLP ; 
vps36L5212 FRT2A/ubi-GFP FRT2A. 
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5.12 Fig. 12. Proliferation and apoptosis phenotypes of ESCRT-II 
mosaics. 
(A-D) Non-autonomous regulation of proliferation in vps22 and vps25 eye mosaics as 
depicted by BrdU incorporation. Compared to control discs vps36 mutants do not 
affect the proliferation pattern significantly. 
(A-D) GFP/BrdU co-labelings of (A) control, (B) vps225F8-3, (C) vps25N55 and (D) 
vps36L5212 eye mosaics. The scale bar represents 50μm. 
(A’-D’) BrdU labeling of (A’) control, (B’) vps225F8-3, (C’) vps25N55 and (D’) 
vps36L5212 eye mosaics. 
(E-G) Labeling of vps22, vps25 and vps36 eye-antennal imaginal discs with cleaved 
Caspase-3 (Cas-3) antibody as apoptotic marker. 
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(E-G) GFP/Caspase-3 co-labelings of (E) vps225F8-3, (F) vps25N55 and (G) vps36L5212 
eye mosaics. 
(E’-G’) Caspase-3 labeling of (E’) vps225F8-3, (F’) vps25N55 and (G’) vps36L5212 eye 
mosaics. 
Genotypes: (A-A’) ey-FLP ; FRT42B/FRT42B ubi-GFP, (B-B’, E-E’) ey-FLP ; 
FRT82B vps225F8-3/FRT82B ubi-GFP, (C-C’, F-F’) ey-FLP ; FRT42D 
vps25N55/FRT42D ubi-GFP and (D-D’, G-G’) ey-FLP ; vps36L5212 FRT2A/ubi-GFP 
FRT2A. 
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5.13 Fig. 13. Growth phenotypes of ESCRT-II mosaics. 
vps22 and vps25 mosaics display strong overgrowth phenotypes of the adult eyes and 
heads and the larval eye imaginal discs. In contrast, vps36 mutants show just mild 
proliferation phenotypes such as a roughening of the adult eye. Removing one copy of 
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N in vps22 and vps25 mosaics reduces the overgrowth phenotypes of eyes and heads 
significantly and a weak effect can be observed on the roughening of vps36 mosaics. 
(A-D) Side view of genetic eye mosaics of (A) control flies, (B) vps225F8-3, (C) 
vps25N55 and (D) vps36L5212 mutants. 
(E-H) Side view of genetic eye mosaics of (E) N264-39 control flies, (F) N264-39 ; 
vps225F8-3, (G) N264-39; vps25N55 and (H) N264-39 ; vps36L5212 mutants. 
(I-L) Top view of genetic eye mosaics of (I) control flies, (J) vps225F8-3, (K) vps25N55 
and (L) vps36L5212 mutants. 
(M-P) Top view of genetic eye mosaics of (E) N264-39 control flies, (F) N264-39 ; 
vps225F8-3, (G) N264-39 ; vps25N55 and (H) N264-39 ; vps36L5212 mutants. 
(Q-T) Size comparison between eye imaginal discs of (Q) control, (R) vps225F8-3, (S) 
vps25N55 and (T) vps36L5212 mutants. The scale bar represents 100μm. 
Genotypes: (A, I, Q) y w ey-FLP ; FRT82B/ FRT82B P[w+], (B, J, R) y w ey-FLP ; 
FRT82B vps225F8-3/FRT82B P[w+], (C, K, S) y w ey-FLP ; FRT42D 
vps25N55/FRT42D P[w+], and (D, L, T) y w ey-FLP ; vps36L5212 FRT2A/P[w+] 
FRT2A, (E, M) y w ey-FLP/N264-39 ; FRT82B/ FRT82B P[w+], (F, N) y w ey-FLP/N264-
39 ; FRT82B vps225F8-3/FRT82B P[w+], (G, O) y w ey-FLP/N264-39 ; FRT42D 
vps25N55/FRT42D P[w+], (H, P) y w ey-FLP/N264-39 ; vps36L5212 FRT2A/P[w+] 
FRT2A. 
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5.14 Fig. 14. Accumulation of Notch protein and JAK/STAT activity in 
ESCRT-II mosaics. 
(A-C) The Notch receptor (detected with an antibody against the intracellular domain 
of Notch) co-localizes with the early endosomal marker Hrs in distinct punctae in 
mutant tissue of ESCRT-II components. 
(A, B, C) GFP/Hrs/Nintra co-labelings of (A) vps225F8-3, (B) vps25N55 and (C) 
vps36L5212 eye mosaics. 
(A’, B’, C’) Hrs/Nintra co-labelings of (A’) vps225F8-3, (B’) vps25N55 and (C’) 
vps36L5212 eye mosaics. 
(A’’, B’’, C’’) Hrs labeling of (A’’) vps225F8-3, (B’’) vps25N55 and (C’’) vps36L5212 eye 
mosaics. 
(A”’, B’’’, C’’’) Nintra labeling of (A’’’) vps225F8-3, (B’’’) vps25N55 and (C’’’) 
vps36L5212 eye mosaics. 
(D-F) Co-localization of accumulated Notch protein (using an antibody detecting the 
intracellular domain of Notch) and increased STAT activity, as visualized using anti-
pSTAT antibody, a readout of JAK/STAT pathway activity. 
(D, E, F) GFP/Nintra/pSTAT92E co-labelings of (D) vps225F8-3, (E) vps25N55 and (F) 
vps36L5212 eye mosaics. 
(D’, E’, F’) Nintra/pSTAT92E co-labelings of (D’) vps225F8-3, (E’) vps25N55 and (F’) 
vps36L5212 eye mosaics. 
(D’’, E’’, F’’) Nintra labeling of (D’’) vps225F8-3, (E’’) vps25N55 and (F’’) vps36L5212 
eye mosaics. 
(D’’’, E’’’, F’’’) pSTAT92E labeling of (D’’’) vps225F8-3, (E’’’) vps25N55 and (F’’’) 
vps36L5212 eye mosaics. 
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Genotypes: (A-A’’’, D-D’’’) ey-FLP ; FRT82B vps225F8-3/FRT82B ubi-GFP, (B-B’’’, 
E-E’’’) ey-FLP ; FRT42D vps25N55/FRT42D ubi-GFP and (C-C’’’, F-F’’’) ey-FLP ; 
vps36L5212 FRT2A/ubi-GFP FRT2A. 
 
 
 
 77
5.15 Fig. 15. The Notch receptor and its ligand Delta accumulate at the 
early endosome in ESCRT-II mosaics 
(A-C)Areas of increased Ubiquitin concentration co-localize with increased levels of 
the Notch receptor (antibody against the extracellular domain of Notch) in ESCRT-II 
mutant tissue. 
(A, B, C) GFP/Ubiquitin/Nextra co-labelings of (A) vps225F8-3, (B) vps25N55 and (C) 
vps36L5212 eye mosaics. 
(A’, B’, C’) Ubiquitin/Nextra co-labeling of (A’) vps225F8-3, (B’) vps25N55 and (C’) 
vps36L5212 eye mosaics. 
(A’’, B’’, C’’) Ubiquitin labeling of (A’’) vps225F8-3, (B’’) vps25N55 and (C’’) 
vps36L5212 eye mosaics. 
(A’’’, B’’’, C’’’) Nextra labeling of (A’’’) vps225F8-3, (B’’’) vps25N55 and (C’’’) 
vps36L5212 eye mosaics. 
(D-F) Aggregation of mono- and poly-ubiquitinylated proteins (detected by the FK2 
antibody) in ESCRT-II mutant tissue. 
(D, E, F) GFP/FK2 co-labeling of (D) vps225F8-3, (E) vps25N55 and (F) vps36L5212 eye 
mosaics. 
(D’, E’, F’) FK2 labeling of (D’) vps225F8-3, (E’) vps25N55 and (F’) vps36L5212 eye 
mosaics. 
(G-I) The Notch ligand Delta accumulates in foci that are reminiscent of the 
phenotype which is observed for the Notch receptor. 
(G, H, I) GFP/Delta co-labeling of (G) vps225F8-3, (H) vps25N55 and (I) vps36L5212 eye 
mosaics. 
(G’, H’, I’) Delta labeling of (G’) vps225F8-3, (H’) vps25N55 and (I’) vps36L5212 eye 
mosaics. 
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Genotypes: (A-A’’’, D-D’, G-G’) ey-FLP ; FRT82B vps225F8-3/FRT82B ubi-GFP, (B-
B’’’, E-E’, H-H’) ey-FLP ; FRT42D vps25N55/FRT42D ubi-GFP and (C-C’’’, F-F’, I-
I’) ey-FLP ; vps36L5212 FRT2A/ubi-GFP FRT2A. 
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5.16 Fig. 16. Suppression of the GMR-hid eye ablation phenotype by 
ESCRT-II mosaics. 
(A) Expression of the pro-apoptotic gene hid under control of the eye-specific GMR 
enhancer (GMR-hid) gives rise to a strong eye ablation phenotype due to excessive 
apoptosis. 
(B-D) vps25 (C) and vps36 (D) eye mosaics are strong suppressors the GMR-hid-
induced eye ablation phenotype in adult flies. vps22 mosaics (B) which cause a strong 
overgrowth phenotype similar to vps25 do not suppress the GMR-hid-eye ablation 
phenotype. 
Genotypes: (A) y w ey-FLP ; GMR-hid ; FRT82B/FRT82B P[w+], (B) y w ey-FLP ; 
GMR-hid ; FRT82B vps225F8-3/FRT82B P[w+], (C) y w GMR-hid ey-FLP ; FRT42D 
vps25N55/FRT42D P[w+] and (D) y w ey-FLP ; GMR-hid ; vps36L5212 FRT2A/P[w+] 
FRT2A. 
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6 Discussion 
The inactivation of signaling pathways is as important for appropriate tissue 
homeostasis as its activation. Interference with the inactivation process often gives 
rise to malignant phenotypes, including cancer. Several strategies to restrict signaling 
exist, including receptor sequestration, receptor inactivation, production of inhibitory 
signaling proteins, and inactivation of intracellular signaling proteins (reviewed in 
Sorkin and Von Zastrow, 2002; Le Roy and Wrana, 2005a). The phenotypic analysis 
of vps22, vps25 and vps36 mutants highlights the importance of receptor down-
regulation by endosomal protein sorting. Lack of vps25 function causes at least three 
phenotypes: non-autonomous proliferation, non-autonomous resistance to cell death, 
and autonomous apoptosis. Vps22 loss results just in two phenotypes: non-
autonomous proliferation and autonomous apoptosis while disrupting vps36 function 
leads to non-autonomous resistance to cell death and autonomous apoptosis. The 
differences and the cause of these combined phenotypes in mutations of different 
ESCRT-II members and the potential role of class E Vps proteins for tumorigenesis 
will be discussed below. 
 
6.1 Endosomal phenotypes in vps22, vps25 and vps36 
mosaics 
So far, a systematic genetic analysis of class E vps genes has only been 
performed in yeast (Raymond et al., 1992) (reviewed in Katzmann et al., 2002). 
Endosomal defects in these mutants in yeast are genetically very similar. Vps22, 
Vps25 and Vps36 are components of the ESCRT-II complex required for 
internalization of cell surface receptors into MVBs at the early endosome (Babst et 
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al., 2002b). The signal for protein sorting into MVBs is provided by mono-
ubiquitinylation (reviewed in Hicke and Dunn, 2003; Haglund and Dikic, 2005; 
Duncan et al., 2006; Huang et al., 2006). In yeast, mutations in ESCRT-II components 
cause aberrant endosomal structures and accumulation of ubiquitinylated proteins 
(Babst et al., 2002b) (reviewed in Katzmann et al., 2002). However, the consequences 
of the loss of appropriate endosomal sorting in multi-cellular organisms have only 
recently been described. In Drosophila, mutants of hrs display enlarged endosomes 
that accumulate ubiquitin-conjugated receptors on their limiting membrane (Lloyd et 
al., 2002; Jekely and Rorth, 2003). Our studies confirm these findings for vps22, 
vps25 and vps36 mosaics as well. Interference with the function of all three ESCRT-II 
members results in accumulation of ubiquitinylated protein cargo on Hrs positive 
endosomal compartments (Fig. 11A-C) confirming a role of ESCRT-II in MVB 
formation. This also implies that Hrs must act upstream of ESCRT-II function 
consistent with the studies that have been performed in yeast. 
 
6.2 Shared and distinct genetic properties of ESCRT-II 
components 
Our analysis and comparison of the mutant phenotypes of the ESCRT-II 
components vps22, vps25 and vps36 show that vps22 mosaics are characterized by 
strong non-autonomous proliferation (Fig. 12B), but not an increase in apoptotic 
resistance (Fig. 16B). vps36 mosaics exhibit the reverse phenotype, i.e. increased 
apoptotic resistance (Fig. 16D) and no or only weak non-autonomous proliferation 
(Fig. 12D). As shown before (Herz et al., 2006), vps25 mosaics combine both 
phenotypes (Fig. 3B, C; 12C and 16C). Nonetheless, mutant tissue of all three 
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ESCRT-II members fails to survive (Fig. 4A and 12E-G). Furthermore, mutant larvae 
of all three ESCRT-II alleles tested in this study die at around the same developmental 
stage in the first or second instar suggesting that they affect larval development to a 
similar extend. Thus, this analysis shows that although these components are part of 
the same structural complex and in many aspects show great similarity, especially for 
endosomal phenotypes, they are not genetically equivalent and display distinct 
properties. 
 
There are at least two reasons that might account for the differences in 
phenotypes. One will be discussed under ‘Non autonomous proliferation by Notch 
signaling in vps mosaics’. The other reason simply considers the possibility that class 
E vps genes have also been reported to function outside of endosomal protein sorting. 
As such they appear to be involved in diverse processes like virus budding (reviewed 
in Martin-Serrano, 2007), cytokinesis (Spitzer et al., 2006; Carlton and Martin-
Serrano, 2007), transcriptional control (Shilatifard, 1998; Sun et al., 1999), chromatin 
modification (Stauffer et al., 2001), mRNA localization (Irion and St Johnston, 2007), 
cell cycle progression (Li et al., 2001; Ruland et al., 2001) and apotosis (Krempler et 
al., 2002; Wagner et al., 2003) (for a more detailed overview see ‘Introduction’). 
Therefore, it is possible that the observed genetic differences of the ESCRT-II 
components may be caused by distinct requirements in addition to and independently 
of endosomal function and possibly independently of the ESCRT-II complex and the 
remaining ESCRT machinery. Future work will be necessary to dissect the roles of 
the ESCRT-II components in processes unrelated to endosomal processing. 
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6.3 Non-autonomous proliferation by Notch signaling in vps 
mosaics 
As we have shown in this study, the lack of appropriate protein sorting at the 
early endosome in vps22, vps25 and vps36 mutant tissue in Drosophila causes 
accumulation of N and its ligand Dl at an early endosomal compartment (Fig. 5A, B 
and Fig. 14A-C) which leads to increased activation of the N pathway (Fig. 5C). Even 
though we find evidence for altered regulation of various pathways in vps25 mutant 
clones and embryos such as EGF receptor, Dpp and Wg signaling (data not shown) it 
appears that deregulation of the N pathway largely accounts for the observed 
overgrowth phenotype of vps25 mosaics. For this reason we will focus on N signaling 
and related processes in the discussion to follow. 
 
Others have shown that N signaling plays an important role in inducing non-
autonomous proliferation through activation of the JAK/STAT pathway (Harrison et 
al., 1998; Chao et al., 2004; Tsai and Sun, 2004; Reynolds-Kenneally and Mlodzik, 
2005). Consistently, our data support these findings as vps22, vps25 and vps36 mutant 
clones display increased pSTAT activity, a readout for JAK/STAT signaling (Fig. 5D 
and Fig. 14D-F). Furthermore, our genetic analysis using a dominant negative N 
transgene (NDN, Fig. 6) suggests that the strong overgrowth phenotype of vps25 
mosaics is largely due to inappropriate N signaling (Fig. 6B) and that the observed 
increase in pSTAT immunoreactivity in vps25 mutant clones is the result of elevated 
N activity (Fig. 6A). Our findings largely correspond with the results of others 
(Thompson et al., 2005; Vaccari and Bilder, 2005) who observe similar phenotypes in 
vps25 clones, suggesting the conserved function of vps25 in Drosophila. Additionally, 
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mutations in erupted, the vps23 homolog which encodes a component of ESCRT-I, 
give rise to similar phenotypes as observed for vps22 and vps25 (Moberg et al., 2005). 
Astonishingly, a puzzling scenario is created by the analysis of vps36 mosaics. vps36 
mutant clones exhibit the same levels of accumulated N receptors at the early 
endosome and display a similar level of activation of the JAK/STAT pathway as 
vps22 and vps25 mutant tissue (Fig. 14D-F) but show a much weaker overgrowth 
phenotype (Fig. 13). It is therefore possible that the strength in activation of the N and 
JAK/STAT pathway cannot be measured by comparing the endosomal phenotypes of 
the different ESCRT-II components alone and that the weaker overgrowth effect in 
vps36 mosaics are the consequence of the hypomorphic nature of the vps36 allele. 
Alternatively, the overgrowth phenotypes might be the result of at least two pathways 
acting synergistically. One of these could be the JAK/STAT pathway which may be 
more susceptible to alterations in regulation than a postulated second pathway. In 
vps36 mosaics this susceptibility threshold might not have been reached for the 
putative second pathway yet and thus results in a weaker overgrowth phenotype that 
is only mediated by the activation of the JAK/STAT pathway. 
 
However, in hrs mosaics in Drosophila, non-autonomous cell proliferation has 
not been observed although signaling receptors including N and Dl accumulate in hrs 
mutant tissue (Lloyd et al., 2002; Jekely and Rorth, 2003). This is a puzzling 
observation as hrs encodes a class E Vps protein acting as a member of the ESCRT-0 
complex. It is possible that N and Dl are not in an environment in the hrs endosome 
which permits signaling. Alternatively, Jekely and Rørth (2003) showed that hrs 
controls the steady-state levels of non-activated receptors at the plasmamembrane. 
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Although this function may apply to vps25, it may also indicate that there are inherent 
differences between different class E proteins regarding protein sorting at the early 
endosome. Further support to the idea that N needs to be in a particular milieu at the 
early endosome in order to be activated comes from a study that analyses genes which 
act upstream of the ESCRT machinery in the endosomal pathway, namely shibire, 
avalanche and Rab5. Mutations in these genes result in accumulation of N on an early 
endosomal compartment but do surprisingly not activate the pathway (Vaccari et al., 
2008). Additionally, mutations in the tumor suppressor lethal giant discs (lgd) have 
been demonstrated to cause very strong activation of N signaling (Childress et al., 
2006; Gallagher and Knoblich, 2006; Jaekel and Klein, 2006). In lgd mutant clones 
Hrs co-localizes with N. Surprisingly, in contrast to lgd single mutant clones hrs lgd 
double mutant tissue did not show ectopic N activation (Childress et al., 2006; Jaekel 
and Klein, 2006). Furthermore, Lgd does not accumulate in hrs mutant clones but co-
localizes with N in aberrant early endosomes in vps25 mutant tissue (Childress et al., 
2006). In summary, this places Lgd between Hrs and Vps25 at the early endosome. 
However, as Lgd does not seem to be required for controlling the activity of many 
other pathways which is the case for Hrs and Vps25 (Lloyd et al., 2002; Jekely and 
Rorth, 2003; Thompson et al., 2005), it probably is not part of the core machinery that 
regulates MVB formation but rather represents a specific modulator of N activation at 
the early endosome (Childress et al., 2006). 
 
Currently, it is unclear whether N exerts its function in a ligand-dependent 
manner in vps25 mosaics. Dl protein also accumulates in vps25 clones (Fig. 5B), and 
endocytosis of Dl is required for N activation (Lai et al., 2001; Pavlopoulos et al., 
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2001; Yeh et al., 2001; Itoh et al., 2003; Le Borgne and Schweisguth, 2003b) 
(reviewed in Le Borgne and Schweisguth, 2003a; Le Borgne et al., 2005; Le Borgne, 
2006). Thus, blocking MVB formation in vps25 clones may lead to accumulation of 
active Dl, resulting in increased N activity. However, we also show that N is required 
for Dl accumulation in vps25 clones (Fig. 6C). There are two possibilities to explain 
these results. First, Dl accumulation is directly or indirectly the result of increased N 
activity in vps25 clones. This conclusion infers that N activation occurs before Dl 
accumulation and would argue in favor of a ligand-independent mechanism for N 
activation in vps25 clones, although Dl may be required for maintaining N activity. 
Ligand-independent activation of N has also been proposed for erupted (vps23) 
(Vaccari et al., 2008) and lgd (Childress et al., 2006; Jaekel and Klein, 2006). 
Alternatively, the use of a dominant-negative form of N in our study may result in cell 
autonomous ‘cis-inhibition’ of Dl through NDN at the plasmamembrane or another 
location. ‘Cis-inhibition’ is a process that describes the cell autonomous binding of Dl 
and Ser to N to inactivate the pathway. It is currently not known where exactly in the 
cell this inhibition occurs (de Celis and Bray, 1997; Klein et al., 1997; Micchelli et al., 
1997; Panin et al., 1997; Jacobsen et al., 1998; Sakamoto et al., 2002; Li and Baker, 
2004; Ladi et al., 2005; Glittenberg et al., 2006). As a result of ‘cis-inhibition’ Dl 
would be trapped and could no longer be shuttled to the early endosome. 
 
As mentioned in the introduction N activity is also controlled by several 
proteolytic cleavages (reviewed in Mumm and Kopan, 2000; Fortini, 2002; Selkoe 
and Kopan, 2003), which result in the translocation of the intracellular domain of N to 
the nucleus where it regulates expression of different target genes. Thus, a potential 
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ligand-independent mode of N activation may include inappropriate cleavage of N at 
the vps25 endosome. Traditionally, it has been thought that after ligand binding S3 
cleavage of N occurs at the plasma membrane (reviewed in Kaether et al., 2006). 
However, Presenilin and other subunits of the γ-secretase complex have largely been 
found to localize to an endosomal compartment (Ray et al., 1999; Pasternak et al., 
2003). It is interesting that mutations in genes that control endosomal trafficking at an 
earlier step than ESCRT members such as Rab5, avalanche -a Drosophila syntaxin-, 
β-arrestin and hrs do not affect N signaling significantly (Jekely and Rorth, 2003; Lu 
and Bilder, 2005; Mukherjee et al., 2005; Vaccari et al., 2008). In stark contrast, 
disrupting the endosomal process just slightly more downstream by interfering with 
the function of members of the ESCRT-I and –II complexes such as erupted (vps23) 
and vps25 leads to strong N activation (Moberg et al., 2005; Thompson et al., 2005; 
Vaccari and Bilder, 2005; Herz et al., 2006). Furthermore, elevated N activity in 
RNAi-treated cells against different ESCRT components is sensitive to a γ-secretase 
inhibitor (Thompson et al., 2005) even though the amount of cleaved N in vps25 
mutant tissue does not change compared to wild-type as judged by an ex vivo assay 
(Vaccari et al., 2008). However, the same assay detects a marked decrease in the 
levels of cleaved N for mutations in endosomal regulators that act more upstream 
such as avalanche and shibire (Vaccari et al., 2008). Taken together, a model emerges 
suggesting that at least for ligand-independent processes S3 cleavage of N occurs in a 
special environment at the early endosome. Interfering with the process of MVB 
formation by disruption of ESCRT function might therefore alter the kinetics of N 
transit through this specific endosomal ‘activation compartment’. Whether this milieu 
for N cleavage is created accidentally and thus might actually have nothing to do with 
the in vivo activation of the N pathway remains to be elucidated for further 
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clarification. Nonetheless, it is possible that ligand-dependent S3 cleavage of N might 
not occur at the same location on the early endosome but rather more upstream or 
even at the plasma membrane. 
 
6.4 Non-autonomous regulation of cell death by vps25 and 
vps36 
Paradoxically, although vps22, vps25 and vps36 clones die by apoptosis (Fig. 
4A and 12F, G) we just identified vps25 and vps36 alleles as recessive suppressors of 
GMR-hid-induced cell death (Fig. 3B, C and 16C, D). Our analysis demonstrates that 
the wild-type tissue in vps25 mosaics accounts for this suppression (Fig. 3K, L) 
although these cells are exposed to GMR-hid. However, these findings do not explain 
why vps36 is a strong suppressor of GMR-hid, while vps22 completely fails to 
suppress GMR-hid (Figure 16B, D). Thus, it does not appear that the phenotypic 
differences observed between vps22 and vps36 are due to allelic strength of the 
mutants. Rather, they appear to be caused by intrinsic differences of the endogenous 
genes which could function in endosomal independent processes as well (see also 
discussion under ‘Shared and distinct genetic properties of ESCRT-II components’). 
 
Our initial explanation for this observation of non-autonomous resistance 
against apoptosis was that non-autonomous proliferation mediated by JAK/STAT 
signaling in vps25 mosaics overrides the apoptotic activity of GMR-hid. However, 
over-expression of upd, the ligand of the JAK/STAT pathway, does not significantly 
suppress GMR-hid (Fig. 6F), although GMR-upd flies have a similar overgrowth 
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phenotype as vps25 mosaics (Bach et al., 2003; Muller et al., 2005). This finding 
excludes non-autonomous proliferation through the JAK/STAT pathway for 
suppression of GMR-hid by vps25. However, Diap1 protein levels are increased in 
tissue abutting vps25 clones (Fig. 7B). GMR-hid is sensitive to altered levels of Diap1 
(Hay et al., 1995) suggesting that the increase of Diap1 outside of vps25 clones may 
account for the suppression of GMR-hid even though it cannot be excluded that non-
autonomous regulation of other apoptotic components causes the GMR-hid 
suppression phenotype. Thus, in addition to non-autonomous proliferation, vps25 
clones also increase the apoptotic resistance of adjacent wild-type tissue in a non-
autonomous manner. The signaling pathway which can induce non-autonomous 
survival by increasing Diap1 protein levels is currently unknown. However, non-
autonomous resistance against cell death might very well be dependent on N signaling 
as over-expression of the intracellular domain of N results in a very strong 
suppression of GMR-hid (Fig. 6G). This is very interesting, especially because N 
activation has been implicated to exert a pro-apoptotic function during retinal 
development of Drosophila (Miller and Cagan, 1998; Yu et al., 2002), but can have 
anti-apoptotic effects in other contexts as well (Deftos et al., 1998; Jehn et al., 1999). 
More recently, a mechanism has been proposed in which the intracellular domain of N 
can mediate the inhibition of apoptosis by binding to and preventing the auto-
ubiquitinylation and thus degradation of XIAP, a mammalian inhibitor of apoptosis 
(Liu et al., 2007). Even though the results of these studies show that N activation can 
lead to even opposite effects depending on the developmental context and tissue in 
which N is functioning, they do not explain how N might mediate non-autonomous 
resistance against cell death. Possible mediators of this anti-apoptotic function of N 
signaling could be identified by performing a deficiency screen with the GMR-hid 
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GMR-Gal4/UAS-Nintra eye phenotype (Fig. 6G). Deficiencies which revert this 
phenotype (at least to a certain extend) would be further analyzed in order to identify 
the genes responsible for mediating the anti-apoptotic effect of the N pathway. In 
parallel, another deficiency screen that would make use of the GMR-hid suppression 
phenotype of vps25 and vps36 mosaics could lead to the identification of another set 
of genes as regulators of apoptosis. A significant overlap in these two sets of genes 
would imply that the non-autonomous resistance against cell death in vps25 and vps36 
mosaics and the GMR-hid suppression by over-expression of Nintra are conveyed by 
the same factors. 
 
6.5 Cell death in vps clones of ESCRT-II members 
Our data also suggest that apoptosis in vps25 mutant tissue is not only executed 
via the Hid/Diap1/Dronc/Ark-pathway. vps25 ark clones still died (Fig. 7F), 
suggesting that in addition to Ark at least one other pro-apoptotic component is 
activated in vps25 clones. We showed previously that a Dronc/Ark-independent cell 
death pathway exists in Drosophila, but did not identify this pathway (Xu et al., 2005; 
Srivastava et al., 2007). Our data here implicate JNK as potential mediator of an 
alternative cell death pathway (Adachi-Yamada et al., 1999; Adachi-Yamada and 
O'Connor, 2002). vps25 ark/Puc mosaic eye discs are extremely overgrown and the 
clones occupy a large area of the disc (Fig. 8D). Caspase-3-dependent apoptosis is 
blocked in these clones (Fig. 8D). Only at the clonal boundaries, Caspase-3 activity is 
still detectable, suggesting that at the interface between vps25 clones and wild-type 
tissue a potentially third apoptotic pathway is activated (Fig. 8D). Alternatively, the 
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surrounding wild-type cells could be outcompeted at the clonal margins and 
subsequently undergo cell death. 
 
Our data show that cell competition is not sufficient to induce cell death in 
vps25 clones (Fig. 9A, B). In contrast, given the extremely large size of cell death-
inhibited vps25 clones (Fig. 8D and 9D), it appears that vps25 clones have no intrinsic 
growth disadvantage, and have the capability to overgrow and outcompete the 
surrounding wild-type tissue if cell death is blocked. Thus, cell competition does not 
contribute significantly to the apoptotic phenotype of vps25 clones. 
 
We show that Hippo signaling is increased in vps25 clones (reviewed in Edgar, 
2006; Harvey and Tapon, 2007; Pan, 2007; Saucedo and Edgar, 2007) Hippo 
signaling can induce cell death, and consistently, hippo mutants block cell death in 
vps25 clones (Fig. 9D). Currently, it is unknown how Hippo signaling is activated in 
vps25 clones. However, in analogy to N, a putative receptor that controls Hippo 
signaling may be deregulated in vps25 clones and triggers Hippo signaling. This 
receptor has been postulated (Hamaratoglu et al., 2006) and lead to the identification 
of Fat, an atypical cadherin (Bennett and Harvey, 2006; Silva et al., 2006; Willecke et 
al., 2006). Even though Diap1 protein levels are upregulated in fat mutant clones 
(Bennett and Harvey, 2006; Silva et al., 2006; Willecke et al., 2006), fat eye mosaics 
do not result in suppression of GMR-hid (data not shown). Additionally, fat mutant 
tissue does not phenocopy hippo mutant clones in all aspects. Therefore, at least one 
other receptor still remains to be identified. This receptor might be responsible for 
mediating the pro-apoptotic signal in vps22, vps25 and vps36 mutant clones. 
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Alternatively, redundancy between several receptors that control the Hippo pathway 
may require the combined activation of all of them. However, it should also be 
pointed out that ESCRT components have additional functions outside of MVB 
protein sorting (see also ‘Introduction’). Certain ESCRT-II members have been 
shown to bind to the transcriptional elongation factor ELL in order to derepress 
transcription by RNA polymerase II (Shilatifard, 1998; Schmidt et al., 1999; Kamura 
et al., 2001). Thus, in the absence of Vps25, transcriptional control of components of 
the Hippo pathway may be deregulated and contribute to cell death. 
 
In summary, our data suggest that impaired ESCRT-II function leads to 
accumulation of N and Dl, and possibly of a receptor controlling the Hippo pathway. 
These receptors control non-autonomous proliferation and autonomous apoptosis, 
respectively. In addition, we postulate a signaling pathway that induces non-
autonomous cell survival by controlling Diap1 protein levels or another anti-apoptotic 
factor. Further characterization of the vps25 mutant phenotype may help identifying 
the postulated receptor of the Hippo pathway and the cell survival signaling pathway 
(for example by a screen as already mentioned above under ‘Suppression of GMR-hid 
by non-autonomous increase of Diap1’). 
 
6.6 ESCRT-II components in Drosophila: a model for human 
cancer? 
Human ESCRT components, most notably Tsg101 (vps23), have been 
implicated in tumor suppression. NIH3T3 cells, depleted of Tsg101 by an antisense 
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approach, formed colonies on soft agar and produced metastatic tumors in nude mice 
(Li and Cohen, 1996). However, the conditional Tsg101 knockout in mouse mammary 
glands did not cause the formation of tumors over a period of two years, making a 
role of Tsg101 as tumor suppressor controversial (Wagner et al., 2003). Tsg101 
mutant cells are very sensitive to apoptotic death (Wagner et al., 2003) implying that 
they die before they become harmful to the organism. 
 
The phenotypic characterization of vps25 mutants in Drosophila provides an 
explanation for the failure to confirm Tsg101 as tumor suppressor. vps25 clones need 
to survive over extended periods of time in order to sustain growth. Even though they 
induce non-autonomous proliferation, after they have died, N signaling is turned off 
and proliferation stops. Furthermore, the size of the adult eye of vps25 mosaics is only 
slightly increased compared to wild-type, and does not match the strong overgrowth 
phenotype of larval imaginal discs which can be twice as large as wild-type discs 
(Fig. 3G-I). Thus, as long as vps25 clones are not resistant to their own apoptotic 
death, tissue repair during pupal stages may partially regress the size of the imaginal 
disc back to almost normal. Instead, it appears that inhibition of cell death is the 
triggering event for a tumorous phenotype of vps25 clones. vps25/Diap1 and vps25 
ark/Puc clones can make up a large fraction of the tissue of imaginal discs, and the 
entire discs can be five times as large as wild-type discs (Fig. 7D and 8D). 
 
Tumorigenesis requires multiple genetic alterations that transform normal cells 
progressively into malignant cancer cells (Hanahan and Weinberg, 2000). Thus, 
additional genetic ‘hits’ may be necessary to inhibit apoptosis of Tsg101 mutant cells, 
 94
which may then be able to induce a similar growth phenotype as observed for vps25. 
The strong neoplastic transformation of vps25 mutant tissue that we observe when cell 
death is blocked is also supported by a Drosophila model which shows the ability of 
transplanted cell death resistant vps25 mutant tissue to form metastases (Thompson et 
al., 2005). Experiments that largely eliminate the surrounding wild-type tissue further 
support the neoplastic nature of ept and vps25 mutant tissue (Moberg et al., 2005; 
Vaccari and Bilder, 2005). Thus, although a tumor suppressor function for Tsg101 
was not confirmed in a mouse model, it still is possible that Tsg101 and other 
mammalian ESCRT members have tumor suppressor properties. 
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7 Significance of research and conclusion 
For a long time the study of the major signaling pathways has been occupied with 
the identification of new components to gain a better understanding of the hierarchy 
of the proteins involved. In many instances this led to a more detailed picture of the 
activation and inhibition mechanisms of each signaling pathway. However, although 
our knowledge about the participating proteins in these pathways is as detailed as 
never before, many questions remain unanswered. For one thing because we do not 
know all components yet, for another thing it also increasingly becomes more obvious 
that there is a significant amount of cross talk and cross regulation going on between 
these pathways. Most importantly, accumulating evidence particularly over the past 
few years suggests that this lack of understanding how signaling pathways are 
regulated has much to do with our inadequate apprehension of the endocytic pathway. 
More and more researchers seem to recognize the fact that our insight into the 
regulation of signaling pathways can ultimately just be satisfied if we gain a better 
understanding of the regulatory mechanisms at the different endocytic compartments 
within the cell. It appears rather that probably all of the major signaling pathways are 
controlled in some way by the endocytic machinery. 
 
Therefore, in this context the discovery of the ESCRT complexes in yeast 
(Katzmann et al., 2001; Babst et al., 2002a; Babst et al., 2002b) contributed largely to 
the progress in the field, giving us some answers to the mechanics of receptor 
turnover through regulation of MVB sorting at the early endosome and thus of the 
control of signaling itself. The general function of these complexes implies an 
interference with various signaling pathways which has been confirmed in various 
studies including ours (see also ‘Introduction’ and ‘Discussion’). As many of the 
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major signaling pathways are involved in developmental decisions including cell fate 
determination, differentiation, growth control and apoptosis it is to be expected that 
these processes are also impaired when certain components of the endocytic 
machinery are disrupted. In fact, this topic has been under extensive review (Sorkin 
and Von Zastrow, 2002; Gonzalez-Gaitan, 2003; Dudu et al., 2004; Le Roy and 
Wrana, 2005a; Fischer et al., 2006; Giebel and Wodarz, 2006; Hariharan and Bilder, 
2006; Polo and Di Fiore, 2006; von Zastrow and Sorkin, 2007) and is supported by 
our findings that components of ESCRT-II in Drosophila regulate development 
through such diverse processes as differentiation, autonomous and non-autonomous 
proliferation, autonomous apoptosis and non-autonomous resistance against cell 
death. Whether all of these phenotypes are dependent on the endosomal functions of 
ESCRT or whether some of them are the result of regulatory control of endosomal 
independent mechanisms remains to be determined in the future. 
 97
8 Materials and Methods 
8.1 Antibodies 
8.1.1 Primary antibodies 
 
Antigen  Host  Source   Concentration 
used 
Armadillo  mouse  Hybridoma Bank (N2 7A1) 1:20 
β-Galactosidase mouse  Promega (Z378A)  1:1000 
β-Galactosidase rabbit  ICL (RGAL-45A)  1:500 
Caspase-3  rabbit  Cell Signaling (9661)  1:100 
Cut   mouse  Hybridoma Bank (2B10) 1:100 
Delta   mouse  Hybridoma Bank (C594.9B) 1:20 
Diap1   guinea pig Pascal Meier (SK10)  1:400 
Diap1   guinea pig Pascal Meier (SK14)  1:400 
Diap1   rabbit  Pascal Meier (227)  1:400 
Diap1   rabbit  Pascal Meier (228)  1:400 
Elav   mouse  Hybridoma Bank (9F8A9) 1:20 
Elav   rat  Hybridoma Bank (7E8A10) 1:40 
dpERK  mouse  Sigma (M-8159)  1:500 
Expanded  rabbit  Allen Laughon  1:1500 
GFP   mouse  Millipore (MAB 2510) 1:100 
GFP   rabbit  Invitrogen (A11122)  1:100 
Hid   guinea pig Hong Don Ryoo  1:50 
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Hrs   guinea pig Hugo Bellen   1:1000 
pJNK   rabbit  Cell Signaling (9251)  1:100 
Nintra   mouse  Hybridoma Bank (C17.9C6) 1:20 
Nextra   mouse  Hybridoma Bank (C458.2H) 1:20 
pSTAT92E  rabbit  Cell Signaling (9357)  1:100 
Ubiquitin  rabbit  Sigma (U5379)  1:10 
Ubiquitin (FK1) mouse  Biomol Intern. (PW8805) 1:100 
Ubiquitin (FK2) mouse  Biomol Intern. (PW8810) 1:100 
Wingless  mouse  Hybridoma Bank (4D4) 1:50 
 
8.1.2 Secondary Antibodies 
All secondary antibodies were obtained from Jackson ImmunoResearch. They were 
conjugated with either FITC-, Cy3- or Cy5-fluorophores and used at a dilution of 
1:600. 
 
8.2 Fly strains 
Lines for P-element and deficiency mapping (Bloomington stock numbers and 
cytolocation included) 
y w ; P{SUP or -P}KG01834    14580  43E11 
y w ; P{SUP or -P}KG01035    13186  49D6 
y w ; P{SUP or -P}KG04965    13534  56D1 
y w ; P{SUP or -P}KG02448    13224  57A5 
w ; Df(2R)H3C1/CyO     198  43F—44D8 
w ; Df(2R)H3E1/CyO     201  44D1—44F12 
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w ; Df(2R)8047, P+Pbac{XP5.RB3}Exel8047/CyO 7863  44D4—44D5 
w ; Df(2R)7098, P+Pbac{XP5.RB3}Exel7098/CyO 7864  44D5—44E3 
 
Cell death genes 
y w; FRT42D y+ arkG8/CyO 
y w ; FRT42D y+ arkH16/CyO 
y w ; FRT42D y+ hippo3D/CyO 
 
vps alleles 
y w ; FRT42D y+ vps222B6-3/TM3, Ser, act-GFP (Daniel St Johnston) 
y w ; FRT42D y+ vps225F8-3/TM3, Ser, act-GFP (Daniel St Johnston) 
y w ; P{lacW}CG14750KG08904/CyO = y w ; P{lacW}vps25KG08904/CyO (Bloomington) 
y w ; FRT42D y+ vps25K2/CyO, act-GFP 
y w ; FRT42D y+ vps25K2 arkG8/CyO 
y w ; FRT42D y+ vps25N55/CyO, act-GFP 
y w ; FRT42D y+ vps25N55 arkH16/CyO 
y w ; FRT42D y+ vps25N55 UAS-NDN/CyO 
y w ; vps36L5212 FRT2A/TM3, Ser, act-GFP (Bloomington) 
 
FLP/FRT lines 
w ; FRT42D y+ (Barry Dickson) 
y w ey-FLP ; ry (Bloomington) 
y w GMR-hid ey-FLP 
y w ey-FLP ; FRT42D w+ (Barry Dickson) 
y w ey-FLP ; FRT42D ubi-GFP (Georg Halder) 
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y w hs-FLP ; FRT42D ubi-GFP (Georg Halder) 
y w hs-FLP UAS-GFP ; FRT42D tub-Gal80/CyO ; tub-Gal4/TM6B, Tb (Georg 
Halder)(Irion and St Johnston, 2007) (Lee and Luo, 2001) 
y w hs-FLP ; FRT42D arm-lacz M(2)/CyO (Graeme Mardon) 
y w GMR-hid ey-FLP ; FRT42D w+
y w ey-FLP ; FRT42D w+/CyO ; GMR-hidw-
w ; ubi-GFP FRT2A (Bloomington) 
w ; FRT82B/TM3, Sb (Bloomington) 
y w ey-FLP ; FRT82B ubi-GFP (Georg Halder) 
y w GMR-hid ey-FLP ; FRT82B ubi-GFP 
 
GMR-hid lines 
y w GMR-hid ey-FLP 
y w ; GMR-hid GMR-Gal4/CyO, act-GFP 
 
UAS constructs 
y w UAS-diap1 (on X) 
y w ; UAS-NDN/CyO (Hugo Bellen) 
y w hs-FLP ; UAS-NNEXT/CyO ; MKRS/TM2 (Gary Struhl) 
y w hs-FLP ; UAS-N751.6F(full length)/CyO ; MKRS/TM2 (Gary Struhl) 
y w ; UAS-Nintra/CyO (Hugo Bellen) 
y w ; UAS-dMyc2.1/CyO (David Stein) 
y w ; UAS-puc (on III) (Georg Halder) 
y w ; UAS-upd26.2/CyO (Erika Bach) 
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Reporter lines 
y w ; E(spl)m8 2.61-lacz/CyO (Kramatschek and Campos-Ortega, 1994) 
y w ; brinker-lacz/TM3, Sb (Georg Halder) 
 
8.3 Plasmids 
pUAST 
 
8.4 Primers 
Primers are aligned in 5’-3’ configuration. Restriction sites are depicted in bold and 
mentioned at the end of each primer. 
 
vps25 
CG14750.1: TGCTATTTAGCGCATATGGTCACTC (sense) 
CG14750.2: CGAGACTGCAATGGCAGGTAA (antisense) 
CG14750.3: GGAATTCACAAATAAGTGTTTTCTTGGGATATT (sense) 
  EcoRI 
CG14750.4: GCTCTAGATCGTGTGGACAGGCTAACCAG (antisense) XbaI 
CG14750.5: GGAATTCGCGCATATGGTCACTCTAGGC (sense) EcoRI 
CG14750.6: GCTCTAGAATGTACATTTTACAATACTTTACTCC (antisense) 
  XbaI 
 
vps36 
vps36.1: TGAATCGCTTCGCTTATGTG (sense) 
vps36.2: CAGGCTACTGAAGTAGGCAGAA (antisense) 
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vps36.3: TCACCACACACCGACTGTTT (sense) 
vps36.4: CGTGGGACTCCAGTTGTAGC (antisense) 
vps36.5: AATGGCCTGAGTGTCGAGTT (sense) 
vps36.6: CAGTCCCTCTACGGACTCGT (antisense) 
 
actin5c 
actin5c.1: TCAGCCTCGCCACTTGCG (sense) 
actin5c.2: TGTTGTGCTGCACTCCAAACTTC (antisense) 
 
8.5 Protocols 
8.5.1 Antibody staining of embryos 
Antibody stainings of embryos were performed using the Vectastain ABC Kit (Vector 
Laboratories, PK-6100). 
 
Embryo fixation 
1. Collect embryos from plate using a brush 
2. Rinse embryos with water 
3. Dechorionate embryos in 50% bleach (Clorox) for 3min 
4. Rinse well with water 
5. Fix embryos in 750μl heptane, 675μl PBS and 75μl formaldehyde (38%) for 
20min on shaker with >400rpm 
6. Remove as much of lower phase as possible 
7. Add 750μl methanol 
8. Devitellinize embryos by shaking vial vigorously by hand for 30s 
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9. Wash embryos 4 x in 500μl methanol 
10. Store embryos in methanol at -20ºC until further processing 
 
Antibody incubation 
1. Rehydrate embryos through two washes each with 500μl PBT containing 90%, 
70%, 50% and 25% methanol 
2. Rinse 4 x in 500μl PBT 
3. Transfer embryos in 500μl tube 
4. Block embryos in 500μl PBT containing 5% normal donkey serum (NDS) for 
20min 
5. Prepare primary antibody solution in PBT containing 3% NDS 
6. Aspirate primary antibody solution 
7. Rinse 4 x with 500μl PBT 
8. Wash embryos 4 x in 500μl PBT for 15min on shaker 
9. Add 100μl of secondary antibody in PBT containing 3% NDS 
10. Incubate for 90min at RT on shaker 
11. Aspirate secondary antibody solution 
12. Rinse 4 x with 500μl PBT 
13. Wash 4 x in 500μl PBT for 15min on shaker 
14. Prepare AB solution about 15-30min before adding to embryos: to 100μl of 
PBT add 1μl of component A and 1μl of component B from Vectastain ABC 
Kit (Vector Laboratories, PK-6100); mix and incubate for 15-30min at RT 
15. Add 100μl of AB solution to embryos; incubate for 45-60min at RT on shaker 
16. Aspirate AB solution 
17. Rinse 4 x with 500μl PBT 
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18. Wash 4 x in 500μl PBT for 15min on shaker 
 
Optional: TSA amplification 
Occasionally it is necessary to amplify the signal even further. This can be 
accomplished by using the TSA Biotin System from PerkinElmer Life Sciences 
(NEL700A). The treatment will result in deposition of additional biotin moieties in 
the vicinity of the antigen. These can then be visualized using the Vectastain ABC 
Kit. 
 
1. Rinse embryos 2 x in 50μl amplification diluent 
2. Prepare TSA solution by diluting TSA reagent 1:50 in amplification diluent 
3. Add 50μl TSA solution to embryos 
4. Incubate for 10-15min at RT on shaker 
5. Aspirate TSA solution 
6. Rinse 4 x with 500μl PBT 
7. Wash 2 x in 500μl PBT for 15min on shaker 
8. Prepare AB solution about 15-30min before adding to embryos: to 100μl of 
PBT add 1μl of component A and 1μl of component B from Vectastain ABC 
Kit; mix and incubate for 15-30min at RT 
9. Add 100μl of AB solution to embryos; incubate for 30min at RT on shaker 
10. Aspirate AB solution 
11. Rinse 4 x with 500μl PBT 
12. Wash 4 x in 500μl PBT for 15min on shaker 
 
Staining reaction 
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1. Dilute H2O2 (30%) from stock bottle 1:10 with PBT 
2. Thaw 3, 3’-diaminobenzidine (DAB) stock solution (1%) (wear gloves) 
3. Add 2μl of diluted H2O2 to 500μl of PBT 
4. Add 500μl of H2O2-containing PBT to embryos 
5. Transfer embryos and H2O2-containing PBT to a well of 24 micro titer plates 
6. Dilute DAB from stock 1:10 with PBT (wear gloves) 
7. Add 500μl diluted DAB to embryos (wear gloves) 
8. Watch progress of reaction under dissecting scope and stop by washing 
embryos several times with PBT; discard DAB-containing solutions in 20-
30% bleach 
9. Transfer embryos to a 500μl eppendorf vial 
10. Wash several times in 500μl PBT 
11. Add 70% glycerol, let embryos settle, mount on slides, view and photograph 
 
8.5.2 Antibody staining of imaginal discs 
1. Dissect larval head in PBS pH 7.0 by pulling gently at the mouth hook to 
retrieve the larval brain with eye discs (for eye discs) or cut the anterior third 
of larvae off in PBS pH 7.0 and invert larval cuticle to expose the discs (for 
eye, wing and leg discs) 
2. Remove extraneous tissue such as trachea, fat body, gut and salivary glands 
3. Fix tissue in 300μl PBS pH 7.0 containing 4% paraformaldehyde for 20min at 
room temperature (RT) 
4. Wash tissue in 300μl PBS pH 7.0 for 10min at RT 
5. Incubate tissue in 300μl Block buffer for >30min at RT 
6. Incubate tissue with primary antibody in wash buffer (100μl) over night at 4ºC 
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7. Wash tissue 3 x 20min in 300μl wash buffer at RT 
8. Incubate tissue with secondary antibody in wash buffer (100μl) for 3 h at RT 
or over night at 4ºC 
9. Wash tissue 3 x 20min in 300μl wash buffer at RT 
10. Fix tissue in 300μl PBS pH 7.0 containing 4% paraformaldehyde for 20min at 
room temperature (RT) 
11. Isolate discs from remaining tissue and add ~15μl of Vectashield (Vector 
Laboratories, H-1000) 
 
8.5.3 BrdU staining of imaginal discs 
Day 1 
1. Dissect imaginal discs in cold Schneider’s medium (Invitrogen, 11720) on ice, 
dissection should be done in less than 15min 
2. Remove extraneous tissue such as trachea, fat body, gut and salivary glands 
3. Incubate tissue in 0.5 mg/ml BrdU in Schneider’s (1mg BrdU powder (Roche, 
10280879) + 2ml Schneider’s, dissolve well) for 1h at RT 
4. Wash tissue 1 x fast and 1 x in 300μl Schneider’s for 5min at 4ºC (RT) 
5. Wash tissue 1 x fast and 2 x in 300μl PBS for 5min at 4ºC (RT) 
6. Fix tissue in 300μl PBS containing 4% paraformaldehyde over night at 4ºC on 
shaker 
 
Day 2 
1. Wash tissue 3 x fast and 4 x in 300μl PBS for 10min at 4ºC (RT) 
2. Incubate tissue in 5μl RQ1-DNAse (1μg/μl) (Promega, M6101) + 95μl DNAse 
buffer for 2h at 37ºC in water bath 
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3. Wash tissue 1 x fast and 3 x in 300μl PBT for 10min at 4ºC (RT) 
4. Block tissue in 300μl PBTN for 1h at 4ºC (RT) 
5. Incubate tissue with α-BrdU primary antibody (Becton Dickinson) in PBTN 
over night at 4ºC (RT) 
 
Day 3 
1. Wash tissue 3 x fast and 4 x in 300μl PBT for 20min at 4ºC (RT) 
2. Incubate tissue with secondary antibody in PBTN for 4h or over night at 4ºC 
(RT) 
3. Wash tissue 3 x fast and 6 x in 300μl PBT for 20min at 4ºC (RT) 
4. Fix tissue in 300μl PBS pH 7.0 containing 4% paraformaldehyde for 20min at 
room temperature (RT) 
5. Isolate discs from remaining tissue and add ~15μl of Vectashield (Vector 
Laboratories, H-1000) 
 
8.5.4 TUNEL staining of imaginal discs 
TUNEL staining was performed using the In Situ Cell Death Detection Kit TMR Red 
from Roche (12156792910) and Dilution Buffer from Roche (11966006001). 
 
Day 1 
1. Dissect larval head in PBS pH 7.0 by pulling gently at the mouth hook to 
retrieve the larval brain with eye discs (for eye discs) or cut the anterior third 
of larvae off in PBS pH 7.0 and invert larval cuticle to expose the discs (for 
eye, wing and leg discs) 
2. Remove extraneous tissue such as trachea, fat body, gut and salivary glands 
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3. Fix tissue in 300μl PBS pH 7.0 containing 4% paraformaldehyde for 20min at 
room temperature (RT) 
4. Wash tissue 3 x fast and 4 x in 300μl PBT for 15min at 4˚C (RT) 
5. Block tissue in 300μl PBTN for 1h at 4˚C (if not performing antibody staining, 
block overnight and proceed to day 3: step #10) 
6. Incubate tissue with primary antibody in PBTN (100μl) overnight at 4˚C 
 
Day 2 
1. Wash tissue 3 x fast and 6 x in 300μl PBT for 20min at 4˚C (RT) 
2. Incubate tissue with secondary antibody [optional: TOPRO 1:2000] in PBTN 
for 4h at 4˚C 
3. Wash tissue 3 x fast and 6 x in 300μl PBT for 20min at 4˚C (RT) 
4. Block tissue in 300μl PBTN overnight at 4˚C 
 
Day 3: 
 
1. Incubate tissue in 495μl 100 mM NaCitrate + 5μl 10% Triton X-100 for 30min 
at 65˚C 
2. Wash tissue 3 x fast in 300μl PBT at RT 
3. Incubate tissue in 100μl of TUNEL Dilution Buffer (Roche, 11966006001), 2 
x 5min each at RT 
4. Incubate tissue in 50μl labeling solution (In Situ Cell Death Detection Kit 
TMR Red, Roche, 12156792910) for 30min at 37˚C in water bath 
5. Add 5μl enzyme solution (In situ Cell Death Detection Kit TMR red), mix 
well, incubate for 2h at 37˚C in water bath 
 109
6. Wash tissue 3 x fast in 300μl PBT at 4˚C (RT) 
7. Optional: Incubate tissue with TOPRO (1:2000) in PBTN for 30min at 4˚C 
8. Wash tissue 3 x fast and 4 x in 300μl PBT for 15min at 4˚C (RT) 
9. Isolate discs from remaining tissue and add ~15μl of Vectashield (Vector 
Laboratories, H-1000) 
 
8.5.5 Preparation of competent E. coli 
1. Inoculate a single colony of competent cells into 5ml of LB medium, shake at 
37ºC overnight 
2. Put 5ml of above cell culture into 1l of LB medium, shake at 37ºC (250rpm), 
follow OD550 till density reaches 0.5 
3. Put cells for 10min on ice, keep everything cold 
4. Spin down culture with 3500rpm for 10min at 4ºC 
5. Remove supernatant from pellet 
6. Gently resuspend pellet in 250ml cold, sterile, 0.1 M MgCl2, keep on ice for 
30min, spin with 3000rpm for 10min at 4ºC 
7. Resuspend pellet in 250ml cold, sterile 0.1 M CaCl2, keep on ice for 20min, 
spin with 3000rpm for 20min at 4ºC 
8. Resuspend pellet in a total of 50ml cold, sterile 0.1 M CaCl2 with 7ml of RT 
100% Glycerol, mix gently, aliquot and freeze in dry ice/Ethanol bath, store at 
-80ºC 
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8.6 Solutions and growth media 
8.6.1 Solutions for imaginal disc labeling 
PBS (50ml):  150 mM NaCl (0.44g NaCl) 
10 mM Na3PO4 pH 7.0 (2.89 ml 0.1 M Na2HPO4 + 2.11ml 0.1 
M NaH2PO4) 
ad 50ml ddH2O 
 
10 x PBS (50ml): 1.5 M NaCl (4.4g NaCl) 
100 mM Na3PO4 pH 7.0 (28.9 ml 0.1 M Na2HPO4 + 21.1ml 0.1 
M NaH2PO4) 
ad 50ml ddH2O 
 
PBT (50ml):  150 mM NaCl (0.44g NaCl) 
10 mM Na3PO4 pH 7.0 (2.89 ml 0.1 M Na2HPO4 + 2.11ml 0.1 
M NaH2PO4) 
   0.3% Triton X-100 (30μl 100% Triton X-100) 
   ad 50ml ddH2O 
 
PBTN (50ml): 150 mM NaCl (0.44g NaCl) 
10 mM Na3PO4 pH 7.0 (2.89 ml 0.1 M Na2HPO4 + 2.11ml 0.1 
M NaH2PO4) 
   0.3% Triton X-100 (30μl 100% Triton X-100) 
   2mg/ml Normal Donkey Serum (NDS) (100mg NDS) 
   ad 50ml ddH2O 
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 Block Buffer (10ml): 50 mM Tris pH 6.8 (1ml 0.5 M Tris pH 6.8) 
   50 mM NaCl (300μl 5 M NaCl) 
   0.5% NP-40 (50μl 100% NP-40) 
   5mg/ml Bovine serum albumin (BSA) (50mg BSA) 
   ad 10ml ddH2O 
 
Wash Buffer (50ml): 50 mM Tris pH 6.8 (5ml 0.5 M Tris pH 6.8) 
   150 mM NaCl (1.5ml 5 M NaCl) 
   0.5% NP-40 (250μl 100% NP-40) 
   1mg/ml BSA (50mg BSA) 
   ad 50ml ddH2O 
 
Fix Solution (40ml): 4ml 10 x PBS 
10ml 16% paraformaldehyde (Electron Microscopy Sciences, 
15710) 
   ad 40ml ddH2O 
 
8.6.2 Solutions for gel electrophoresis 
50 x TAE (1l): 242g Tris base pH 8.5 
   57.1ml Acetic acid 
   100ml 0.5M EDTA 
   ad 1l ddH2O 
 
 112
8.6.3 Solutions for genomic DNA isolation 
TE:   10 mM Tris-HCl pH 7.5 
   1 mM EDTA 
 
Solution A:  0.1 M Tris-HCl pH 9.0 
0.1 M EDTA 
1% SDS 
 
8.6.4 Growth media 
LB:   10g NaCl 
   10g Tryptone (DIFCO, 211705) 
   5g yeast extract (DIFCO, 212750) 
   ad 1l ddH2O 
 
LB plates:  LB components 
   15g agar (DIFCO, 214510) 
   (alternatively 50mg Ampicillin = 50μg/ml) 
   ad 1l ddH2O 
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8.7 Techniques 
8.7.1 Gel electrophoresis 
Gels were prepared with 150ml TAE and 1.5g of agarose (1%). Agarose was 
dissolved in a microwave and cooled at RT for 10min. 10μl ethidium bromide was 
added and Gels poured in chambers. Gels were run with 100V for 35min. 
 
8.7.2 Isolation of genomic DNA 
The following protocol describes the isolation of DNA from adult flies but can be 
used equally well to extract DNA from other developmental stages. DNA prepared 
according to this method is readily digested by restriction enzymes and has an average 
size of 40-60kb. In order to remove RNA contaminating the DNA preparations 
DNase-free RNase should be included when digesting with restriction enzymes. 
 
1. Anaesthetize flies with CO2 and put 30 flies in an eppendorf tube, keep on ice 
until next step 
2. Add solution A and 0.5-1% DEPC (added directly before use) and 
homogenize gently with a glass or metal rod. Use 100μl of solution A for 
extracting DNA from 1-5 flies, 200μl for 6-10 flies and 500μl for up to 50 
flies. Incubate for 20-30min at 70ºC 
3. Add 14μl of 8 M potassium acetate for each 100μl homogenate and leave on 
ice for 30min. 
4. Spin at full speed for 15min at 4ºC. Transfer the supernatant into a fresh 
eppendorf tube being careful not to disturb the pellet. If you get flakes in the 
supernatant respin. 
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5. Precipitate DNA by adding 0.5 volumes of isopropanol at RT and spin at full 
speed for 5min at RT. Wash the pellet carefully with 70% ethanol, respin at 
full speed for 5min at RT, dry and dissolve pellet in 10μl (1 fly) to 100μl (50 
flies) ddH2O (TE) 
 
8.7.3 RNA isolation 
10mg of vps36L5212 or y w first instar larvae were collected. RNA isolation was 
performed using the RNeasy Mini Kit from Qiagen (74104) following the description 
in the manual. 
 
8.7.4 RT PCR (Invitrogen) 
RT PCR was performed following the description for the Super Script First-Strand 
Synthesis System for RT-PCR from Invitrogen (12371-019). 
 
1. Heat to 65ºC for 5min, put on ice 
2. Prepare reaction mix: x μl 10 x RT buffer (2 x total # of reactions) 
x μl 25 mM MgCl2 (4 x total # of reactions) 
x μl 0.1 M DTT (2 x total # of reactions) 
x μl RNAse OUT (1 x total # of reactions) 
3. Add 9μl reaction mix to each tube, spin down, incubate for 2min at RT 
4. Add 1μl reverse transcriptase (RT) to each tube, incubate for 10min at RT 
5. Incubate for 1h at 42ºC 
6. Incubate for 15min at 70ºC, put on ice 
7. Spin down briefly, add 1μl RNAse H 
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8. Incubate for 20min at 37ºC 
9. Store cDNA at -20ºC 
 
8.7.5 PCR amplification of genomic DNA and cDNA 
Primers CG14750.3 together with CG14750.4 and CG14750.5 together with 
CG14750.6 were used for PCR amplification of genomic vps25 DNA. cDNA 
amplification was performed with primer pairs vps36.1 and vps36.2, vps36.3 and 
vps36.4, vps36.5 and vps36.6, CG14750.3 and CG14750.4, actin5c.1 and actin5c.2. 
 
PCR reaction for genomic DNA 
1μl primer1 (30 μM) 
1μl primer2 (30 μM) 
2μl dNTPs (10 mM) 
5μl 10 x PCR buffer 
1μl MgCl2 (25 mM) 
1μl genomic DNA 
1μl Taq polymerase 
38μl ddH2O 
 
PCR reaction for cDNA 
1μl primer1 (30 μM) 
1μl primer2 (30 μM) 
2μl dNTPs (10 mM) 
5μl 10 x PCR buffer 
1μl MgCl2 (25 mM) 
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20μl cDNA 
1μl Taq polymerase 
19μl ddH2O 
 
PCR program 
5min 94ºC 
30s 94ºC (melting) 
1min annealing temperature of primers 
1min 30s 72ºC 
10min 72ºC (final extension) 
∞ 4ºC 
 
30 cycles were run for genomic DNA and 35 cycles for cDNA. 
 
8.7.6 Purification of PCR-amplified DNA 
Plasmids and PCR-amplified DNA were purified using either the QIAquick PCR 
Purification Kit (28106) or QIAquick Gel Extraction Kit (28704) from Qiagen 
following the description in the manuals, respectively. 
 
8.7.7 Sequencing of amplified DNA 
Primers CG14750.1, CG14750.2, CG14750.3, CG14750.4, CG14750.5 and 
CG14750.6 were used for sequence analysis of vps25K2 and vps25N55 and the genomic 
rescue constructs (see also ‘Genomic rescue construct’). Sequencing of amplified 
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DNA was performed by the ‘DNA Analysis Core Facility’ of M.D. Anderson Cancer 
Center. 
http://inside.mdanderson.org/departments/dna/index.html
 
8.7.8 Amplification of plasmids and constructs 
Plasmids and constructs were amplified using either the QIAprep Spin Mini Prep Kit 
(12243) or QIAfilter Plasmid Midi Kit (28704) from Qiagen following the description 
in the manuals, respectively. 
 
8.7.9 Bacterial transformation 
1. Thaw competent bacteria on ice 
2. Add 0.5μl of plasmid or construct DNA (1mg/ml) 
3. Incubate on ice for 30min 
4. Heat shock for 1min at 42ºC 
5. Add 1ml of LB 
6. Shake for 1h at 37ºC 
7. Plate 50μl and rest on Ampicillin-containing (50μg/ml) LB plates 
8. Incubate plates at 37ºC overnight 
 
8.7.10 Genomic rescue construct 
DNA was extracted via the ‘Isolation of genomic DNA’ protocol from w ; FRT42D 
y+ flies and PCR-amplified with the primer pairs CG14750.3, CG14750.4 and 
CG14750.5, CG14750.6 as described under ‘PCR amplification of genomic DNA and 
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cDNA’. Purification was obtained as reported under ‘Purification of PCR-amplified 
DNA’. The resulting PCR products were digested with EcoRI and XbaI and cloned 
into a pUAST plasmid. The genomic rescue construct was transformed into competent 
E. coli as described under ‘Bacterial transformation’ and amplified following 
‘Amplification of plasmids and constructs’. Correct vps25 sequences were confirmed 
as described under ‘Sequencing of amplified DNA’. The genomic rescue constructs 
were injected with self-pulled glass needles in preblastoderm embryos using an 
Axiovert 25 platform from Zeiss and the FemtoJet injection apparatus from 
Eppendorf. 
 
8.8 Genetic methods 
8.8.1 EMS screen 
1. Starve 50-100 males per empty bottle for 12h 
2. Prepare 25mM ethyl methane sulfonate (EMS) (240μl) suspension in 5% 
Sucrose (100ml) 
3. For inactivation of EMS use 10% Sodiumthiosulfate (500ml) 
4. Fold Kleenex towels to fit in empty bottles 
5. Fix Kleenex towels with pipette tip at bottom of bottle 
6. Add ~9ml of EMS suspension on Kleenex towel 
7. Transfer starved flies in prepared bottle 
8. Incubate flies for 24h 
9. Cross EMS treated males to ~double number of females 
10. Transfer flies every day to new bottle (about 10 days) 
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8.8.2 Recombination mapping 
See Fig. 2 for a detailed description of recombination mapping of the K2/N55 alleles 
according to the method described in (Zhai et al., 2003). 
 
8.8.3 Gal4-UAS system 
The Gal4-UAS system was used for over-expression of various genes of interest. Gal4 
is a transcriptional activator from yeast that targets genes which contain UAS 
sequences. By combining the Gal4 gene with tissue specific promoters (i. e. in this 
study Glass Multimer Reporter GMR) targeted over-expression of UAS-linked genes 
of interest can be achieved (Fischer et al., 1988). 
 
8.8.4 FLP/FRT system 
The FLP/FRT system was designed to create mutant tissue in a wild-type environment 
to be able to comparatively study the effects of certain genes of interest (in our case 
vps25). Tissue-specific (in our study the eyeless promoter) or heat shock-driven 
activation of Flippase induces mitotic recombination at FLP recombinase targets 
(FRTs) resulting in two different clones. One clone is mutant for the gene of interest 
and the other clone homozygous wild-type. Tissue that has not undergone mitotic 
recombination is heterozygous mutant. The phenotypes of the various clones can be 
visualized by appropriate markers (for example GFP and w+) located distally to the 
respective FRT (Xu and Rubin, 1993). 
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8.9 Photography 
8.9.1 Fly eye and head images 
To be prepared for photography, flies were anaesthetized with CO2 and frozen for 
20min at -80ºC. Flies were simply turned on their sides for photography of fly eyes. 
For pictures that were taken from the top the abdomen was glued (superglue) to the 
surface of a paper card. In order to prevent light reflection on the cuticle of the fly a 
2.5cm high ring was cut out of a white styrofoam cup and placed around the 
specimen. The two ends of a ‘goose neck’ light source ‘goose neck’ light source (KL 
1500 LCD from Leica or KL 2500 LCD from Zeiss) were pointed from the outside 
from opposite directions on the inside of the cup, allowing the light to reflect of the 
cup and onto the fly. Pictures were taken using the Z16 APO from Leica or the 
Imager.Z1 from Zeiss. Cameras were either the DFC 300 FX from Leica or tha 
AxioCam HRc from Zeiss. Software used was ImagePro Plus 6.1 for Leica or 
AxioVision Rel. 4.5 for Zeiss applications. For Zeiss applications individual pictures 
of one Z-stack were merged using the CZ Focus software. 
 
8.9.2 Fluorescence images 
Fluorescence pictures were taken using the confocal microscope Fluoview FV500 
with Fluoview software from Olympus or especially for lower magnification images 
the Imager.Z1 light microscope with Apotome technology, AxioVision Rel. 4.5 
software and the camera AxioCam MRm from Zeiss. For Zeiss applications 
individual pictures of one Z-stack were merged using the CZ Focus software. 
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8.9.3 Gel images 
Gel images were acquired with the AlphaImager 2200 from Alpha Innotech with 
AlphaImager 2200 software. 
 122
9 References 
 
Abrams, J. M. (2002). Competition and compensation: coupled to death in 
development and cancer. Cell 110, 403-6. 
Adachi-Yamada, T., Fujimura-Kamada, K., Nishida, Y. and Matsumoto, K. 
(1999). Distortion of proximodistal information causes JNK-dependent apoptosis in 
Drosophila wing. Nature 400, 166-9. 
Adachi-Yamada, T. and O'Connor, M. B. (2002). Morphogenetic apoptosis: a 
mechanism for correcting discontinuities in morphogen gradients. Dev Biol 251, 74-
90. 
Agromayor, M. and Martin-Serrano, J. (2006). Interaction of AMSH with ESCRT-
III and deubiquitination of endosomal cargo. J Biol Chem 281, 23083-91. 
Alam, S. L., Langelier, C., Whitby, F. G., Koirala, S., Robinson, H., Hill, C. P. 
and Sundquist, W. I. (2006). Structural basis for ubiquitin recognition by the human 
ESCRT-II EAP45 GLUE domain. Nat Struct Mol Biol 13, 1029-30. 
Alam, S. L., Sun, J., Payne, M., Welch, B. D., Blake, B. K., Davis, D. R., Meyer, 
H. H., Emr, S. D. and Sundquist, W. I. (2004). Ubiquitin interactions of NZF zinc 
fingers. Embo J 23, 1411-21. 
Allenspach, E. J., Maillard, I., Aster, J. C. and Pear, W. S. (2002). Notch signaling 
in cancer. Cancer Biol Ther 1, 466-76. 
 123
Amerik, A. Y., Nowak, J., Swaminathan, S. and Hochstrasser, M. (2000). The 
Doa4 deubiquitinating enzyme is functionally linked to the vacuolar protein-sorting 
and endocytic pathways. Mol Biol Cell 11, 3365-80. 
Azmi, I., Davies, B., Dimaano, C., Payne, J., Eckert, D., Babst, M. and 
Katzmann, D. J. (2006). Recycling of ESCRTs by the AAA-ATPase Vps4 is 
regulated by a conserved VSL region in Vta1. J Cell Biol 172, 705-17. 
Azmi, I. F., Davies, B. A., Xiao, J., Babst, M., Xu, Z. and Katzmann, D. J. (2008). 
ESCRT-III family members stimulate Vps4 ATPase activity directly or via Vta1. Dev 
Cell 14, 50-61. 
Babst, M. (2005). A protein's final ESCRT. Traffic 6, 2-9. 
Babst, M., Katzmann, D. J., Estepa-Sabal, E. J., Meerloo, T. and Emr, S. D. 
(2002a). Escrt-III: an endosome-associated heterooligomeric protein complex 
required for mvb sorting. Dev Cell 3, 271-82. 
Babst, M., Katzmann, D. J., Snyder, W. B., Wendland, B. and Emr, S. D. 
(2002b). Endosome-associated complex, ESCRT-II, recruits transport machinery for 
protein sorting at the multivesicular body. Dev Cell 3, 283-9. 
Babst, M., Odorizzi, G., Estepa, E. J. and Emr, S. D. (2000). Mammalian tumor 
susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in 
late endosomal trafficking. Traffic 1, 248-58. 
Babst, M., Sato, T. K., Banta, L. M. and Emr, S. D. (1997). Endosomal transport 
function in yeast requires a novel AAA-type ATPase, Vps4p. Embo J 16, 1820-31. 
 124
Babst, M., Wendland, B., Estepa, E. J. and Emr, S. D. (1998). The Vps4p AAA 
ATPase regulates membrane association of a Vps protein complex required for 
normal endosome function. Embo J 17, 2982-93. 
Bach, E. A., Vincent, S., Zeidler, M. P. and Perrimon, N. (2003). A sensitized 
genetic screen to identify novel regulators and components of the Drosophila janus 
kinase/signal transducer and activator of transcription pathway. Genetics 165, 1149-
66. 
Bache, K. G., Brech, A., Mehlum, A. and Stenmark, H. (2003a). Hrs regulates 
multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 162, 
435-42. 
Bache, K. G., Raiborg, C., Mehlum, A. and Stenmark, H. (2003b). STAM and Hrs 
are subunits of a multivalent ubiquitin-binding complex on early endosomes. J Biol 
Chem 278, 12513-21. 
Bache, K. G., Slagsvold, T., Cabezas, A., Rosendal, K. R., Raiborg, C. and 
Stenmark, H. (2004). The growth-regulatory protein HCRP1/hVps37A is a subunit 
of mammalian ESCRT-I and mediates receptor down-regulation. Mol Biol Cell 15, 
4337-46. 
Baehrecke, E. H. (2002). How death shapes life during development. Nat Rev Mol 
Cell Biol 3, 779-87. 
Bailey, A. M. and Posakony, J. W. (1995). Suppressor of hairless directly activates 
transcription of enhancer of split complex genes in response to Notch receptor 
activity. Genes Dev 9, 2609-22. 
 125
Bennett, F. C. and Harvey, K. F. (2006). Fat Cadherin Modulates Organ Size in 
Drosophila via the Salvador/Warts/Hippo Signaling Pathway. Curr Biol 16, 2101-10. 
Bergmann, A., Yang, A. Y. and Srivastava, M. (2003). Regulators of IAP function: 
coming to grips with the grim reaper. Curr Opin Cell Biol 15, 717-24. 
Bilodeau, P. S., Urbanowski, J. L., Winistorfer, S. C. and Piper, R. C. (2002). The 
Vps27p Hse1p complex binds ubiquitin and mediates endosomal protein sorting. Nat 
Cell Biol 4, 534-9. 
Bilodeau, P. S., Winistorfer, S. C., Kearney, W. R., Robertson, A. D. and Piper, 
R. C. (2003). Vps27-Hse1 and ESCRT-I complexes cooperate to increase efficiency 
of sorting ubiquitinated proteins at the endosome. J Cell Biol 163, 237-43. 
Bishop, N. and Woodman, P. (2000). ATPase-defective mammalian VPS4 localizes 
to aberrant endosomes and impairs cholesterol trafficking. Mol Biol Cell 11, 227-39. 
Bonifacino, J. S. (2004). The GGA proteins: adaptors on the move. Nat Rev Mol Cell 
Biol 5, 23-32. 
Bonifacino, J. S. and Traub, L. M. (2003). Signals for sorting of transmembrane 
proteins to endosomes and lysosomes. Annu Rev Biochem 72, 395-447. 
Bouamr, F., Houck-Loomis, B. R., De Los Santos, M., Casaday, R. J., Johnson, 
M. C. and Goff, S. P. (2007). The C-terminal portion of the Hrs protein interacts with 
Tsg101 and interferes with human immunodeficiency virus type 1 Gag particle 
production. J Virol 81, 2909-22. 
 126
Bowers, K., Lottridge, J., Helliwell, S. B., Goldthwaite, L. M., Luzio, J. P. and 
Stevens, T. H. (2004). Protein-protein interactions of ESCRT complexes in the yeast 
Saccharomyces cerevisiae. Traffic 5, 194-210. 
Bray, S. J. (2006). Notch signalling: a simple pathway becomes complex. Nat Rev 
Mol Cell Biol 7, 678-89. 
Brou, C., Logeat, F., Gupta, N., Bessia, C., LeBail, O., Doedens, J. R., Cumano, 
A., Roux, P., Black, R. A. and Israel, A. (2000). A novel proteolytic cleavage 
involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol 
Cell 5, 207-16. 
Brown, S., Hu, N. and Hombria, J. C. (2001). Identification of the first invertebrate 
interleukin JAK/STAT receptor, the Drosophila gene domeless. Curr Biol 11, 1700-5. 
Bucci, C., Parton, R. G., Mather, I. H., Stunnenberg, H., Simons, K., Hoflack, B. 
and Zerial, M. (1992). The small GTPase rab5 functions as a regulatory factor in the 
early endocytic pathway. Cell 70, 715-28. 
Burd, C. G. and Emr, S. D. (1998). Phosphatidylinositol(3)-phosphate signaling 
mediated by specific binding to RING FYVE domains. Mol Cell 2, 157-62. 
Burgdorf, S., Leister, P. and Scheidtmann, K. H. (2004). TSG101 interacts with 
apoptosis-antagonizing transcription factor and enhances androgen receptor-mediated 
transcription by promoting its monoubiquitination. J Biol Chem 279, 17524-34. 
Cabezas, A., Bache, K. G., Brech, A. and Stenmark, H. (2005). Alix regulates 
cortical actin and the spatial distribution of endosomes. J Cell Sci 118, 2625-35. 
 127
Carlton, J. G. and Martin-Serrano, J. (2007). Parallels between cytokinesis and 
retroviral budding: a role for the ESCRT machinery. Science 316, 1908-12. 
Carstens, M. J., Krempler, A., Triplett, A. A., Van Lohuizen, M. and Wagner, K. 
U. (2004). Cell cycle arrest and cell death are controlled by p53-dependent and p53-
independent mechanisms in Tsg101-deficient cells. J Biol Chem 279, 35984-94. 
Cashio, P., Lee, T. V. and Bergmann, A. (2005). Genetic control of programmed 
cell death in Drosophila melanogaster. Semin Cell Dev Biol 16, 225-35. 
Chao, J. L., Tsai, Y. C., Chiu, S. J. and Sun, Y. H. (2004). Localized Notch signal 
acts through eyg and upd to promote global growth in Drosophila eye. Development 
131, 3839-47. 
Chen, H. W., Chen, X., Oh, S. W., Marinissen, M. J., Gutkind, J. S. and Hou, S. 
X. (2002). mom identifies a receptor for the Drosophila JAK/STAT signal 
transduction pathway and encodes a protein distantly related to the mammalian 
cytokine receptor family. Genes Dev 16, 388-98. 
Chen, M. S., Obar, R. A., Schroeder, C. C., Austin, T. W., Poodry, C. A., 
Wadsworth, S. C. and Vallee, R. B. (1991). Multiple forms of dynamin are encoded 
by shibire, a Drosophila gene involved in endocytosis. Nature 351, 583-6. 
Chen, P., Nordstrom, W., Gish, B. and Abrams, J. M. (1996). grim, a novel cell 
death gene in Drosophila. Genes Dev 10, 1773-82. 
Childress, J. L., Acar, M., Tao, C. and Halder, G. (2006). Lethal Giant Discs, a 
Novel C2-Domain Protein, Restricts Notch Activation during Endocytosis. Curr Biol 
16, 2228-33. 
 128
Chu, T., Sun, J., Saksena, S. and Emr, S. D. (2006). New component of ESCRT-I 
regulates endosomal sorting complex assembly. J Cell Biol 175, 815-23. 
Cornell, M., Evans, D. A., Mann, R., Fostier, M., Flasza, M., Monthatong, M., 
Artavanis-Tsakonas, S. and Baron, M. (1999). The Drosophila melanogaster 
Suppressor of deltex gene, a regulator of the Notch receptor signaling pathway, is an 
E3 class ubiquitin ligase. Genetics 152, 567-76. 
Curtiss, M., Jones, C. and Babst, M. (2007). Efficient cargo sorting by ESCRT-I 
and the subsequent release of ESCRT-I from multivesicular bodies requires the 
subunit Mvb12. Mol Biol Cell 18, 636-45. 
Danial, N. N. and Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 
116, 205-19. 
de Celis, J. F. and Bray, S. (1997). Feed-back mechanisms affecting Notch 
activation at the dorsoventral boundary in the Drosophila wing. Development 124, 
3241-51. 
de Celis, J. F., Garcia-Bellido, A. and Bray, S. J. (1996). Activation and function of 
Notch at the dorsal-ventral boundary of the wing imaginal disc. Development 122, 
359-69. 
de Gassart, A., Geminard, C., Hoekstra, D. and Vidal, M. (2004). Exosome 
secretion: the art of reutilizing nonrecycled proteins? Traffic 5, 896-903. 
De Strooper, B., Annaert, W., Cupers, P., Saftig, P., Craessaerts, K., Mumm, J. 
S., Schroeter, E. H., Schrijvers, V., Wolfe, M. S., Ray, W. J. et al. (1999). A 
 129
presenilin-1-dependent gamma-secretase-like protease mediates release of Notch 
intracellular domain. Nature 398, 518-22. 
Deblandre, G. A., Lai, E. C. and Kintner, C. (2001). Xenopus neuralized is a 
ubiquitin ligase that interacts with XDelta1 and regulates Notch signaling. Dev Cell 1, 
795-806. 
Deftos, M. L., He, Y. W., Ojala, E. W. and Bevan, M. J. (1998). Correlating notch 
signaling with thymocyte maturation. Immunity 9, 777-86. 
Demirov, D. G. and Freed, E. O. (2004). Retrovirus budding. Virus Res 106, 87-
102. 
Diederich, R. J., Matsuno, K., Hing, H. and Artavanis-Tsakonas, S. (1994). 
Cytosolic interaction between deltex and Notch ankyrin repeats implicates deltex in 
the Notch signaling pathway. Development 120, 473-81. 
Dorstyn, L., Colussi, P. A., Quinn, L. M., Richardson, H. and Kumar, S. (1999). 
DRONC, an ecdysone-inducible Drosophila caspase. Proc Natl Acad Sci U S A 96, 
4307-12. 
Dudu, V., Pantazis, P. and Gonzalez-Gaitan, M. (2004). Membrane traffic during 
embryonic development: epithelial formation, cell fate decisions and differentiation. 
Curr Opin Cell Biol 16, 407-14. 
Dukes, J. D., Richardson, J. D., Simmons, R. and Whitley, P. (2008). A dominant-
negative ESCRT-III protein perturbs cytokinesis and trafficking to lysosomes. 
Biochem J 411, 233-9. 
 130
Duncan, L. M., Piper, S., Dodd, R. B., Saville, M. K., Sanderson, C. M., Luzio, J. 
P. and Lehner, P. J. (2006). Lysine-63-linked ubiquitination is required for 
endolysosomal degradation of class I molecules. Embo J 25, 1635-45. 
Edgar, B. A. (2006). From cell structure to transcription: Hippo forges a new path. 
Cell 124, 267-73. 
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D. 
and Sklar, J. (1991). TAN-1, the human homolog of the Drosophila notch gene, is 
broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66, 649-
61. 
Fan, Y. and Bergmann, A. (2008). Distinct mechanisms of apoptosis-induced 
compensatory proliferation in proliferating and differentiating tissues in the 
Drosophila eye. Dev Cell 14, 399-410. 
Fehon, R. G., Kooh, P. J., Rebay, I., Regan, C. L., Xu, T., Muskavitch, M. A. and 
Artavanis-Tsakonas, S. (1990). Molecular interactions between the protein products 
of the neurogenic loci Notch and Delta, two EGF-homologous genes in Drosophila. 
Cell 61, 523-34. 
Felder, S., Miller, K., Moehren, G., Ullrich, A., Schlessinger, J. and Hopkins, C. 
R. (1990). Kinase activity controls the sorting of the epidermal growth factor receptor 
within the multivesicular body. Cell 61, 623-34. 
Feng, G. H., Lih, C. J. and Cohen, S. N. (2000). TSG101 protein steady-state level 
is regulated posttranslationally by an evolutionarily conserved COOH-terminal 
sequence. Cancer Res 60, 1736-41. 
 131
Filimonenko, M., Stuffers, S., Raiborg, C., Yamamoto, A., Malerod, L., Fisher, 
E. M., Isaacs, A., Brech, A., Stenmark, H. and Simonsen, A. (2007). Functional 
multivesicular bodies are required for autophagic clearance of protein aggregates 
associated with neurodegenerative disease. J Cell Biol 179, 485-500. 
Fischer, J. A., Eun, S. H. and Doolan, B. T. (2006). Endocytosis, endosome 
trafficking, and the regulation of Drosophila development. Annu Rev Cell Dev Biol 
22, 181-206. 
Fischer, J. A., Giniger, E., Maniatis, T. and Ptashne, M. (1988). GAL4 activates 
transcription in Drosophila. Nature 332, 853-6. 
Fiuza, U. M. and Arias, A. M. (2007). Cell and molecular biology of Notch. J 
Endocrinol 194, 459-74. 
Fortini, M. E. (2002). Gamma-secretase-mediated proteolysis in cell-surface-receptor 
signalling. Nat Rev Mol Cell Biol 3, 673-84. 
Fortini, M. E. and Artavanis-Tsakonas, S. (1994). The suppressor of hairless 
protein participates in notch receptor signaling. Cell 79, 273-82. 
Fostier, M., Evans, D. A., Artavanis-Tsakonas, S. and Baron, M. (1998). Genetic 
characterization of the Drosophila melanogaster Suppressor of deltex gene: A 
regulator of notch signaling. Genetics 150, 1477-85. 
Fraser, A. G. and Evan, G. I. (1997). Identification of a Drosophila melanogaster 
ICE/CED-3-related protease, drICE. Embo J 16, 2805-13. 
Fraser, A. G., McCarthy, N. J. and Evan, G. I. (1997). drICE is an essential 
caspase required for apoptotic activity in Drosophila cells. Embo J 16, 6192-9. 
 132
Fujii, K., Hurley, J. H. and Freed, E. O. (2007). Beyond Tsg101: the role of Alix in 
'ESCRTing' HIV-1. Nat Rev Microbiol 5, 912-6. 
Fujimuro, M., Sawada, H. and Yokosawa, H. (1994). Production and 
characterization of monoclonal antibodies specific to multi-ubiquitin chains of 
polyubiquitinated proteins. FEBS Lett 349, 173-80. 
Fujimuro, M., Sawada, H. and Yokosawa, H. (1997). Dynamics of ubiquitin 
conjugation during heat-shock response revealed by using a monoclonal antibody 
specific to multi-ubiquitin chains. Eur J Biochem 249, 427-33. 
Fujita, H., Yamanaka, M., Imamura, K., Tanaka, Y., Nara, A., Yoshimori, T., 
Yokota, S. and Himeno, M. (2003). A dominant negative form of the AAA ATPase 
SKD1/VPS4 impairs membrane trafficking out of endosomal/lysosomal 
compartments: class E vps phenotype in mammalian cells. J Cell Sci 116, 401-14. 
Gallagher, C. M. and Knoblich, J. A. (2006). The conserved c2 domain protein 
lethal (2) giant discs regulates protein trafficking in Drosophila. Dev Cell 11, 641-53. 
Gallahan, D. and Callahan, R. (1987). Mammary tumorigenesis in feral mice: 
identification of a new int locus in mouse mammary tumor virus (Czech II)-induced 
mammary tumors. J Virol 61, 66-74. 
Garrus, J. E., von Schwedler, U. K., Pornillos, O. W., Morham, S. G., Zavitz, K. 
H., Wang, H. E., Wettstein, D. A., Stray, K. M., Cote, M., Rich, R. L. et al. 
(2001). Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 
budding. Cell 107, 55-65. 
 133
Gayther, S. A., Barski, P., Batley, S. J., Li, L., de Foy, K. A., Cohen, S. N., 
Ponder, B. A. and Caldas, C. (1997). Aberrant splicing of the TSG101 and FHIT 
genes occurs frequently in multiple malignancies and in normal tissues and mimics 
alterations previously described in tumours. Oncogene 15, 2119-26. 
Giebel, B. and Wodarz, A. (2006). Tumor suppressors: control of signaling by 
endocytosis. Curr Biol 16, R91-2. 
Gill, D. J., Teo, H., Sun, J., Perisic, O., Veprintsev, D. B., Emr, S. D. and 
Williams, R. L. (2007). Structural insight into the ESCRT-I/-II link and its role in 
MVB trafficking. Embo J 26, 600-12. 
Glittenberg, M., Pitsouli, C., Garvey, C., Delidakis, C. and Bray, S. (2006). Role 
of conserved intracellular motifs in Serrate signalling, cis-inhibition and endocytosis. 
Embo J 25, 4697-706. 
Gonzalez-Gaitan, M. (2003). Signal dispersal and transduction through the endocytic 
pathway. Nat Rev Mol Cell Biol 4, 213-24. 
Gorvel, J. P., Chavrier, P., Zerial, M. and Gruenberg, J. (1991). rab5 controls 
early endosome fusion in vitro. Cell 64, 915-25. 
Grabher, C., von Boehmer, H. and Look, A. T. (2006). Notch 1 activation in the 
molecular pathogenesis of T-cell acute lymphoblastic leukaemia. Nat Rev Cancer 6, 
347-59. 
Grether, M. E., Abrams, J. M., Agapite, J., White, K. and Steller, H. (1995). The 
head involution defective gene of Drosophila melanogaster functions in programmed 
cell death. Genes Dev 9, 1694-708. 
 134
Gruenberg, J. and Stenmark, H. (2004). The biogenesis of multivesicular 
endosomes. Nat Rev Mol Cell Biol 5, 317-23. 
Gruenberg, J. and van der Goot, F. G. (2006). Mechanisms of pathogen entry 
through the endosomal compartments. Nat Rev Mol Cell Biol 7, 495-504. 
Gupta-Rossi, N., Six, E., LeBail, O., Logeat, F., Chastagner, P., Olry, A., Israel, 
A. and Brou, C. (2004). Monoubiquitination and endocytosis direct gamma-secretase 
cleavage of activated Notch receptor. J Cell Biol 166, 73-83. 
Haas, T. J., Sliwinski, M. K., Martinez, D. E., Preuss, M., Ebine, K., Ueda, T., 
Nielsen, E., Odorizzi, G. and Otegui, M. S. (2007). The Arabidopsis AAA ATPase 
SKD1 is involved in multivesicular endosome function and interacts with its positive 
regulator LYST-INTERACTING PROTEIN5. Plant Cell 19, 1295-312. 
Haglund, K. and Dikic, I. (2005). Ubiquitylation and cell signaling. Embo J 24, 
3353-9. 
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., 
Jafar-Nejad, H. and Halder, G. (2006). The tumour-suppressor genes NF2/Merlin 
and Expanded act through Hippo signalling to regulate cell proliferation and 
apoptosis. Nat Cell Biol 8, 27-36. 
Hanahan, D. and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70. 
Hariharan, I. K. and Bilder, D. (2006). Regulation of imaginal disc growth by 
tumor-suppressor genes in Drosophila. Annu Rev Genet 40, 335-61. 
 135
Harrison, D. A., McCoon, P. E., Binari, R., Gilman, M. and Perrimon, N. (1998). 
Drosophila unpaired encodes a secreted protein that activates the JAK signaling 
pathway. Genes Dev 12, 3252-63. 
Harvey, K. and Tapon, N. (2007). The Salvador-Warts-Hippo pathway - an 
emerging tumour-suppressor network. Nat Rev Cancer 7, 182-91. 
Harvey, K. F., Pfleger, C. M. and Hariharan, I. K. (2003). The Drosophila Mst 
ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 
114, 457-67. 
Hawkins, C. J., Wang, S. L. and Hay, B. A. (1999). A cloning method to identify 
caspases and their regulators in yeast: identification of Drosophila IAP1 as an 
inhibitor of the Drosophila caspase DCP-1. Proc Natl Acad Sci U S A 96, 2885-90. 
Hay, B. A., Huh, J. R. and Guo, M. (2004). The genetics of cell death: approaches, 
insights and opportunities in Drosophila. Nat Rev Genet 5, 911-22. 
Hay, B. A., Wassarman, D. A. and Rubin, G. M. (1995). Drosophila homologs of 
baculovirus inhibitor of apoptosis proteins function to block cell death. Cell 83, 1253-
62. 
Hengartner, M. O. (2000). The biochemistry of apoptosis. Nature 407, 770-6. 
Herz, H. M., Chen, Z., Scherr, H., Lackey, M., Bolduc, C. and Bergmann, A. 
(2006). vps25 mosaics display non-autonomous cell survival and overgrowth, and 
autonomous apoptosis. Development 133, 1871-80. 
Hicke, L. and Dunn, R. (2003). Regulation of membrane protein transport by 
ubiquitin and ubiquitin-binding proteins. Annu Rev Cell Dev Biol 19, 141-72. 
 136
Hicke, L., Schubert, H. L. and Hill, C. P. (2005). Ubiquitin-binding domains. Nat 
Rev Mol Cell Biol 6, 610-21. 
Hierro, A., Sun, J., Rusnak, A. S., Kim, J., Prag, G., Emr, S. D. and Hurley, J. H. 
(2004). Structure of the ESCRT-II endosomal trafficking complex. Nature 431, 221-5. 
Hinshaw, J. E. (2000). Dynamin and its role in membrane fission. Annu Rev Cell Dev 
Biol 16, 483-519. 
Hipfner, D. R. and Cohen, S. M. (2004). Connecting proliferation and apoptosis in 
development and disease. Nat Rev Mol Cell Biol 5, 805-15. 
Hirano, S., Suzuki, N., Slagsvold, T., Kawasaki, M., Trambaiolo, D., Kato, R., 
Stenmark, H. and Wakatsuki, S. (2006). Structural basis of ubiquitin recognition by 
mammalian Eap45 GLUE domain. Nat Struct Mol Biol 13, 1031-2. 
Holley, C. L., Olson, M. R., Colon-Ramos, D. A. and Kornbluth, S. (2002). Reaper 
eliminates IAP proteins through stimulated IAP degradation and generalized 
translational inhibition. Nat Cell Biol 4, 439-44. 
Howard, T. L., Stauffer, D. R., Degnin, C. R. and Hollenberg, S. M. (2001). 
CHMP1 functions as a member of a newly defined family of vesicle trafficking 
proteins. J Cell Sci 114, 2395-404. 
Huang, F., Kirkpatrick, D., Jiang, X., Gygi, S. and Sorkin, A. (2006). Differential 
regulation of EGF receptor internalization and degradation by multiubiquitination 
within the kinase domain. Mol Cell 21, 737-48. 
 137
Huh, J. R., Guo, M. and Hay, B. A. (2004). Compensatory proliferation induced by 
cell death in the Drosophila wing disc requires activity of the apical cell death caspase 
Dronc in a nonapoptotic role. Curr Biol 14, 1262-6. 
Hurley, J. H. (2008). ESCRT complexes and the biogenesis of multivesicular bodies. 
Curr Opin Cell Biol 20, 4-11. 
Hurley, J. H. and Emr, S. D. (2006). The ESCRT complexes: structure and 
mechanism of a membrane-trafficking network. Annu Rev Biophys Biomol Struct 35, 
277-98. 
Igaki, T., Yamamoto-Goto, Y., Tokushige, N., Kanda, H. and Miura, M. (2002). 
Down-regulation of DIAP1 triggers a novel Drosophila cell death pathway mediated 
by Dark and DRONC. J Biol Chem 277, 23103-6. 
Irion, U. and St Johnston, D. (2007). bicoid RNA localization requires specific 
binding of an endosomal sorting complex. Nature 445, 554-8. 
Itoh, M., Kim, C. H., Palardy, G., Oda, T., Jiang, Y. J., Maust, D., Yeo, S. Y., 
Lorick, K., Wright, G. J., Ariza-McNaughton, L. et al. (2003). Mind bomb is a 
ubiquitin ligase that is essential for efficient activation of Notch signaling by Delta. 
Dev Cell 4, 67-82. 
Jacobsen, T. L., Brennan, K., Arias, A. M. and Muskavitch, M. A. (1998). Cis-
interactions between Delta and Notch modulate neurogenic signalling in Drosophila. 
Development 125, 4531-40. 
Jacobson, M. D., Weil, M. and Raff, M. C. (1997). Programmed cell death in 
animal development. Cell 88, 347-54. 
 138
Jaekel, R. and Klein, T. (2006). The Drosophila Notch inhibitor and tumor 
suppressor gene lethal (2) giant discs encodes a conserved regulator of endosomal 
trafficking. Dev Cell 11, 655-69. 
Jehn, B. M., Bielke, W., Pear, W. S. and Osborne, B. A. (1999). Cutting edge: 
protective effects of notch-1 on TCR-induced apoptosis. J Immunol 162, 635-8. 
Jehn, B. M., Dittert, I., Beyer, S., von der Mark, K. and Bielke, W. (2002). c-Cbl 
binding and ubiquitin-dependent lysosomal degradation of membrane-associated 
Notch1. J Biol Chem 277, 8033-40. 
Jekely, G. and Rorth, P. (2003). Hrs mediates downregulation of multiple signalling 
receptors in Drosophila. EMBO Rep 4, 1163-8. 
Jennings, B., Preiss, A., Delidakis, C. and Bray, S. (1994). The Notch signalling 
pathway is required for Enhancer of split bHLH protein expression during 
neurogenesis in the Drosophila embryo. Development 120, 3537-48. 
Johnson, M. C., Spidel, J. L., Ako-Adjei, D., Wills, J. W. and Vogt, V. M. (2005). 
The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters 
Gag into unique nonendosomal structures. J Virol 79, 3775-86. 
Kaether, C., Haass, C. and Steiner, H. (2006). Assembly, trafficking and function 
of gamma-secretase. Neurodegener Dis 3, 275-83. 
Kaiser, W. J., Vucic, D. and Miller, L. K. (1998). The Drosophila inhibitor of 
apoptosis D-IAP1 suppresses cell death induced by the caspase drICE. FEBS Lett 440, 
243-8. 
 139
Kamura, T., Burian, D., Khalili, H., Schmidt, S. L., Sato, S., Liu, W. J., Conrad, 
M. N., Conaway, R. C., Conaway, J. W. and Shilatifard, A. (2001). Cloning and 
characterization of ELL-associated proteins EAP45 and EAP20. a role for yeast EAP-
like proteins in regulation of gene expression by glucose. J Biol Chem 276, 16528-33. 
Kastan, M. B. and Bartek, J. (2004). Cell-cycle checkpoints and cancer. Nature 432, 
316-23. 
Katzmann, D. J., Babst, M. and Emr, S. D. (2001). Ubiquitin-dependent sorting 
into the multivesicular body pathway requires the function of a conserved endosomal 
protein sorting complex, ESCRT-I. Cell 106, 145-55. 
Katzmann, D. J., Odorizzi, G. and Emr, S. D. (2002). Receptor downregulation and 
multivesicular-body sorting. Nat Rev Mol Cell Biol 3, 893-905. 
Katzmann, D. J., Stefan, C. J., Babst, M. and Emr, S. D. (2003). Vps27 recruits 
ESCRT machinery to endosomes during MVB sorting. J Cell Biol 162, 413-23. 
Khoury, C. M., Yang, Z., Ismail, S. and Greenwood, M. T. (2007). 
Characterization of a novel alternatively spliced human transcript encoding an N-
terminally truncated Vps24 protein that suppresses the effects of Bax in an ESCRT 
independent manner in yeast. Gene 391, 233-41. 
Klein, T., Brennan, K. and Arias, A. M. (1997). An intrinsic dominant negative 
activity of serrate that is modulated during wing development in Drosophila. Dev Biol 
189, 123-34. 
 140
Kopan, R., Schroeter, E. H., Weintraub, H. and Nye, J. S. (1996). Signal 
transduction by activated mNotch: importance of proteolytic processing and its 
regulation by the extracellular domain. Proc Natl Acad Sci U S A 93, 1683-8. 
Kostelansky, M. S., Schluter, C., Tam, Y. Y., Lee, S., Ghirlando, R., Beach, B., 
Conibear, E. and Hurley, J. H. (2007). Molecular architecture and functional model 
of the complete yeast ESCRT-I heterotetramer. Cell 129, 485-98. 
Kostelansky, M. S., Sun, J., Lee, S., Kim, J., Ghirlando, R., Hierro, A., Emr, S. 
D. and Hurley, J. H. (2006). Structural and functional organization of the ESCRT-I 
trafficking complex. Cell 125, 113-26. 
Kramatschek, B. and Campos-Ortega, J. A. (1994). Neuroectodermal transcription 
of the Drosophila neurogenic genes E(spl) and HLH-m5 is regulated by proneural 
genes. Development 120, 815-26. 
Kramer, H. and Phistry, M. (1996). Mutations in the Drosophila hook gene inhibit 
endocytosis of the boss transmembrane ligand into multivesicular bodies. J Cell Biol 
133, 1205-15. 
Kranz, A., Kinner, A. and Kolling, R. (2001). A family of small coiled-coil-forming 
proteins functioning at the late endosome in yeast. Mol Biol Cell 12, 711-23. 
Krempler, A., Henry, M. D., Triplett, A. A. and Wagner, K. U. (2002). Targeted 
deletion of the Tsg101 gene results in cell cycle arrest at G1/S and p53-independent 
cell death. J Biol Chem 277, 43216-23. 
 141
Kuranaga, E., Kanuka, H., Igaki, T., Sawamoto, K., Ichijo, H., Okano, H. and 
Miura, M. (2002). Reaper-mediated inhibition of DIAP1-induced DTRAF1 
degradation results in activation of JNK in Drosophila. Nat Cell Biol 4, 705-10. 
Kyuuma, M., Kikuchi, K., Kojima, K., Sugawara, Y., Sato, M., Mano, N., Goto, 
J., Takeshita, T., Yamamoto, A., Sugamura, K. et al. (2007). AMSH, an ESCRT-
III associated enzyme, deubiquitinates cargo on MVB/late endosomes. Cell Struct 
Funct 31, 159-72. 
Ladi, E., Nichols, J. T., Ge, W., Miyamoto, A., Yao, C., Yang, L. T., Boulter, J., 
Sun, Y. E., Kintner, C. and Weinmaster, G. (2005). The divergent DSL ligand Dll3 
does not activate Notch signaling but cell autonomously attenuates signaling induced 
by other DSL ligands. J Cell Biol 170, 983-92. 
Lai, E. C., Deblandre, G. A., Kintner, C. and Rubin, G. M. (2001). Drosophila 
neuralized is a ubiquitin ligase that promotes the internalization and degradation of 
delta. Dev Cell 1, 783-94. 
Lai, E. C., Roegiers, F., Qin, X., Jan, Y. N. and Rubin, G. M. (2005). The ubiquitin 
ligase Drosophila Mind bomb promotes Notch signaling by regulating the localization 
and activity of Serrate and Delta. Development 132, 2319-32. 
Lambert, C., Doring, T. and Prange, R. (2007). Hepatitis B virus maturation is 
sensitive to functional inhibition of ESCRT-III, Vps4, and gamma 2-adaptin. J Virol 
81, 9050-60. 
Langelier, C., von Schwedler, U. K., Fisher, R. D., De Domenico, I., White, P. L., 
Hill, C. P., Kaplan, J., Ward, D. and Sundquist, W. I. (2006). Human ESCRT-II 
 142
complex and its role in human immunodeficiency virus type 1 release. J Virol 80, 
9465-80. 
Le Borgne, R. (2006). Regulation of Notch signalling by endocytosis and endosomal 
sorting. Curr Opin Cell Biol 18, 213-22. 
Le Borgne, R., Bardin, A. and Schweisguth, F. (2005). The roles of receptor and 
ligand endocytosis in regulating Notch signaling. Development 132, 1751-62. 
Le Borgne, R. and Schweisguth, F. (2003a). Notch signaling: endocytosis makes 
delta signal better. Curr Biol 13, R273-5. 
Le Borgne, R. and Schweisguth, F. (2003b). Unequal segregation of Neuralized 
biases Notch activation during asymmetric cell division. Dev Cell 5, 139-48. 
Le Roy, C. and Wrana, J. L. (2005a). Clathrin- and non-clathrin-mediated endocytic 
regulation of cell signalling. Nat Rev Mol Cell Biol 6, 112-26. 
Le Roy, C. and Wrana, J. L. (2005b). Signaling and endocytosis: a team effort for 
cell migration. Dev Cell 9, 167-8. 
Lee, J. A., Beigneux, A., Ahmad, S. T., Young, S. G. and Gao, F. B. (2007). 
ESCRT-III Dysfunction Causes Autophagosome Accumulation and 
Neurodegeneration. Curr Biol 17, 1561-7. 
Lee, J. A. and Gao, F. B. (2008). Roles of ESCRT in autophagy-associated 
neurodegeneration. Autophagy 4, 230-2. 
Lee, M. P. and Feinberg, A. P. (1997). Aberrant splicing but not mutations of 
TSG101 in human breast cancer. Cancer Res 57, 3131-4. 
 143
Lee, T. and Luo, L. (2001). Mosaic analysis with a repressible cell marker 
(MARCM) for Drosophila neural development. Trends Neurosci 24, 251-4. 
Lee, T. V., Ding, T., Chen, Z., Rajendran, V., Scherr, H., Lackey, M., Bolduc, C. 
and Bergmann, A. (2008). The E1 ubiquitin-activating enzyme Uba1 in Drosophila 
controls apoptosis autonomously and tissue growth non-autonomously. Development 
135, 43-52. 
Levine, B. and Kroemer, G. (2008). Autophagy in the pathogenesis of disease. Cell 
132, 27-42. 
Li, L. and Cohen, S. N. (1996). Tsg101: a novel tumor susceptibility gene isolated by 
controlled homozygous functional knockout of allelic loci in mammalian cells. Cell 
85, 319-29. 
Li, L., Li, X., Francke, U. and Cohen, S. N. (1997). The TSG101 tumor 
susceptibility gene is located in chromosome 11 band p15 and is mutated in human 
breast cancer. Cell 88, 143-54. 
Li, L., Liao, J., Ruland, J., Mak, T. W. and Cohen, S. N. (2001). A 
TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 
feedback control. Proc Natl Acad Sci U S A 98, 1619-24. 
Li, Y. and Baker, N. E. (2004). The roles of cis-inactivation by Notch ligands and of 
neuralized during eye and bristle patterning in Drosophila. BMC Dev Biol 4, 5. 
Licata, J. M., Simpson-Holley, M., Wright, N. T., Han, Z., Paragas, J. and Harty, 
R. N. (2003). Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 
 144
protein function independently as late budding domains: involvement of host proteins 
TSG101 and VPS-4. J Virol 77, 1812-9. 
Lin, S. Y., Chen, Y. J. and Chang, J. G. (1998). Multiple truncated transcripts of 
TSG101 in gastrointestinal cancers. J Gastroenterol Hepatol 13, 1111-4. 
Liu, W. H., Hsiao, H. W., Tsou, W. I. and Lai, M. Z. (2007). Notch inhibits 
apoptosis by direct interference with XIAP ubiquitination and degradation. Embo J 
26, 1660-9. 
Lloyd, T. E., Atkinson, R., Wu, M. N., Zhou, Y., Pennetta, G. and Bellen, H. J. 
(2002). Hrs regulates endosome membrane invagination and tyrosine kinase receptor 
signaling in Drosophila. Cell 108, 261-9. 
Lohi, O. and Lehto, V. P. (2001). STAM/EAST/Hbp adapter proteins--integrators of 
signalling pathways. FEBS Lett 508, 287-90. 
Lottridge, J. M., Flannery, A. R., Vincelli, J. L. and Stevens, T. H. (2006). Vta1p 
and Vps46p regulate the membrane association and ATPase activity of Vps4p at the 
yeast multivesicular body. Proc Natl Acad Sci U S A 103, 6202-7. 
Lowe, S. W., Cepero, E. and Evan, G. (2004). Intrinsic tumour suppression. Nature 
432, 307-15. 
Lu, H. and Bilder, D. (2005). Endocytic control of epithelial polarity and 
proliferation in Drosophila. Nat Cell Biol 7, 1232-9. 
Lu, Q., Hope, L. W., Brasch, M., Reinhard, C. and Cohen, S. N. (2003). TSG101 
interaction with HRS mediates endosomal trafficking and receptor down-regulation. 
Proc Natl Acad Sci U S A 100, 7626-31. 
 145
Luhtala, N. and Odorizzi, G. (2004). Bro1 coordinates deubiquitination in the 
multivesicular body pathway by recruiting Doa4 to endosomes. J Cell Biol 166, 717-
29. 
Luzio, J. P., Pryor, P. R. and Bright, N. A. (2007). Lysosomes: fusion and function. 
Nat Rev Mol Cell Biol 8, 622-32. 
Ma, Y. M., Boucrot, E., Villen, J., Affar el, B., Gygi, S. P., Gottlinger, H. G. and 
Kirchhausen, T. (2007). Targeting of AMSH to endosomes is required for epidermal 
growth factor receptor degradation. J Biol Chem 282, 9805-12. 
Mahul-Mellier, A. L., Hemming, F. J., Blot, B., Fraboulet, S. and Sadoul, R. 
(2006). Alix, making a link between apoptosis-linked gene-2, the endosomal sorting 
complexes required for transport, and neuronal death in vivo. J Neurosci 26, 542-9. 
Maiuri, M. C., Zalckvar, E., Kimchi, A. and Kroemer, G. (2007). Self-eating and 
self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8, 
741-52. 
Mao, Y., Nickitenko, A., Duan, X., Lloyd, T. E., Wu, M. N., Bellen, H. and 
Quiocho, F. A. (2000). Crystal structure of the VHS and FYVE tandem domains of 
Hrs, a protein involved in membrane trafficking and signal transduction. Cell 100, 
447-56. 
Martin-Blanco, E., Gampel, A., Ring, J., Virdee, K., Kirov, N., Tolkovsky, A. M. 
and Martinez-Arias, A. (1998). puckered encodes a phosphatase that mediates a 
feedback loop regulating JNK activity during dorsal closure in Drosophila. Genes Dev 
12, 557-70. 
 146
Martin-Serrano, J. (2007). The role of ubiquitin in retroviral egress. Traffic 8, 1297-
303. 
Martin-Serrano, J., Yarovoy, A., Perez-Caballero, D. and Bieniasz, P. D. (2003a). 
Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by 
using alternative adaptor proteins. Proc Natl Acad Sci U S A 100, 12414-9. 
Martin-Serrano, J., Zang, T. and Bieniasz, P. D. (2001). HIV-1 and Ebola virus 
encode small peptide motifs that recruit Tsg101 to sites of particle assembly to 
facilitate egress. Nat Med 7, 1313-9. 
Martin-Serrano, J., Zang, T. and Bieniasz, P. D. (2003b). Role of ESCRT-I in 
retroviral budding. J Virol 77, 4794-804. 
Massague, J. (2004). G1 cell-cycle control and cancer. Nature 432, 298-306. 
Mathew, R., Karantza-Wadsworth, V. and White, E. (2007). Role of autophagy in 
cancer. Nat Rev Cancer 7, 961-7. 
Matsuno, K., Diederich, R. J., Go, M. J., Blaumueller, C. M. and Artavanis-
Tsakonas, S. (1995). Deltex acts as a positive regulator of Notch signaling through 
interactions with the Notch ankyrin repeats. Development 121, 2633-44. 
McCullough, J., Clague, M. J. and Urbe, S. (2004). AMSH is an endosome-
associated ubiquitin isopeptidase. J Cell Biol 166, 487-92. 
McCullough, J., Row, P. E., Lorenzo, O., Doherty, M., Beynon, R., Clague, M. J. 
and Urbe, S. (2006). Activation of the endosome-associated ubiquitin isopeptidase 
AMSH by STAM, a component of the multivesicular body-sorting machinery. Curr 
Biol 16, 160-5. 
 147
Medina, G., Zhang, Y., Tang, Y., Gottwein, E., Vana, M. L., Bouamr, F., Leis, J. 
and Carter, C. A. (2005). The functionally exchangeable L domains in RSV and 
HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic 6, 880-
94. 
Meier, P., Finch, A. and Evan, G. (2000a). Apoptosis in development. Nature 407, 
796-801. 
Meier, P., Silke, J., Leevers, S. J. and Evan, G. I. (2000b). The Drosophila caspase 
DRONC is regulated by DIAP1. Embo J 19, 598-611. 
Micchelli, C. A., Rulifson, E. J. and Blair, S. S. (1997). The function and regulation 
of cut expression on the wing margin of Drosophila: Notch, Wingless and a dominant 
negative role for Delta and Serrate. Development 124, 1485-95. 
Miele, L., Golde, T. and Osborne, B. (2006). Notch signaling in cancer. Curr Mol 
Med 6, 905-18. 
Miller, D. T. and Cagan, R. L. (1998). Local induction of patterning and 
programmed cell death in the developing Drosophila retina. Development 125, 2327-
35. 
Misra, S. and Hurley, J. H. (1999). Crystal structure of a phosphatidylinositol 3-
phosphate-specific membrane-targeting motif, the FYVE domain of Vps27p. Cell 97, 
657-66. 
Mizushima, N. (2007). Autophagy: process and function. Genes Dev 21, 2861-73. 
 148
Moberg, K. H., Schelble, S., Burdick, S. K. and Hariharan, I. K. (2005). 
Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility 
gene 101, elicit non-cell-autonomous overgrowth. Dev Cell 9, 699-710. 
Morata, G. and Ripoll, P. (1975). Minutes: mutants of drosophila autonomously 
affecting cell division rate. Dev Biol 42, 211-21. 
Moreno, E., Basler, K. and Morata, G. (2002). Cells compete for decapentaplegic 
survival factor to prevent apoptosis in Drosophila wing development. Nature 416, 
755-9. 
Morita, E., Sandrin, V., Chung, H. Y., Morham, S. G., Gygi, S. P., Rodesch, C. 
K. and Sundquist, W. I. (2007). Human ESCRT and ALIX proteins interact with 
proteins of the midbody and function in cytokinesis. Embo J 26, 4215-27. 
Morita, E. and Sundquist, W. I. (2004). Retrovirus budding. Annu Rev Cell Dev 
Biol 20, 395-425. 
Mukherjee, A., Veraksa, A., Bauer, A., Rosse, C., Camonis, J. and Artavanis-
Tsakonas, S. (2005). Regulation of Notch signalling by non-visual beta-arrestin. Nat 
Cell Biol 7, 1191-201. 
Muller, P., Kuttenkeuler, D., Gesellchen, V., Zeidler, M. P. and Boutros, M. 
(2005). Identification of JAK/STAT signalling components by genome-wide RNA 
interference. Nature 436, 871-5. 
Mumm, J. S. and Kopan, R. (2000). Notch signaling: from the outside in. Dev Biol 
228, 151-65. 
 149
Mumm, J. S., Schroeter, E. H., Saxena, M. T., Griesemer, A., Tian, X., Pan, D. J., 
Ray, W. J. and Kopan, R. (2000). A ligand-induced extracellular cleavage regulates 
gamma-secretase-like proteolytic activation of Notch1. Mol Cell 5, 197-206. 
Muziol, T., Pineda-Molina, E., Ravelli, R. B., Zamborlini, A., Usami, Y., 
Gottlinger, H. and Weissenhorn, W. (2006). Structural basis for budding by the 
ESCRT-III factor CHMP3. Dev Cell 10, 821-30. 
Newsome, T. P., Asling, B. and Dickson, B. J. (2000). Analysis of Drosophila 
photoreceptor axon guidance in eye-specific mosaics. Development 127, 851-60. 
Nickerson, D. P., Russell, M. R. and Odorizzi, G. (2007). A concentric circle model 
of multivesicular body cargo sorting. EMBO Rep 8, 644-50. 
Nickerson, D. P., West, M. and Odorizzi, G. (2006). Did2 coordinates Vps4-
mediated dissociation of ESCRT-III from endosomes. J Cell Biol 175, 715-20. 
Nikko, E. and Andre, B. (2007). Split-ubiquitin two-hybrid assay to analyze protein-
protein interactions at the endosome: application to Saccharomyces cerevisiae Bro1 
interacting with ESCRT complexes, the Doa4 ubiquitin hydrolase, and the Rsp5 
ubiquitin ligase. Eukaryot Cell 6, 1266-77. 
Nishi, T. and Forgac, M. (2002). The vacuolar (H+)-ATPases--nature's most 
versatile proton pumps. Nat Rev Mol Cell Biol 3, 94-103. 
Obita, T., Saksena, S., Ghazi-Tabatabai, S., Gill, D. J., Perisic, O., Emr, S. D. and 
Williams, R. L. (2007). Structural basis for selective recognition of ESCRT-III by the 
AAA ATPase Vps4. Nature 449, 735-9. 
 150
Odorizzi, G., Babst, M. and Emr, S. D. (1998). Fab1p PtdIns(3)P 5-kinase function 
essential for protein sorting in the multivesicular body. Cell 95, 847-58. 
Odorizzi, G., Katzmann, D. J., Babst, M., Audhya, A. and Emr, S. D. (2003). 
Bro1 is an endosome-associated protein that functions in the MVB pathway in 
Saccharomyces cerevisiae. J Cell Sci 116, 1893-903. 
Oestreich, A. J., Davies, B. A., Payne, J. A. and Katzmann, D. J. (2007). Mvb12 is 
a novel member of ESCRT-I involved in cargo selection by the multivesicular body 
pathway. Mol Biol Cell 18, 646-57. 
Oh, H., Mammucari, C., Nenci, A., Cabodi, S., Cohen, S. N. and Dotto, G. P. 
(2002). Negative regulation of cell growth and differentiation by TSG101 through 
association with p21(Cip1/WAF1). Proc Natl Acad Sci U S A 99, 5430-5. 
Oh, K. B., Stanton, M. J., West, W. W., Todd, G. L. and Wagner, K. U. (2007). 
Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted 
overexpression in transgenic mice reveals weak oncogenic properties for mammary 
cancer initiation. Oncogene 26, 5950-9. 
Overstreet, E., Fitch, E. and Fischer, J. A. (2004). Fat facets and Liquid facets 
promote Delta endocytosis and Delta signaling in the signaling cells. Development 
131, 5355-66. 
Pan, D. (2007). Hippo signaling in organ size control. Genes Dev 21, 886-97. 
Panin, V. M., Papayannopoulos, V., Wilson, R. and Irvine, K. D. (1997). Fringe 
modulates Notch-ligand interactions. Nature 387, 908-12. 
 151
Pantalacci, S., Tapon, N. and Leopold, P. (2003). The Salvador partner Hippo 
promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5, 921-7. 
Parkinson, N., Ince, P. G., Smith, M. O., Highley, R., Skibinski, G., Andersen, P. 
M., Morrison, K. E., Pall, H. S., Hardiman, O., Collinge, J. et al. (2006). ALS 
phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). 
Neurology. 
Pasternak, S. H., Bagshaw, R. D., Guiral, M., Zhang, S., Ackerley, C. A., Pak, B. 
J., Callahan, J. W. and Mahuran, D. J. (2003). Presenilin-1, nicastrin, amyloid 
precursor protein, and gamma-secretase activity are co-localized in the lysosomal 
membrane. J Biol Chem 278, 26687-94. 
Pavlopoulos, E., Pitsouli, C., Klueg, K. M., Muskavitch, M. A., Moschonas, N. K. 
and Delidakis, C. (2001). neuralized Encodes a peripheral membrane protein 
involved in delta signaling and endocytosis. Dev Cell 1, 807-16. 
Peck, J. W., Bowden, E. T. and Burbelo, P. D. (2004). Structure and function of 
human Vps20 and Snf7 proteins. Biochem J 377, 693-700. 
Perez-Garijo, A., Martin, F. A. and Morata, G. (2004). Caspase inhibition during 
apoptosis causes abnormal signalling and developmental aberrations in Drosophila. 
Development 131, 5591-8. 
Petcherski, A. G. and Kimble, J. (2000). LAG-3 is a putative transcriptional 
activator in the C. elegans Notch pathway. Nature 405, 364-8. 
Philips, J. A., Porto, M. C., Wang, H., Rubin, E. J. and Perrimon, N. (2008). 
ESCRT factors restrict mycobacterial growth. Proc Natl Acad Sci U S A 105, 3070-5. 
 152
Polo, S. and Di Fiore, P. P. (2006). Endocytosis conducts the cell signaling 
orchestra. Cell 124, 897-900. 
Poodry, C. A. (1990). shibire, a neurogenic mutant of Drosophila. Dev Biol 138, 464-
72. 
Pornillos, O., Alam, S. L., Davis, D. R. and Sundquist, W. I. (2002a). Structure of 
the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. 
Nat Struct Biol 9, 812-7. 
Pornillos, O., Alam, S. L., Rich, R. L., Myszka, D. G., Davis, D. R. and 
Sundquist, W. I. (2002b). Structure and functional interactions of the Tsg101 UEV 
domain. Embo J 21, 2397-406. 
Pornillos, O., Garrus, J. E. and Sundquist, W. I. (2002c). Mechanisms of 
enveloped RNA virus budding. Trends Cell Biol 12, 569-79. 
Pornillos, O., Higginson, D. S., Stray, K. M., Fisher, R. D., Garrus, J. E., Payne, 
M., He, G. P., Wang, H. E., Morham, S. G. and Sundquist, W. I. (2003). HIV Gag 
mimics the Tsg101-recruiting activity of the human Hrs protein. J Cell Biol 162, 425-
34. 
Prag, G., Watson, H., Kim, Y. C., Beach, B. M., Ghirlando, R., Hummer, G., 
Bonifacino, J. S. and Hurley, J. H. (2007). The Vps27/Hse1 complex is a GAT 
domain-based scaffold for ubiquitin-dependent sorting. Dev Cell 12, 973-86. 
Qi, H., Rand, M. D., Wu, X., Sestan, N., Wang, W., Rakic, P., Xu, T. and 
Artavanis-Tsakonas, S. (1999). Processing of the notch ligand delta by the 
metalloprotease Kuzbanian. Science 283, 91-4. 
 153
Radtke, F. and Raj, K. (2003). The role of Notch in tumorigenesis: oncogene or 
tumour suppressor? Nat Rev Cancer 3, 756-67. 
Raiborg, C., Bache, K. G., Gillooly, D. J., Madshus, I. H., Stang, E. and 
Stenmark, H. (2002). Hrs sorts ubiquitinated proteins into clathrin-coated 
microdomains of early endosomes. Nat Cell Biol 4, 394-8. 
Raiborg, C., Bache, K. G., Mehlum, A., Stang, E. and Stenmark, H. (2001a). Hrs 
recruits clathrin to early endosomes. Embo J 20, 5008-21. 
Raiborg, C., Bremnes, B., Mehlum, A., Gillooly, D. J., D'Arrigo, A., Stang, E. 
and Stenmark, H. (2001b). FYVE and coiled-coil domains determine the specific 
localisation of Hrs to early endosomes. J Cell Sci 114, 2255-63. 
Raiborg, C., Rusten, T. E. and Stenmark, H. (2003). Protein sorting into 
multivesicular endosomes. Curr Opin Cell Biol 15, 446-55. 
Ray, W. J., Yao, M., Mumm, J., Schroeter, E. H., Saftig, P., Wolfe, M., Selkoe, D. 
J., Kopan, R. and Goate, A. M. (1999). Cell surface presenilin-1 participates in the 
gamma-secretase-like proteolysis of Notch. J Biol Chem 274, 36801-7. 
Raymond, C. K., Howald-Stevenson, I., Vater, C. A. and Stevens, T. H. (1992). 
Morphological classification of the yeast vacuolar protein sorting mutants: evidence 
for a prevacuolar compartment in class E vps mutants. Mol Biol Cell 3, 1389-402. 
Reid, E., Connell, J., Edwards, T. L., Duley, S., Brown, S. E. and Sanderson, C. 
M. (2005). The hereditary spastic paraplegia protein spastin interacts with the 
ESCRT-III complex-associated endosomal protein CHMP1B. Hum Mol Genet 14, 19-
38. 
 154
Reynolds-Kenneally, J. and Mlodzik, M. (2005). Notch signaling controls 
proliferation through cell-autonomous and non-autonomous mechanisms in the 
Drosophila eye. Dev Biol 285, 38-48. 
Reynolds, T. C., Smith, S. D. and Sklar, J. (1987). Analysis of DNA surrounding 
the breakpoints of chromosomal translocations involving the beta T cell receptor gene 
in human lymphoblastic neoplasms. Cell 50, 107-17. 
Richter, C., West, M. and Odorizzi, G. (2007). Dual mechanisms specify Doa4-
mediated deubiquitination at multivesicular bodies. Embo J 26, 2454-64. 
Rodriguez, A., Oliver, H., Zou, H., Chen, P., Wang, X. and Abrams, J. M. (1999). 
Dark is a Drosophila homologue of Apaf-1/CED-4 and functions in an evolutionarily 
conserved death pathway. Nat Cell Biol 1, 272-9. 
Row, P. E., Liu, H., Hayes, S., Welchman, R., Charalabous, P., Hofmann, K., 
Clague, M. J., Sanderson, C. M. and Urbe, S. (2007). The MIT domain of UBPY 
constitutes a CHMP binding and endosomal localization signal required for efficient 
epidermal growth factor receptor degradation. J Biol Chem 282, 30929-37. 
Ruland, J., Sirard, C., Elia, A., MacPherson, D., Wakeham, A., Li, L., de la 
Pompa, J. L., Cohen, S. N. and Mak, T. W. (2001). p53 accumulation, defective 
cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl 
Acad Sci U S A 98, 1859-64. 
Russell, D. G. (2001). Mycobacterium tuberculosis: here today, and here tomorrow. 
Nat Rev Mol Cell Biol 2, 569-77. 
 155
Rusten, T. E., Filimonenko, M., Rodahl, L. M., Stenmark, H. and Simonsen, A. 
(2007a). ESCRTing autophagic clearance of aggregating proteins. Autophagy 4. 
Rusten, T. E., Vaccari, T., Lindmo, K., Rodahl, L. M., Nezis, I. P., Sem-Jacobsen, 
C., Wendler, F., Vincent, J. P., Brech, A., Bilder, D. et al. (2007b). ESCRTs and 
Fab1 regulate distinct steps of autophagy. Curr Biol 17, 1817-25. 
Ryoo, H. D., Bergmann, A., Gonen, H., Ciechanover, A. and Steller, H. (2002). 
Regulation of Drosophila IAP1 degradation and apoptosis by reaper and ubcD1. Nat 
Cell Biol 4, 432-8. 
Ryoo, H. D., Gorenc, T. and Steller, H. (2004). Apoptotic cells can induce 
compensatory cell proliferation through the JNK and the Wingless signaling 
pathways. Dev Cell 7, 491-501. 
Sachse, M., Urbe, S., Oorschot, V., Strous, G. J. and Klumperman, J. (2002). 
Bilayered clathrin coats on endosomal vacuoles are involved in protein sorting toward 
lysosomes. Mol Biol Cell 13, 1313-28. 
Sakamoto, K., Ohara, O., Takagi, M., Takeda, S. and Katsube, K. (2002). 
Intracellular cell-autonomous association of Notch and its ligands: a novel mechanism 
of Notch signal modification. Dev Biol 241, 313-26. 
Sakata, T., Sakaguchi, H., Tsuda, L., Higashitani, A., Aigaki, T., Matsuno, K. 
and Hayashi, S. (2004). Drosophila Nedd4 regulates endocytosis of notch and 
suppresses its ligand-independent activation. Curr Biol 14, 2228-36. 
Saksena, S., Sun, J., Chu, T. and Emr, S. D. (2007). ESCRTing proteins in the 
endocytic pathway. Trends Biochem Sci 32, 561-73. 
 156
Saucedo, L. J. and Edgar, B. A. (2007). Filling out the Hippo pathway. Nat Rev Mol 
Cell Biol 8, 613-21. 
Scheuring, S., Bodor, O., Rohricht, R. A., Muller, S., Beyer, A. and Kohrer, K. 
(1999). Cloning, characterisation, and functional expression of the Mus musculus 
SKD1 gene in yeast demonstrates that the mouse SKD1 and the yeast VPS4 genes are 
orthologues and involved in intracellular protein trafficking. Gene 234, 149-59. 
Scheuring, S., Rohricht, R. A., Schoning-Burkhardt, B., Beyer, A., Muller, S., 
Abts, H. F. and Kohrer, K. (2001). Mammalian cells express two VPS4 proteins 
both of which are involved in intracellular protein trafficking. J Mol Biol 312, 469-80. 
Schmidt, A. E., Miller, T., Schmidt, S. L., Shiekhattar, R. and Shilatifard, A. 
(1999). Cloning and characterization of the EAP30 subunit of the ELL complex that 
confers derepression of transcription by RNA polymerase II. J Biol Chem 274, 21981-
5. 
Schmidt, M. H., Chen, B., Randazzo, L. M. and Bogler, O. (2003). 
SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal 
elements, including FAKs, and modulate cell adhesion. J Cell Sci 116, 2845-55. 
Schroeter, E. H., Kisslinger, J. A. and Kopan, R. (1998). Notch-1 signalling 
requires ligand-induced proteolytic release of intracellular domain. Nature 393, 382-6. 
Schweisguth, F. (2004). Regulation of notch signaling activity. Curr Biol 14, R129-
38. 
 157
Scott, A., Chung, H. Y., Gonciarz-Swiatek, M., Hill, G. C., Whitby, F. G., 
Gaspar, J., Holton, J. M., Viswanathan, R., Ghaffarian, S., Hill, C. P. et al. 
(2005a). Structural and mechanistic studies of VPS4 proteins. Embo J 24, 3658-69. 
Scott, A., Gaspar, J., Stuchell-Brereton, M. D., Alam, S. L., Skalicky, J. J. and 
Sundquist, W. I. (2005b). Structure and ESCRT-III protein interactions of the MIT 
domain of human VPS4A. Proc Natl Acad Sci U S A 102, 13813-8. 
Selkoe, D. and Kopan, R. (2003). Notch and Presenilin: regulated intramembrane 
proteolysis links development and degeneration. Annu Rev Neurosci 26, 565-97. 
Sen, A., Reddy, G. V. and Rodrigues, V. (2003). Combinatorial expression of 
Prospero, Seven-up, and Elav identifies progenitor cell types during sense-organ 
differentiation in the Drosophila antenna. Dev Biol 254, 79-92. 
Seto, E. S. and Bellen, H. J. (2004). The ins and outs of Wingless signaling. Trends 
Cell Biol 14, 45-53. 
Seto, E. S. and Bellen, H. J. (2006). Internalization is required for proper Wingless 
signaling in Drosophila melanogaster. J Cell Biol 173, 95-106. 
Seugnet, L., Simpson, P. and Haenlin, M. (1997). Requirement for dynamin during 
Notch signaling in Drosophila neurogenesis. Dev Biol 192, 585-98. 
Sevrioukov, E. A., Moghrabi, N., Kuhn, M. and Kramer, H. (2005). A mutation in 
dVps28 reveals a link between a subunit of the endosomal sorting complex required 
for transport-I complex and the actin cytoskeleton in Drosophila. Mol Biol Cell 16, 
2301-12. 
 158
Shih, S. C., Katzmann, D. J., Schnell, J. D., Sutanto, M., Emr, S. D. and Hicke, L. 
(2002). Epsins and Vps27p/Hrs contain ubiquitin-binding domains that function in 
receptor endocytosis. Nat Cell Biol 4, 389-93. 
Shilatifard, A. (1998). Identification and purification of the Holo-ELL complex. 
Evidence for the presence of ELL-associated proteins that suppress the transcriptional 
inhibitory activity of ELL. J Biol Chem 273, 11212-7. 
Silva, E., Tsatskis, Y., Gardano, L., Tapon, N. and McNeill, H. (2006). The 
Tumor-Suppressor Gene fat Controls Tissue Growth Upstream of Expanded in the 
Hippo Signaling Pathway. Curr Biol 16, 2081-9. 
Simpson, P. and Morata, G. (1981). Differential mitotic rates and patterns of growth 
in compartments in the Drosophila wing. Dev Biol 85, 299-308. 
Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., 
Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T. et 
al. (2005). Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in 
frontotemporal dementia. Nat Genet 37, 806-8. 
Slagsvold, T., Aasland, R., Hirano, S., Bache, K. G., Raiborg, C., Trambaiolo, D., 
Wakatsuki, S. and Stenmark, H. (2005). Eap45 in mammalian ESCRT-II binds 
ubiquitin via a phosphoinositide-interacting GLUE domain. J Biol Chem 280, 19600-
6. 
Slagsvold, T., Pattni, K., Malerod, L. and Stenmark, H. (2006). Endosomal and 
non-endosomal functions of ESCRT proteins. Trends Cell Biol 16, 317-26. 
 159
Song, Z., McCall, K. and Steller, H. (1997). DCP-1, a Drosophila cell death 
protease essential for development. Science 275, 536-40. 
Sorkin, A. and Von Zastrow, M. (2002). Signal transduction and endocytosis: close 
encounters of many kinds. Nat Rev Mol Cell Biol 3, 600-14. 
Spitzer, C., Schellmann, S., Sabovljevic, A., Shahriari, M., Keshavaiah, C., 
Bechtold, N., Herzog, M., Muller, S., Hanisch, F. G. and Hulskamp, M. (2006). 
The Arabidopsis elch mutant reveals functions of an ESCRT component in 
cytokinesis. Development 133, 4679-89. 
Srivastava, M., Scherr, H., Lackey, M., Xu, D., Chen, Z., Lu, J. and Bergmann, 
A. (2007). ARK, the Apaf-1 related killer in Drosophila, requires diverse domains for 
its apoptotic activity. Cell Death Differ 14, 92-102. 
Stauffer, D. R., Howard, T. L., Nyun, T. and Hollenberg, S. M. (2001). CHMP1 is 
a novel nuclear matrix protein affecting chromatin structure and cell-cycle 
progression. J Cell Sci 114, 2383-93. 
Steiner, P., Barnes, D. M., Harris, W. H. and Weinberg, R. A. (1997). Absence of 
rearrangements in the tumour susceptibility gene TSG101 in human breast cancer. Nat 
Genet 16, 332-3. 
Struhl, G. and Adachi, A. (2000). Requirements for presenilin-dependent cleavage 
of notch and other transmembrane proteins. Mol Cell 6, 625-36. 
Struhl, G. and Greenwald, I. (1999). Presenilin is required for activity and nuclear 
access of Notch in Drosophila. Nature 398, 522-5. 
 160
Stuchell-Brereton, M. D., Skalicky, J. J., Kieffer, C., Karren, M. A., Ghaffarian, 
S. and Sundquist, W. I. (2007). ESCRT-III recognition by VPS4 ATPases. Nature 
449, 740-4. 
Stuchell, M. D., Garrus, J. E., Muller, B., Stray, K. M., Ghaffarian, S., 
McKinnon, R., Krausslich, H. G., Morham, S. G. and Sundquist, W. I. (2004). 
The human endosomal sorting complex required for transport (ESCRT-I) and its role 
in HIV-1 budding. J Biol Chem 279, 36059-71. 
Sun, Z., Pan, J., Bubley, G. and Balk, S. P. (1997). Frequent abnormalities of 
TSG101 transcripts in human prostate cancer. Oncogene 15, 3121-5. 
Sun, Z., Pan, J., Hope, W. X., Cohen, S. N. and Balk, S. P. (1999). Tumor 
susceptibility gene 101 protein represses androgen receptor transactivation and 
interacts with p300. Cancer 86, 689-96. 
Sweeney, N. T., Brenman, J. E., Jan, Y. N. and Gao, F. B. (2006). The coiled-coil 
protein shrub controls neuronal morphogenesis in Drosophila. Curr Biol 16, 1006-11. 
Tamura, K., Taniguchi, Y., Minoguchi, S., Sakai, T., Tun, T., Furukawa, T. and 
Honjo, T. (1995). Physical interaction between a novel domain of the receptor Notch 
and the transcription factor RBP-J kappa/Su(H). Curr Biol 5, 1416-23. 
Tanaka, N., Kyuuma, M. and Sugamura, K. (2008). Endosomal sorting complex 
required for transport proteins in cancer pathogenesis, vesicular transport, and non-
endosomal functions. Cancer Sci. 
 161
Tarassishin, L., Yin, Y. I., Bassit, B. and Li, Y. M. (2004). Processing of Notch and 
amyloid precursor protein by gamma-secretase is spatially distinct. Proc Natl Acad 
Sci U S A 101, 17050-5. 
Taylor, R. C., Cullen, S. P. and Martin, S. J. (2008). Apoptosis: controlled 
demolition at the cellular level. Nat Rev Mol Cell Biol 9, 231-41. 
Teo, H., Gill, D. J., Sun, J., Perisic, O., Veprintsev, D. B., Vallis, Y., Emr, S. D. 
and Williams, R. L. (2006). ESCRT-I core and ESCRT-II GLUE domain structures 
reveal role for GLUE in linking to ESCRT-I and membranes. Cell 125, 99-111. 
Teo, H., Perisic, O., Gonzalez, B. and Williams, R. L. (2004). ESCRT-II, an 
endosome-associated complex required for protein sorting: crystal structure and 
interactions with ESCRT-III and membranes. Dev Cell 7, 559-69. 
ter Haar, E., Harrison, S. C. and Kirchhausen, T. (2000). Peptide-in-groove 
interactions link target proteins to the beta-propeller of clathrin. Proc Natl Acad Sci U 
S A 97, 1096-100. 
Thery, C., Zitvogel, L. and Amigorena, S. (2002). Exosomes: composition, 
biogenesis and function. Nat Rev Immunol 2, 569-79. 
Thompson, B. J., Mathieu, J., Sung, H. H., Loeser, E., Rorth, P. and Cohen, S. 
M. (2005). Tumor suppressor properties of the ESCRT-II complex component Vps25 
in Drosophila. Dev Cell 9, 711-20. 
Tian, X., Hansen, D., Schedl, T. and Skeath, J. B. (2004). Epsin potentiates Notch 
pathway activity in Drosophila and C. elegans. Development 131, 5807-15. 
 162
Toyoshima, M., Tanaka, N., Aoki, J., Tanaka, Y., Murata, K., Kyuuma, M., 
Kobayashi, H., Ishii, N., Yaegashi, N. and Sugamura, K. (2007). Inhibition of 
tumor growth and metastasis by depletion of vesicular sorting protein Hrs: its 
regulatory role on E-cadherin and beta-catenin. Cancer Res 67, 5162-71. 
Trajkovic, K., Hsu, C., Chiantia, S., Rajendran, L., Wenzel, D., Wieland, F., 
Schwille, P., Brugger, B. and Simons, M. (2008). Ceramide triggers budding of 
exosome vesicles into multivesicular endosomes. Science 319, 1244-7. 
Tsai, Y. C. and Sun, Y. H. (2004). Long-range effect of upd, a ligand for Jak/STAT 
pathway, on cell cycle in Drosophila eye development. Genesis 39, 141-53. 
Tsang, H. T., Connell, J. W., Brown, S. E., Thompson, A., Reid, E. and 
Sanderson, C. M. (2006). A systematic analysis of human CHMP protein 
interactions: additional MIT domain-containing proteins bind to multiple components 
of the human ESCRT III complex. Genomics 88, 333-46. 
Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. and Halder, G. (2003). Hippo 
promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell 
Biol 5, 914-20. 
Urbanowski, J. L. and Piper, R. C. (2001). Ubiquitin sorts proteins into the 
intralumenal degradative compartment of the late-endosome/vacuole. Traffic 2, 622-
30. 
Uyttendaele, H., Marazzi, G., Wu, G., Yan, Q., Sassoon, D. and Kitajewski, J. 
(1996). Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific 
mammalian Notch gene. Development 122, 2251-9. 
 163
Vaccari, T. and Bilder, D. (2005). The Drosophila tumor suppressor vps25 prevents 
nonautonomous overproliferation by regulating notch trafficking. Dev Cell 9, 687-98. 
Vaccari, T., Lu, H., Kanwar, R., Fortini, M. E. and Bilder, D. (2008). Endosomal 
entry regulates Notch receptor activation in Drosophila melanogaster. J Cell Biol 180, 
755-62. 
Vajjhala, P. R., Catchpoole, E., Nguyen, C. H., Kistler, C. and Munn, A. L. 
(2007). Vps4 regulates a subset of protein interactions at the multivesicular 
endosome. Febs J 274, 1894-907. 
van der Bliek, A. M. and Meyerowitz, E. M. (1991). Dynamin-like protein encoded 
by the Drosophila shibire gene associated with vesicular traffic. Nature 351, 411-4. 
Vetrivel, K. S., Cheng, H., Lin, W., Sakurai, T., Li, T., Nukina, N., Wong, P. C., 
Xu, H. and Thinakaran, G. (2004). Association of gamma-secretase with lipid rafts 
in post-Golgi and endosome membranes. J Biol Chem 279, 44945-54. 
Vieira, O. V., Harrison, R. E., Scott, C. C., Stenmark, H., Alexander, D., Liu, J., 
Gruenberg, J., Schreiber, A. D. and Grinstein, S. (2004). Acquisition of Hrs, an 
essential component of phagosomal maturation, is impaired by mycobacteria. Mol 
Cell Biol 24, 4593-604. 
von Schwedler, U. K., Stuchell, M., Muller, B., Ward, D. M., Chung, H. Y., 
Morita, E., Wang, H. E., Davis, T., He, G. P., Cimbora, D. M. et al. (2003). The 
protein network of HIV budding. Cell 114, 701-13. 
von Zastrow, M. and Sorkin, A. (2007). Signaling on the endocytic pathway. Curr 
Opin Cell Biol 19, 436-45. 
 164
Wagner, K. U., Krempler, A., Qi, Y., Park, K., Henry, M. D., Triplett, A. A., 
Riedlinger, G., Rucker, I. E. and Hennighausen, L. (2003). Tsg101 is essential for 
cell growth, proliferation, and cell survival of embryonic and adult tissues. Mol Cell 
Biol 23, 150-62. 
Wang, W. and Struhl, G. (2004). Drosophila Epsin mediates a select endocytic 
pathway that DSL ligands must enter to activate Notch. Development 131, 5367-80. 
Weijzen, S., Rizzo, P., Braid, M., Vaishnav, R., Jonkheer, S. M., Zlobin, A., 
Osborne, B. A., Gottipati, S., Aster, J. C., Hahn, W. C. et al. (2002). Activation of 
Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed 
cells. Nat Med 8, 979-86. 
Wells, B. S., Yoshida, E. and Johnston, L. A. (2006). Compensatory Proliferation in 
Drosophila Imaginal Discs Requires Dronc-Dependent p53 Activity. Curr Biol 16, 
1606-15. 
Welsch, S., Muller, B. and Krausslich, H. G. (2007). More than one door - Budding 
of enveloped viruses through cellular membranes. FEBS Lett 581, 2089-97. 
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P. t., Silverman, L. B., 
Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T. and Aster, J. C. (2004). 
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. 
Science 306, 269-71. 
Wernimont, A. K. and Weissenhorn, W. (2004). Crystal structure of subunit VPS25 
of the endosomal trafficking complex ESCRT-II. BMC Struct Biol 4, 10. 
 165
Weston, C. R. and Davis, R. J. (2007). The JNK signal transduction pathway. Curr 
Opin Cell Biol 19, 142-9. 
White, K., Grether, M. E., Abrams, J. M., Young, L., Farrell, K. and Steller, H. 
(1994). Genetic control of programmed cell death in Drosophila. Science 264, 677-83. 
Wilkin, M. B., Carbery, A. M., Fostier, M., Aslam, H., Mazaleyrat, S. L., Higgs, 
J., Myat, A., Evans, D. A., Cornell, M. and Baron, M. (2004). Regulation of notch 
endosomal sorting and signaling by Drosophila Nedd4 family proteins. Curr Biol 14, 
2237-44. 
Willecke, M., Hamaratoglu, F., Kango-Singh, M., Udan, R., Chen, C. L., Tao, C., 
Zhang, X. and Halder, G. (2006). The Fat Cadherin Acts through the Hippo Tumor-
Suppressor Pathway to Regulate Tissue Size. Curr Biol 16, 2090-100. 
Williams, R. L. and Urbe, S. (2007). The emerging shape of the ESCRT machinery. 
Nat Rev Mol Cell Biol 8, 355-68. 
Wirblich, C., Bhattacharya, B. and Roy, P. (2006). Nonstructural protein 3 of 
bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101. J Virol 
80, 460-73. 
Wolfe, M. S., Xia, W., Ostaszewski, B. L., Diehl, T. S., Kimberly, W. T. and 
Selkoe, D. J. (1999). Two transmembrane aspartates in presenilin-1 required for 
presenilin endoproteolysis and gamma-secretase activity. Nature 398, 513-7. 
Wu, L., Aster, J. C., Blacklow, S. C., Lake, R., Artavanis-Tsakonas, S. and 
Griffin, J. D. (2000). MAML1, a human homologue of Drosophila mastermind, is a 
transcriptional co-activator for NOTCH receptors. Nat Genet 26, 484-9. 
 166
Wu, S., Huang, J., Dong, J. and Pan, D. (2003). hippo encodes a Ste-20 family 
protein kinase that restricts cell proliferation and promotes apoptosis in conjunction 
with salvador and warts. Cell 114, 445-56. 
Xie, W., Li, L. and Cohen, S. N. (1998). Cell cycle-dependent subcellular 
localization of the TSG101 protein and mitotic and nuclear abnormalities associated 
with TSG101 deficiency. Proc Natl Acad Sci U S A 95, 1595-600. 
Xie, Z. and Klionsky, D. J. (2007). Autophagosome formation: core machinery and 
adaptations. Nat Cell Biol 9, 1102-9. 
Xu, D., Li, Y., Arcaro, M., Lackey, M. and Bergmann, A. (2005). The CARD-
carrying caspase Dronc is essential for most, but not all, developmental cell death in 
Drosophila. Development 132, 2125-34. 
Xu, T. and Rubin, G. M. (1993). Analysis of genetic mosaics in developing and 
adult Drosophila tissues. Development 117, 1223-37. 
Yamada, M., Takeshita, T., Miura, S., Murata, K., Kimura, Y., Ishii, N., Nose, 
M., Sakagami, H., Kondo, H., Tashiro, F. et al. (2001). Loss of hippocampal CA3 
pyramidal neurons in mice lacking STAM1. Mol Cell Biol 21, 3807-19. 
Ye, Y., Lukinova, N. and Fortini, M. E. (1999). Neurogenic phenotypes and altered 
Notch processing in Drosophila Presenilin mutants. Nature 398, 525-9. 
Yeh, E., Dermer, M., Commisso, C., Zhou, L., McGlade, C. J. and Boulianne, G. 
L. (2001). Neuralized functions as an E3 ubiquitin ligase during Drosophila 
development. Curr Biol 11, 1675-9. 
 167
Yoo, S. J., Huh, J. R., Muro, I., Yu, H., Wang, L., Wang, S. L., Feldman, R. M., 
Clem, R. J., Muller, H. A. and Hay, B. A. (2002). Hid, Rpr and Grim negatively 
regulate DIAP1 levels through distinct mechanisms. Nat Cell Biol 4, 416-24. 
Yorikawa, C., Shibata, H., Waguri, S., Hatta, K., Horii, M., Katoh, K., 
Kobayashi, T., Uchiyama, Y. and Maki, M. (2005). Human CHMP6, a 
myristoylated ESCRT-III protein, interacts directly with an ESCRT-II component 
EAP20 and regulates endosomal cargo sorting. Biochem J 387, 17-26. 
Yoshimori, T., Yamagata, F., Yamamoto, A., Mizushima, N., Kabeya, Y., Nara, 
A., Miwako, I., Ohashi, M., Ohsumi, M. and Ohsumi, Y. (2000). The mouse 
SKD1, a homologue of yeast Vps4p, is required for normal endosomal trafficking and 
morphology in mammalian cells. Mol Biol Cell 11, 747-63. 
Yu, S. Y., Yoo, S. J., Yang, L., Zapata, C., Srinivasan, A., Hay, B. A. and Baker, 
N. E. (2002). A pathway of signals regulating effector and initiator caspases in the 
developing Drosophila eye. Development 129, 3269-78. 
Zamborlini, A., Usami, Y., Radoshitzky, S. R., Popova, E., Palu, G. and 
Gottlinger, H. (2006). Release of autoinhibition converts ESCRT-III components 
into potent inhibitors of HIV-1 budding. Proc Natl Acad Sci U S A 103, 19140-5. 
Zhai, R. G., Hiesinger, P. R., Koh, T. W., Verstreken, P., Schulze, K. L., Cao, Y., 
Jafar-Nejad, H., Norga, K. K., Pan, H., Bayat, V. et al. (2003). Mapping 
Drosophila mutations with molecularly defined P element insertions. Proc Natl Acad 
Sci U S A 100, 10860-5. 
 168
Zhou, L., Song, Z., Tittel, J. and Steller, H. (1999). HAC-1, a Drosophila homolog 
of APAF-1 and CED-4 functions in developmental and radiation-induced apoptosis. 
Mol Cell 4, 745-55. 
Zhou, S., Fujimuro, M., Hsieh, J. J., Chen, L., Miyamoto, A., Weinmaster, G. 
and Hayward, S. D. (2000). SKIP, a CBF1-associated protein, interacts with the 
ankyrin repeat domain of NotchIC To facilitate NotchIC function. Mol Cell Biol 20, 
2400-10. 
 
 
 169
